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CHAPTER 1 INTRODUCTION 
1.1 Post translational modifications 
Human genome (~20,000-25,000 genes) encodes more than 1 million proteins (1). 
The higher complexity of the proteome has been found during last two decades due to 
the development of technology in identifying post-translational modifications (PTMs) 
(1,2). Proteins carry unique functions within the cellular context and their maturation, 
localization, function and interactions with other proteins or nucleic acids regulated by 
PTMs. A PTM typically occurs at the specific type of amino acid residues within the 
protein. Many PTMs are reversible and depend on the accessibility of the enzymes that 
catalyze the formation and removal of a specific PTM. Local environment around the 
modification also important (3). For example, the sensitivity of protein cysteine oxidation 
depends on the solvent exposure and the presence of positively charge amino acids in 
the local environment. In nature, most of PTMs are reversible and involved in regulating 
protein function. Due to the reversibility nature, PTMs are playing an important role in cell 
signaling pathways by turning on or off the function of signaling molecules in response to 
different physiological and pathological stimuli (4). For instance, kinases catalyze protein 
phosphorylation and involved in regulating cellular signaling. Phosphatases are a class 
of enzymes that can remove phosphate groups from serine, threonine or tyrosine, thereby 
reversing the effect of phosphorylation (5). Similarly, protein oxidative modifications, 
including sulfenylation, nitrosylation and glutathionylation are also important for regulation 
of redox signaling pathways associated with important cellular processes such as cell 
proliferation, apoptosis, differentiation and migration (6).  
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1.2 Redox homeostasis and oxidative and nitrosative stress 
Reactive oxygen species (ROS) and reactive nitrogen species (RNS) are 
considered as by-products of cellular metabolism and catalytic reactions (7). In nature, 
cells evolved in a way that regulate the production and the removal of ROS and RNS. 
High levels of reactive species can damage cellular components and dysregulate 
numerous cellular processes by inactivating or hyperactivating signaling proteins. Under 
physiological conditions, ROS and RNS are mainly involved in regulation of redox 
signaling pathways by reversible cysteine oxidation (6). Therefore, it is crucial to have a 
balance between ROS production and detoxification for a maximum productivity of 
cellular functions.  
 
 
Figure 1.1 - Schematic representation of ROS and RNS production, and antioxidant 
system, i.e. redox homeostasis vs. oxidative stress. 
Redox homeostasis is the maintenance of the balance between the production and 
removal of reactive species (Figure 1.1) (8). Dysregulation of cellular metabolism and 
improper ROS disposal system can result in a high level of ROS leading to an oxidative 
or nitrosative stress (Figure 1.1).  
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Oxidative and nitrosative stress associated with many disease conditions, 
including diabetes, cardiovascular diseases, neurodegenerative diseases and cancer 
(9,10). The major molecular mechanism of ROS and RNS is oxidation of cysteine 
residues in proteins. Protein cysteine thiols are sensitive towards the change in cellular 
redox state (11). Under control generation of ROS, cysteine residues can undergo 
reversible oxidation. On the other hand, an increased level of ROS can irreversibly oxidize 
cysteine residues of a protein.  Many oxidative modifications, if not all, affect protein 
function. The reactive cysteine residues can present in the active site or in distal sites. 
For example, protein phosphatase has a cysteine residue in the active site that is highly 
susceptible to oxidation (5).  Oxidation of surface cysteine residues act as a redox sensor 
of the protein as well as a protective mechanism for spreading the effect of ROS into the 
other critical cysteines. Oxidation of cysteine residues away from the active site may not 
affect enzyme activity, but it alters protein-protein interactions and protein structure that 
can affect protein function (12). Among various cysteine oxidations, S-glutathionylation is 
reversible and referred to as formation of disulfide bond between protein cysteine and a 
glutathione (GSH). S-Glutathionylation regulates protein function not only under 
physiological concentrations of ROS/RNS, but also under oxidative or nitrosative stress 
(13).  
1.3 Sources of reactive oxygen and nitrogen species  
The existence of reactive species such as ROS and RNS are first identified nearly 
six decades ago in 1954 and predicted to be related with aging process (14-16). Mostly, 
free radicals, such as super oxide anion (O2•−) and nitric oxide (NO•) can produce from 
different intracellular processes. These free radicals are highly reactive and have a very 
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short half-life (nanoseconds) (17). Further reactions can generate other free radicals or 
non-radical ROS and RNS (Table 1.1).  
Table 1.1- Different forms of ROS and RNS. 
 
Due to the presence of one or more unpaired electrons in a single orbit, free 
radicals are highly unstable and quickly react with other species or converted to less 
reactive and stable forms. For example, after generation of O2•−, these radicals are 
converted in to less reactive and stable non-radical hydrogen peroxide (H2O2) by 
superoxide dismutase (18). Hydrogen peroxide is more cell permeable than O2•− and 
diffuses to other cellular compartments to mediate redox signaling under physiological 
concentrations. NO can be reacted with H2O2 to generate more reactive peroxynitrite 
(ONOO-). Similarly, H2O2 can further generate more reactive radicals, such as hydroxyl 
(.OH), hydroperoxyl radicals (.OOH) (Scheme 1.1). 
Fe2+ + H2O2 ----> Fe3+ + .OH + OH- 
Fe3+ + H2O2 ----> Fe2+ + .OOH + H+ 
Scheme 1.1 – Fenton’s reaction. Metal ion can react with H2O2 and have electron transfer ability. 
H2O2 can be either oxidized or reduced by metal ion and generate hydroxyl radicals as byproducts.  
However, intracellular ROS and RNS generation can divide into two broad 
categories, including extracellular sources and intracellular sources. Extracellular sources 
include small molecule drugs, pollutants, tobacco and radiation. Radiolysis of water can 
also lead to formation of .OH, .OOH and O2•− (19). Intracellular sources are more diverse 
and readily involve in generation of ROS and RNS through their biochemical reactions. 
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Intracellular sources can further divide into two main classes. ROS and RNS generated 
as a byproduct of enzyme activity or as a result of cellular processes at different cellular 
organelles.   
 
Figure 1.2 – The major intracellular sources of ROS and RNS. NADPH oxidase, nitric oxide 
synthase and mitochondrial ETC are responsible for producing intracellular ROS.  This figure 
adopted from Kira et al. 2014, with permission from copy rights clearance center (20). 
1.3.1 Enzyme-mediated ROS/RNS production 
1.3.1.1 NADPH oxidases  
NADPH oxidase is a multi-subunit membrane complex that closely interacts with 
growth factor receptors and mediate the superoxide production in response to different 
exogenous stimuli, including tumor necrosis factor (TNF), angiotensin II, platelet-derived 
growth factor (PDGF) and epidermal growth factor (EGF) (21-25). There are seven 
members of NADPH family oxidases (also known as NOX enzymes) which include NOX1, 
NOX2, NOX3, NOX4, NOX5, dual oxidase 1(DUOX1) and DUOX2 (26,27). NOX 
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enzymes generate lower levels of ROS that are involved in regulating signal transduction, 
innate immune system and modulation of the extracellular matrix (28). NOX enzymes also 
play an important role in host defense against toxic microorganisms. For example, 
Neutrophils that have a high level of NOX enzymes can generate a large amount of ROS 
as a response to host pathogen interaction. During phagocytosis, neutrophils internalize 
microorganisms into a phagosome and deactivate them with NOX derived ROS (29). In 
addition to neutrophils, NOX enzymes are expressed in other immune or non-immune 
cells , such as endothelial cells, monocytes and smooth muscle cells (27). NOX enzymes 
composed with five subunits: three subunits, such as p47phox, p67phox, p40phox are 
localized to the cytosol while other two subunits gp91phox (catalytic subunit gp91phox or 
NOX2; homologous to NOX1 and NOX4) and p22phox are found in membrane.  
2O2 + NAD(P)H →    2O2•− + NADP+  +   H + 
Scheme 1.2 – NOX enzyme catalyzed univalent reduction of molecular oxygen. 
Upon activation, the cytosolic part, p47phox undergoes phosphorylation and forms 
complex with other two subunits, p67phox and p40phox. The three-subunit complex 
translocate to the membrane and produces superoxide by the single electron reduction 
of molecular oxygen. In this reaction, NADPH acts as the electron donor, and one electron 
is transferred through flavin and heme containing catalytic gp91phox subunit to molecular 
oxygen (30). 
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Figure 1.3 – NOX enzyme mediated ROS. Growth factor can activate NOX multicomplex 
membrane protein through activation of PI3K and small GTPase RAC1. One electron reduction 
of molecular oxygen by NOX enzyme will produce superoxide anion to extracellular space, which 
will be further dismutated to H2O2 and transferred to the cell through aquaporin. Since H2O2 has 
a higher half-life, H2O2 can mediate the effect to oxidizing effect to sensitive cysteines in a range 
of signaling proteins. This figure adopted from Kira et al. 2014, with permission from copy rights 
clearance center (20). 
The inability to generate enough ROS due to mutations in NOX2 catalytic subunit 
associates with frequent or periodic bacterial and fungal infections, a condition called 
chronic granulomatous disease (31). Therefore, a controlled production of ROS by NOX 
enzymes is an essential physiological process that helps to keep cells healthy. ROS 
produced by NOX enzymes are also involved in redox signaling that can mediate cell 
growth, proliferation, survival and motility (32,33).  
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1.3.1.2 Xanthine Oxidases 
 Xanthine oxidase (XO) is involved in ROS generation under pathological 
conditions. Xanthine dehydrogenase (XDH) and XO are two forms of xanthine 
oxidoreductase. Fundamental chemical reaction of XO is the oxidation of hypoxanthine 
into uric acid. In this reaction, XO catalyzes the reduction of molecular oxygen to produce 
H2O2 and O2.- (34).   
XO + H2 O + O2   →     Uric acid + H2O2 
XO + O2  →    XO −1 + O2 •− 
Scheme 1.3 – ROS production by xanthine oxidase. 
 XO uses NADPH as an electron donor to produce NO. and ONOO-. XO catalyzes 
the conversion of cellular nitrate into nitrite and NO.. It is also known that XO is feedback 
inhibited by NO. (35).   
1.3.1.3 Nitric oxide synthase (NOS) 
 NOS enzymes are a class of NO. producing enzymes and there are three isoforms 
of NOS. NOS constitutively expressed in neuronal cells and endothelial cells are known 
as nNOS and eNOS, respectively (36,37). These enzymes are regulated by calcium ion 
levels to produce NO.. Calcium ion binds to calmodulin which is a calcium binding protein, 
and this complex can bind to NOS (38-40). In the presence of other essential cofactors 
(FAD, FMN, NADPH, tetrahydrobiopterin and heme), NOS produces NO. by converting 
L-arginine to l-citrulline (41-43). In addition to NO. production, NOS also generate 
superoxide under uncoupling conditions.  
NOS + L-Arginine + O2•− + NADPH → NO• + L-Citrulline + NADP+ 
Scheme 1.4 – ROS production by nitric oxide synthase. 
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NO. can react with superoxide to give rise other reactive chemicals such as ONOO-. NO. 
plays an important role in vasculature including cell adhesion, inhibition of platelet 
aggregation, and leukocyte interaction with the endothelium (44).  
 The third isoform of NOS is inducible NOS (iNOS) that mediates inflammatory 
processes in macrophages. Macrophages form phagosome by engulfing and killing 
invading pathogens. iNOS plays an indispensable role in deactivating pathogens, and 
iNOS is constantly active in producing NO, independent of calcium levels (45). NO. is 
highly diffusible across cell membrane and have a long half-life (~15 seconds). Therefore, 
NO. can act on neighboring cells and react with other free radicals, proteins, and DNA.      
1.3.2 Cellular organelles   
1.3.2.1 Mitochondria   
 Mitochondrion is the power house of the cell. It produces the energy that is required 
for the normal cellular functions. Mitochondria produce adenosine triphosphate (ATP) by 
oxidative phosphorylation. These organelles are composed with inner and outer double 
membrane, inter membrane space and matrix (46). A typical mitochondrion is about 2.5 
µm in diameter and the number of mitochondrion within a cell can vary depending on the 
cell type (47). 
 Mitochondrial metabolism consists with citric acid cycle (TCA) and oxidative 
phosphorylation (OXPHOS). These metabolic processes are mainly powered by the 
availability of metabolic intermediates, including pyruvate, fatty acids and amino acids 
(46). TCA cycle produces the electron carriers, such as NADH and FADH, which shuttled 
to the electron transport chain (ETC) to synthesize ATP. During electron transfer, isolated 
mitochondria produce O2•− by consuming 1-2% of the available oxygen for respiration 
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(48). The complex I and complex III are the major sites for O2•− generation. Mitochondrial 
superoxide dismutase (mSOD) convert the unstable O2•− to stable and less reactive H2O2. 
In addition to ETC, several other mitochondrial enzymes can also generate ROS. For 
example, cytochrome b5 reductase and monoamine oxidases (MAO-A) are both found in 
outer mitochondrial membrane and generate O2•− and H2O2 respectively (49,50). 
Cytochrome b5 reductase uses NADPH as the substrate while MAO-A catalyzes the 
oxidation of biogenic amines to generate ROS (49,51). There are several other 
mitochondrial enzymes found in inner mitochondrial membrane and known to generate 
ROS, including dihydroorotate dehydrogenase, dehydrogenase of α-glycerophosphate 
and succinate dehydrogenase (52-54). Aconitase found in mitochondrial matrix and 
produces hydroxyl radicals through Fenton’s reaction (55,56). α-Ketoglutarate 
dehydrogenase catalyzes the oxidation of α-ketoglutarate to succinyl-CoA. Inhibition of 
α-Ketoglutarate dehydrogenase and low levels of NAD+ are known to produce ROS (57-
59).    
ROS generation by complex I  
 Complex I, also known as NADH-ubiquinone oxidoreductase, is a transmembrane 
multi-protein complex and is located in the inner membrane of mitochondria (60). 
Complex I is the entry site for electron carriers, such as TCA cycle derived NADH. 
Complex I hold FMN, seven ion-sulfur (FeS) centers, and CoQ (61,62). Two electrons 
from NADH transfer to CoQ through the shielded FeS centers. Therefore, it is less likely 
to transfer electron from FeS clusters to molecular oxygen. Therefore, ROS will be 
minimally produced during this process. Rotenone is a pharmacological inhibitor of 
complex I and is known to generate ROS (63). Rotenone binds to the CoQ binding site, 
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and blocks electron transfer from FeS to CoQ, thereby generating ROS (64,65). 
Superoxide production by complex I depends on the redox state of FMN and NADH/NAD+ 
ratio. In contrast, when mitochondria are respiring under normal conditions, superoxide 
generation at complex I is minimal (66). An additional mechanism of ROS production at 
complex I is the reverse electron transfer (RET) (48,66-68). When ATP production is low 
and CoQH2/CoQ ratio is high, electrons are moving backward from CoQH2 towards 
Complex I. ROS production by RET was inhibited when complex I is treated with 
rotenone, indicating a back flow of electrons to complex I is through CoQ-binding site.  
Therefore, electrons can further push back to the FMN site and oxidize NAD+ to form the 
reduced NADH and superoxide (69).   
 
Figure 1.4 – ROS production at mitochondrial complex I. Under increased NADH levels, FMN 
can be in fully reduced form and generate superoxide by a reaction with molecular oxygen at a 
FMN site. Revers electron transfer (RET) can generate ROS at CoQ-binding site of complex I. 
This figure adopted from Kira et al. 2014, with permission from copy rights clearance center (20). 
ROS generation in complex III 
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 Mitochondrial complex III, Ubiquinone: cytochrome c reductase, shuttles electrons 
from CoQH2 to cytochrome c. Complex III holds 11 polypeptides, three heme groups and 
an FeS center (70). During electron transfer, complex III interact with CoQ at Qi and Qo 
sites. Isolated mitochondria treated with CoQH2 produced a large amount of superoxide 
(54,71-73). Antimycin A (AMA), myxothiazol and stigmatellin are known complex III 
inhibitors. AMA binds to Qi site and blocks electron transfer from Q0 site to Q1 site (Figure 
1.5). Therefore, ROS are produced as a result of leakage of electron to molecular oxygen 
by ubisemiquinone at Qo site (Figure 1.5). In contrast, Myxothiazol and stigmatellin 
interact with Qo site by blocking electron transfer from CoQH2 to Qo site and Q0 to FeS 
center respectively. Myxothiazol and stigmatellin do not produce superoxide, indicating 
that blocking Qi site is the major reason for ROS production within the complex III (74,75). 
Under normal conditions, in the absence of AMA, complex III does not produce a 
significant amount of superoxide compared to RET in complex I.     
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Figure 1.5 – Mitochondrial complex III electron movement and Q-cycle. Antimycin A inhibits 
electron flow from Qo to Qi site and increases ROS production at a Qo site.  This figure 
modified from Zorov et al. 2014, with permission from copy rights clearance center (76).                              
1.3.2.2 Peroxisome  
 Peroxisome is a small organelle found in the cytoplasm of every eukaryotic cells 
(77).  Peroxisome is also known as microbodies, and it has a catabolic activity towards 
long chain fatty acids, branched chain fatty acids, D-amino acids, and detoxification of 
ROS (78). Peroxisome-associated catabolic enzymes produce ROS and RNS. For 
example, peroxisomal oxidases catalyze the oxidative catabolism of fatty acids, purines 
and D-amino acids and transfer electrons directly to molecular oxygen. Acyl-CoA oxidase, 
xanthine oxidase, urate oxidase, D-amino acid oxidase and several other oxidases are 
readily available in peroxisome for catabolic processes and involved in generating ROS, 
such as H2O2 and O2•− (79-81). In addition to ROS, peroxisome also produces NO. by 
iNOS (82). Although peroxisome consists with ROS detoxifying enzymes, such as 
catalase, H2O2 and NO. can still penetrate the cytoplasm and participate either in redox 
signaling or oxidative damage.  
1.3.2.3 Endoplasmic reticulum (ER) 
Endoplasmic reticulum (ER) is an organelle found in most cell types, while absent 
in red blood cells (83). ER associates with protein synthesis, and lipid metabolism. The 
accumulation of unfolded or misfolded proteins in the ER can lead to ER stress. As a 
response to the ER stress, unfolded protein response pathway will be activated (UPR) 
(84,85). During UPR, protein disulfide isomerase (PDI) is catalyzing the formation of 
disulfide bond between cysteine residues of target proteins. Endoplasmic reticulum 
oxidoreductin 1 (ERO1) can reduce the oxidized PDI through electron transfer from PDI 
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to molecular oxygen in FAD-dependent manner (86,87). During this process, there is a 
higher chance to generate O2•−  and H2O2. In ER associated oxidative protein folding, 
many disulfide exchange reactions occur. Therefore, as a side reaction of disulfide 
formation, electrons can leak and react with molecular oxygen to produce ROS. Nearly 
25% of ROS produced in the ER are estimated to be generated as a byproduct of 
oxidative disulfide bond formation (88). In addition, the constitutively active NOX4 is 
known to generate ROS under ER stress. Interestingly, during phagocytosis, PDI directly 
interacts with NOX4 and produces superoxide (89).    
1.4 ROS detoxifying system  
Control generation of free radical species and other reactive species are involved 
in regulation of cellular processes. However, over the time, continues production of these 
species can accumulate inside the cell, which would be deleterious to the cell. Therefore, 
cells have evolved with ROS detoxifying system, also called an antioxidant system. 
Antioxidant system broadly divided into two major categories, including redox enzymes 
and small-molecule antioxidants. Superoxide dismutase, catalase, glutathione reductase, 
glutathione peroxidase, and peroxiredoxins are examples of redox enzyme that play a 
vital role in maintaining redox homeostasis by neutralizing the harmful effect of ROS. 
Small molecule antioxidants include glutathione, vitamin A, C, and E, β-carotene, zinc, 
selenium, NADPH and pyruvate that are found in green vegetables (90). 
1.4.1 Superoxide dismutase (SOD) 
During ETC, highly reactive and unstable O2•− produced as a by-product of 
respiration. Manganese-containing Mitochondrial superoxide dismutase (MnSOD) or 
SOD2 are solely found in mitochondrial matrix, and neutralizes O2•−  to produce less 
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reactive H2O2 (91). The dismutase activity depends on the level of MnSOD expression, 
and does not require other cofactors. However, overexpression of MnSOD closely 
associates with deficiencies in development and fertility in mice (92), suggesting that a 
controlled level of MnSOD or ROS is necessary for cellular function. MnSOD can be found 
in range of tissues including heart, liver, muscle, brain and spleen, showing the 
importance of MnSOD (93).  
1.4.2 Catalase 
Catalase found in most organisms, including plants, fungi, aerobic and anaerobic 
microorganisms. Catalase is a homo-tetramer and each subunit holds one porphyrin 
heme group that reacts with H2O2 (94). Catalase catalyzes the conversion of H2O2 to 
molecular oxygen and water with a high turnover number (millions of H2O2 molecules per 
second). Since, mitochondria and peroxisomes are generating a large amount of O2•−, 
catalase is mostly found in mitochondrial matrix and peroxisomes (95). The lack of 
catalase activity increases the risk of developing obesity, fatty liver and type 2 diabetes 
(96).  
1.4.3 Glutathione reductase  
Glutathione reductase (GR) is an essential antioxidant enzyme for maintaining the 
balance between oxidized glutathione (GSSG) and reduced glutathione (GSH). Typically, 
the ratio of a reduced form over an oxidized form of glutathione represents the redox state 
of the cell. In normal conditions, the ratio of GSH/GSSG is high (97). GSH is an essential 
antioxidant that involves in detoxifying intracellular ROS (98). Therefore, reduction of 
GSSG back to GSH is important, and this process catalyzed by GR. GR uses NADPH as 
the reducing source, and a FAD prosthetic group used as an electron carrier during the 
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catalysis (99).  Two catalytic cysteine residues (Cys58 and Cys63) are in proximity with 
NADH and FAD. In general, catalytic mechanism of GR divided into two steps. In the first 
step, NADPH will reduce oxidized GR. In the second step, GSSG is reduced by two 
catalytic cysteine residues in GR, releasing two GSH molecules. (100).  Since many of 
antioxidant activities of GSH take place in mitochondria, GR mostly found in mitochondrial 
matrix (101,102). In addition to the detoxification of ROS, GR activity is also important in 
glutathione homeostasis because GSSG cannot cross the membrane (103).  
1.4.4 Glutathione peroxidase 
Glutathione peroxidases (GPx) are a family of selenium-containing enzymes that 
scavenge H2O2 and use two GSH molecules to restore its catalytic function (104). There 
are at least eight different isoforms of GPx (GPx1-8), which are widely expressed in 
different tissues and found in different subcellular locations, including mitochondria (105). 
Mitochondrial Gpx1 provides the protection against oxidative stress by detoxifying H2O2 
produced by SOD. Active site selenocysteine in Gpx1 detoxify H2O2 to water. During the 
catalysis selenocysteine oxidizes to selenol. Oxidized Selenocysteine will be then 
reduced back with the reaction of two consecutive oxidation and reduction steps by GSH 
(104). GPx1-knockout mice did not show any apparent complications, compromised 
growth and fertility, and a severe damage under oxidative stress. However, lower levels 
of GPx were associated with type 2 diabetes, multiple sclerosis and coronary heart 
diseases, suggesting a role of GPx in maintaining redox homeostasis (106-109). 
1.4.5 Peroxiredoxin  
Peroxiredoxins (Prx) can efficiently detoxify H2O2 and lipid peroxides with the 
activity of other redox enzymes, such as thioredoxin and thioredoxin reductase (110). In 
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addition to scavenging mitochondrial hydroperoxides, Prx are also involved in redox 
signaling (111). Peroxiredoxins categorized into six isoforms, including Prx1-Prx6. Prx3 
and Prx5 are ubiquitously expressed in different tissues including mitochondria (112). 
Therefore, Prx3 and Prx5 considered as mitochondrial peroxides, and their 
overexpression protect against H2O2-induced oxidative damage in different tissues. All 
peroxiredoxins are sharing the same catalytic mechanism, and broadly divided into two 
categories depending on the number of cysteine residues in the active site. After one 
catalytic round, Prx active site cysteines undergo catalytically inactive oxidation state. In 
order to restore enzymatic activity, the oxidized form of peroxiredoxins are reduced by 
thioredoxin, ascorbate or GSH. The oxidized thioredoxin formed during the reaction, then 
reduced by thioredoxin reductase using NADPH as the reducing source.  
1.4.6 Glutathione (GSH) 
Glutathione is a tripeptide composed of glutamate, cysteine and glycine. GSH is 
the most abundant thiol-containing small molecule that acts as an antioxidant in 
mammalian and plant cells. GSH is involved in many cellular events, including ROS 
scavenging (113). GSH concentration largely varies among subcellular locations where  
GSH  concentration is in the range of 2-10 mM (114). Since mitochondria handle more 
than 90% of total ROS production in the cell, mitochondria have a higher concentration 
of GSH than other organelles. GSH is biosynthesized intracellularly while it is degraded 
outside of the cell (114). Two consecutive enzyme catalyzed reactions biosynthesize 
GSH in cells. Firstly, g-glutamyl-cysteine ligase (GCL) catalyzes the formation of γ-
glutamyl-cysteine peptide bond between cysteine and glutamate. Typically, cysteine is a 
limiting amino acid, and GSH inhabits GCL. Therefore, GCL catalyzed first step is 
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considered as the rate limiting step of GSH biosynthesis. Secondly, glutathione 
synthetase (GS) catalyzes the coupling of γ-glutamyl-cysteine with glycine to form 
glutathione (γ-glutamyl-cysteinyl-glycine or GSH). (this topic will discuss in chapter 2, 
section 2.1). GSH is stable and present in high concentrations, because, it is evolved in 
a way that can resist to intracellular peptidases and γ-glutamyl cyclotransferase due to 
the γ-glutamyl-cysteine linkage and the presence of glycine residue respectively (115).         
 
Figure 1.6 – Chemical structures of the reduce gluathione (GSH) and the oxidized 
glutathione (GSSG).  
GSH and GSSG are involved in maintaining the redox state of the cell with the 
activity of other antioxidant agents and reducing sources, such as NADPH and FADH2 
(116). An Intracellular redox potential of GSH/GSSG couple is estimated to be in the 
range of -250 mV to -150 mV (116). GSH can either directly react with free radicals or 
take part as a cofactor in other redox enzymes. GSH can directly react and detoxify 
hydroxyl radicals or peroxynitrite (116,117). Direct reaction of GSH with free radicals can 
generate thiyl radicals and finally generating GSSG (118). Gpx uses glutathione to 
detoxify ROS, such as H2O2, organic peroxides and lipid peroxides. In this reaction, GSH 
is oxidized to GSSG. Increased GSSG level is an indicative of oxidative stress. GSSG in 
the ER serves as the main oxidizing source that induce formation of disulfide bond in 
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nascent polypeptides, which is a critical step in protein maturation (119). In addition, GSH 
can directly react with RNS, such as NO.. In this reaction, NO. first reacts to give 
nitrosonium ion (NO+) by a copper-catalyzed reaction, which subsequently react with 
GSH to form GSNO, S-nitrosoglutathione (120). Formation of GSNO is involved in 
transportation of less stable NO., and GSNO reacts with the redox-sensitive cysteine 
residues of proteins, which is known as protein nitrosylation.      
1.4.7 Pyruvate 
Pyruvate is a 3-C metabolic intermediate and the final product of glycolysis. D-
Glucose is the major precursor for pyruvate synthesis. Glucose is breaking down to 
pyruvate by 9 sequential enzyme catalyzed reactions. Hexokinase catalyzes the first 
reaction of glycolysis by converting glucose to glucose-6-phosphate. As a result of several 
other enzymatic reactions, fructose1,6-bisphosphate will be produced as an intermediary 
metabolite. Fructose1,6-bisphosphate then break down into two 3-C units by fructose 
bisphosphate aldolase. These two 3-C units are further metabolized in to 
phosphoenolpyruvate. Finally, pyruvate kinase catalyzes the synthesis of pyruvate from 
phosphoenolpyruvate. Overall, in glycolysis, one glucose molecule generates two 
pyruvate molecules, two NADH, two ATP and two water molecules (121). In addition to 
the metabolic role, pyruvate non-enzymatically detoxifies O2•− and H2O2 to acetate and 
CO2 (122). Physiological antioxidant properties of pyruvate are dependent on the 
metabolic state of the cell. For example, when non-respiring diplomonads were 
supplemented with physiological concentrations of pyruvate, the production of H2O2 was 
diminished compared to the respiring saccharomyces cerevisiae (122). Therefore, the 
availability of glucose is an important determinant of antioxidant capacity of the cell.  
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1.4.8 Nicotinamide adenine dinucleotide phosphate (NADPH) 
Well known antioxidant function of NADPH is to provide the reducing power to 
other redox enzymes to maintain redox homeostasis. For example, the ratio of 
GSH/GSSG is decreasing under increased production of ROS, due to the accumulation 
of GSSG inside the cell. GR can reduce GSSG to regenerate GSH by using NADPH. 
Also, when catalase binds to NADPH, it dramatically increases the life time of catalase, 
thereby indirectly involves in detoxification of H2O2 (123).  In addition to its indirect 
antioxidant function, NADPH also known to act as a direct ROS scavenger and found in 
high concentrations (~5 mM) in mitochondria (124). Mitochondrial NADPH can be 
generated via isocitrate dehydrogenase and malic enzyme in a NADP+ dependent 
manner (125). Also, NADPH is produced by hydride transfer from NADH, during proton 
transfer across the membrane, is also common (126). A significant portion of NADPH 
pool is synthesized by pentose phosphate pathway (PPP) (127). Since, glucose-6-
phosphate is the preferred substrate for PPP, glucose availability is an important factor in 
determining the NADPH biosynthesis (127). 
Usually, peroxynitrite derived reactive species such as tricarbonate anion (CO3•−) 
and nitrogen dioxide (NO2•) are involved in damaging macromolecules such as proteins 
and nucleic acids. Therefore, alteration in protein structure and function will lead to 
pathological conditions (128,129). Since, a large portion of ROS are produced within the 
mitochondria, higher concentration of NAD(P)H is needed to detoxify them. Because, 
several reports showed that NADPH can acts as a non-enzymatic ROS scavenger by 
directly involving in detoxification of peroxynitrite derived CO3•−  and NO2•. During this 
reaction, O2•− and H2O2 are produced and detoxified by SOD and catalase (130).           
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1.5 ROS and RNS in protein oxidation 
Mitochondrial respiration and other enzymatic reactions can generate ROS and 
RNS. ROS and RNS are involved in different cellular processes by modifying redox 
sensitive proteins associated with signaling. Reactive species can damage normal protein 
function by irreversible protein oxidation (24,131). ROS can react with protein thiols to 
form both reversible and irreversible modifications such as sulfenic acid, sulfinic and 
sulfonic acids. Protein function can be finely regulated or permanently inactivated by 
cysteine oxidation (132). For example, glutathionylation, a reversible protein cysteine 
oxidation, is not only involved in protecting reactive cysteine from irreversible oxidation, 
but also it plays an important role in redox signaling. Glutathionylation is a well-studied 
reversible oxidative modification, where it refers to the formation of disulfide bond 
between a protein thiol and GSH (Figure 1.7 A) (133). On the other hand, the irreversible 
cysteine oxidation, such as sulfonic acids, can inhibit enzyme activity by directly modifying 
active site cysteine residues or other cysteines that are important for maintaining the 
structure (134).    
Glutathione is the major low molecular weight thiol in cells and acts as an 
antioxidant to protect the cell from oxidative stress. Glutathionylation can form through 
several transient intermediates, including sulfenic acid or nitrosothiol. While 
glutathionylation can occur non-enzymatically, a few redox enzymes, including 
glutathione transferase pi and glutaredoxin, are reported to enzymatically catalyze the 
formation and reversal of glutathionylation, respectively (135). 
Multiple proteins are regulated by glutathionylation in important cellular events, 
such as proliferation, migration, cell signaling, and apoptosis (136). However, their 
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functional importance is much less understood due to lack of chemical tools. 
Development of effective biochemical tools for identifying and characterizing protein 
glutathionylation will help profiling target proteins and furthering our understanding of 
glutathionylation in redox regulation. 
 
Figure 1.7 - An illustration of protein cysteine oxidation. Reactive cysteines can react 
with H2O2 / O2
-. 
 and reactive nitrogen species to generate sulfenic or nitrosothiol, which can act 
as intermediates for forming protein glutathionylation. Glutathionylation can take place chemically 
or enzymatically by GSH and GSTP respectively. B) A Prolonged exposure to reactive species 
can form irreversible cysteine modifications, such as sulfinic and sulfonic acids.  
1.5.1 Protein S-glutathionylation 
Under both physiological and oxidative stress conditions, a subset of protein 
cysteines is oxidized (13). Among many thiol oxidations, protein glutathionylation is one 
of the major oxidations. S-glutathionylation is mostly found in redox-sensitive cysteine 
residues that depends on the local environment around the cysteine residue (137). The 
addition of a GSH molecule to a protein cysteine can increase its overall negative charge 
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and an increase in molecular weight by 305 Da. The downstream effect of such 
modifications depends on the site of modification in the protein structure (137). For 
example, S-glutathionylation in the active site cysteine residue can enhance or inhibit its 
catalytic activity. S-Glutathionylation in cysteine residues distal to active site can alter 
protein function by interfering with binding partners or affecting protein structure (138).  
The susceptibility of cysteine thiol to undergo S-glutathionylation depends on 
several factors. The first important determinant is accessibility of cysteine residues to 
proximal donors of S-glutathionylation, such as superoxide, nitric oxide GSSG and 
nitrosoglutathione (139).  Secondly, the local environment that can increase the 
nucleophilicity of cysteine thiol is also one of the major factors in determining the 
modification site of a protein. Proximity of cysteine residue to basic amino acids such as 
lysine, arginine and histidine can increase the formation of thiolate anion by increasing its 
nucleophilicity (3). Selenocysteine has a lower pKa value at physiological pH (~7.4), due 
to hydrogen bonding with neighboring charged residues, including lysine. Cysteines that 
are coordinated with metal ions, such as Mg2+ or Zn2+ can also lower the pKa of cysteine 
thiol making them more nucleophilic (140). Because of low availability of reactive 
cysteines and thiol reactive radicals, only a limited number of cysteine residues is 
glutathionylated under physiological conditions. Under oxidative stress, there is a higher 
chance for most of cysteine thiols to get oxidized through a disulfide bond with GSH. 
Reversible S-glutathionylation regulates many of cellular processes under both normal 
and pathological conditions. Therefore, it is important to understand chemical and 
enzymatic routes of formation of protein S-glutathionylation and deglutathionylation.  
S-glutathionylation from chemical reactions: 
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In general, S-glutathionylation occurs by a thiol exchange reaction. A thiolate anion 
can nucleophilically attack GSSG or another protein-GSH adduct. In this reaction, GSH 
forms disulfide with a protein cysteine residue. Alternatively, different oxidative 
intermediates of protein cysteine, including sulfenic acid, can react with glutathione to 
form disulfide (Figure 1.8 A). But, there are several other chemical mechanisms that 
facilitate formation of S-glutathionylation (Figure 1.8 B). Typically, ROS-mediated 
reactions and RNS-mediated reactions are more common but it is very difficult to dissect 
an exact mechanism for S-glutathionylation.   In the presence of ROS, such as O2•−, thiols 
in GSH or protein cysteine residues can oxidize to a highly reactive thiolate anion (GS-) 
or a thiyl radical (GS.). These reactive intermediates can react with H2O2 to form sulfenic 
acid (GSOH and PSOH) (equation 1). Further, GSOH can react again with GS- to 
generate GSSG (equation 2). Protein thiolate can easily react with these glutathione 
intermediates (GS., GS- and GSSG) to form S-glutathionylated cysteines (equation 3). 
RNS are also involved as intermediates in S-glutathionylation. Several proteins, including 
GAPDH and p21Ras, are known to undergo both S-nitrosation and S-glutathionylation. 
RNS, such as NO. and N2O3, are involved in generation of nitrosothiols, such as GSNO 
and PS-NO. As in Figure 1.8, the resulting RNS intermediates can react to give S-
glutathionylation.   
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Figure 1.8 – Chemical mechanisms of protein S-glutathionylation. A) The mechanisms for 
S-glutathionylation via intermediates of thiolate and sulfenic acid. B) The chemical equations for 
generating ROS and RNS intermediates that are mediate S-glutathionylation.    
Enzyme catalyzed mechanism of S-glutathionylation: 
In addition to chemical formation of S-glutathionylation, enzymatic formation and 
removal of glutathionylation is also known. Glutathione S-transferases (GST’s) are a class 
of enzymes that decrease the pKa of thiol group in GSH, thus increasing the 
nucleophilicity and the reactivity of GSH for S-glutathionylation. GSTP is one of seven in 
GST family and is reported to increase S-glutathionylation in specific substrates. For 
example, oxidation of catalytic cysteine in peroxiredoxin to sulfenic acid can inhibit its 
peroxidase activity. GSTP interacts with peroxiredoxin and facilitates the enzymatic 
formation of S-glutathionylation of the active site cysteine, hence restoring the catalytic 
activity. Other enzymes, such as glutaredoxin 1 (Grx1), glutaredoxin 2 (Grx2) and 
gamma-glutamyl transpeptidase also play a role in S-glutathionylation. The enzyme-
catalyzed S-glutathionylation may occur on the less reactive cysteine in a specific protein. 
For example, glyceraldehyde 3-phosphate dehydrogenase (GAPDH) does not possess 
cysteine residue with a low pKa. However, glutathionylation occur by reacting with GS. as 
26 
 
the proximal donor that is catalyzed by glutaredoxin. In addition, Grx catalyzes S-
glutathionylation in several other proteins, including actin and protein-tyrosine 
phosphatase 1B (PTP1B).  
 
Figure 1.9 – Glutaredoxin (Grx) for deglutathionylation. Grx catalyzes deglutathionylation 
through A) monothiol and B) dithiol mechanism. GSSG is produced as result of both reactions. 
GR reduces GSSG to generate reduced glutathione (GSH) with NADPH as a reducing source. 
This figure adopted from Mashamaite et al. 2015, with permission from Portland press (141). 
Another extensively studied role of Grx is its deglutathionylating function (6). Grx 
catalyzes a removal of GSH from protein cysteine residues by the disulfide-exchange 
mechanism through the reaction of catalytic cysteine of Grx or by GS- (142). First, catalytic 
cysteine of Grx attacks and reduces disulfide on a target protein. During the first step, the 
catalytic cysteine of Grx forms a disulfide with GSH. Secondly, a thiolate anion of 
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glutathione can restore the catalytic cysteine by forming GSSG (monothiol mechanism). 
In dithiol mechanism, catalytic cysteine forms a disulfide with an adjacent cysteine, which 
releases reduced glutathione. An Oxidized form of Grx enzyme can be reduced to a 
catalytically active form by two molecules of glutathione. In both mechanisms, GSSG is 
released and will be reduced back to GSH by GR. In addition to Grx, sulfiredoxin (Srx) is 
also engaged in deglutathionylation of several proteins, such as PRX1, actin and PTP1B 
(143). Since glutathionylation of catalytic cysteine in PTP1B inactivates its phosphatase 
activity, deglutathionylation plays a crucial role in regulating important signaling pathways.            
1.5.2 Other protein cysteine modifications 
In the presence of H2O2, reactive cysteine residues can be oxidized to form 
reversible sulfenic acid (Figure 1.7 A). Several proteins are known to form sulfenic acid, 
including Prx, NADH peroxidase, NF-kB, PTP’s and several mitogen-activated protein 
kinases (MAPK’s) (132,144). Identification of sulfenic acid formation in proteins has been 
approached indirectly by using a biotin-switch method and by direct methods, such as 
azido- and alkyne-containing dimedone derivatives (145,146). Alternatively, the sulfenic 
acid adducts formed by reacting with dimedone has been probed by using an antibody 
(147). Sulfenic acid formation is labile to form glutathionylation. Alternatively, a constant 
exposure to ROS can oxidize sulfenic acid irreversible cysteine oxidations such as sulfinic 
acid and sulfonic acid. However, it is recently found that  sulfinic acid can be reduced 
back to sulfenic acid by Srx enzyme (148). A Prolonged exposure to ROS, Prx can be 
oxidized to sulfinic acid.  Srx selectively reduce the sulfinic acid to sulfenic acid in plant 
and mammals (149,150). Sulfinic acid formation has been reported in several studies, 
including matrix metalloproteases (MMP’s) and the Parkinson’s disease protein, Dj-1 
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(151). In addition to ROS, NO. can react with protein thiols to form S-nitrosylated proteins. 
Like S-glutathionylation, S-nitrosylation is involved in regulating different cellular 
processes, such as trafficking, apoptosis and neural transmission (152-154).   
1.6 Protein S-glutathionylation and its relevance to human diseases 
1.6.1 Regulation of protein function by S-glutathionylation 
protein thiols can be oxidized irreversibly to sulfinic and sulfonic acids under 
oxidative stress. Not only the irreversible oxidation can lead to the inactivation of protein 
function, but also result in the subsequent protein degradation (155). Protein S-
glutathionylation serves two important functions under increased production of ROS or 
RNS. First, S-glutathionylation protects protein thiols from permanent oxidation. Second, 
the reversible S-glutathionylation involves in regulating protein function by inactivating or 
altering its structure and protein-protein or protein-DNA interactions. the reversibility of S-
glutathionylation allows for protein thiols to be reduced back to sulfhydryl form while 
restoring the protein function. Some protein cysteine residues are glutathionylated even 
under basal conditions indicating a regulatory function in different cellular processes 
(156). S-glutathionylation can inhibit or active protein activity, or stabilizes protein 
structure (157). For instance, some of metabolic enzymes, including tyrosine hydroxylate, 
aldose reductase, creatine kinase and GAPDH, are inhibited upon glutathionylation (158-
161). S-glutathionylation of Cys186 and Cys181 in carbonic anhydrase III activate and 
inhibit its phosphatase activity, respectively (162). In HIV-1 protease, there are two 
conserved cysteine residues (163). While, glutathionylation of Cys67 is involved in 
stabilization and activation of protease activity, glutathionylation of Cys95 is associated 
with inhibition of protease activity (163).   
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S-glutathionylation plays important roles in cellular signaling pathways in many 
physiological processes, such as proliferation, apoptosis, differentiation and immunity 
(164). Many kinases and phosphatases are found to be regulated by S-glutathionylation. 
Protein kinase A, MAPK/extracellular -signal regulated kinase or ERK, PTP1B, and 
MAPK/ERK kinase kinase (MEKK1) are glutathionylated under physiological and stress 
conditions (4,165). Most of kinases are inhibited upon S-glutathionylation. For example, 
an active site cysteine residue (Cys199) of protein kinase A (PKA) is glutathionylated, 
which inactivates the kinase activity in a reversible manner (166). S-glutathionylation of 
small GTPase, Ras, activates downstream signaling of ERK and AKT. Angiotensin II 
induces glutathionylation of Ras, which is involved in hypotrophy in both smooth muscles 
and cardiac myocyte (167,168). Also, Ras glutathionylation is involved in inhibition of 
insulin signaling in endothelial cells (169). In addition to signaling proteins, S-
glutathionylation regulates several transcription factors such as NF-Kb and Pax-8 
(170,171). NF-kB is S-glutathionylated in both p65 and p50 subunits, which interferes with 
its binding to DNA. Therefore, NF-kB glutathionylation can inhibits the transcription of 
targeted genes (169,172).    
1.6.2 Protein S-glutathionylation in human diseases 
Age-related human pathologies are associated with increased production of ROS 
and RNS (173). Diabetes is a complication where body does not respond to insulin or has 
insufficient production of insulin due to destruction of β-cells (174). In both conditions, 
glucose in blood can be found in a high level. This can lead to an excessive 
supplementation of metabolites to mitochondria and generate increased amount of ROS, 
which leads to mitochondrial dysfunction (175). In addition to an increased production of 
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ROS, type 1 and type 2 diabetes show low levels of GSH and Gpx (176,177). Due to the 
oxidized environment in diabetics, a high level of GSSG can induce protein S-
glutathionylation. S-glutathionylation of certain proteins are considered as biomarkers for 
identification of several disease conditions in human. Due to the difficulty of access in 
human tissue samples, identification of S-glutathionylation in body fluids such as blood 
are more common. For example, an increased level of S-glutathionylated hemoglobin is 
a characteristic of type 2 diabetes (178). Hemoglobin S-glutathionylation may be a 
potential biomarker for different pathologies, including hyperlipidemia, iron deficiency 
anemia, chronic renal failure and hemodialysis (179-181).  
Cancer cells rapidly proliferate partially due to the loss of control of different cellular 
events involved in apoptosis, metabolism and redox homeostasis (182). Cancer cells rely 
on aerobic glycolysis, namely Warburg effect (183). The increased glucose metabolism 
is found to support the essential antioxidant activity by generating pyruvate and NADPH.   
In a solid tumor, tumor cells largely experience a short of nutrients, which may 
augment metastasis of tumor cells. Interestingly, several metastasis-related proteins are 
found to be regulated by S-glutathionylation. Nucleoside diphosphate kinase (Nm23) is 
considered as a tumor suppressor, and the decreased mRNA levels and mutations of 
Nm23 are identified in several metastatic cancers, including breast and colon (184). S-
glutathionylation of Nm23 at Cys109 can suppress its activity and increases the 
metastatic properties (185). Similarly, actin S-glutathionylation inhibits its polymerization 
and deglutathionylation by Grx1 can facilitate the actin polymerization (186,187). Since 
the actin polymerization and depolymerization are essential to cell migration, S-
glutathionylation of actin may play an important role in controlling cancer cell migration 
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under altered redox state (188). Moreover, MAPK, such as p38, JNK and ERK, play key 
roles in regulating cell migration (189-191). ERK is involved in regulating cell movement 
by phosphorylating myosin light chain kinase or calpain while p38 governs the 
directionality of the cell migration through phosphorylating MAPK-activated protein kinase 
2/3. A recent study revealed that ROS produced by NOX4 induce MAPK phosphatase 1 
(MKP-1) glutathionylation and subsequent inactivation of phosphatase activity, thereby 
facilitating the monocyte migration (192). These data provide evidences for a possible 
role of S-glutathionylation of MKP1 or other MKPs in cancer cell migration.        
1.7 Analytical and biochemical methods for detection of S-glutathionylation 
S-glutathionylation is the most extensively studied protein oxidation in an array of 
human diseases. Over the years, several analytical and biochemical approaches have 
been developed to visualize and identify glutathionylated proteins and their modification 
sites. Most common detection method is an antibody approach. A range of antibodies 
have been developed for different epitopes including glutathione, glutathione-BSA, 
glutathione-glutaraldehyde-BSA, glutathione conjugated to Kyhole Limpet Hemocyanin, 
and glutathione-conjugated protein complexes. Antibodies against glutathione derivatives 
have been widely used for Western blot analysis and for immunoprecipitation of individual 
glutathionylated protein (193-195).  
 Other detection methods include an indirect biotin-switch method, biotinylated 
glutathione ethyl ester (BIOGEE), radiolabeled GSH, isotope-labeled GSH and tagged 
GSH using glutathionyl-spermidine synthetase (196-198).  
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1.7.1 Biotinylated glutathione ethyl ester (BIOGEE) 
Biotinylated glutathione ethyl ester generated by derivatizing GSH molecule at 
amine group of glutamate residue. This biotin tagged-GSH is not cell permeable. 
Therefore, a carboxyl group of GSH molecule was modified to be an ethyl ester group. It 
is expected that intracellular esterase can hydrolyze ethyl group once getting into the cell. 
The released biotin-GSH could modify any protein cysteine residue in response to ROS 
(Figure 1.10).  
 
Figure 1.10 – A scheme for identification of S-glutathionylation by BIOGEE. This figure 
adopted from Samarasinghe et al. (199). 
Biotin-derivatized oxidized glutathione was also used for studying S-
glutathionylation (200). BIOGEE has been used to identify various glutathionylated 
proteins in response to ROS and growth factors (201,202). The biotin group allows to 
enrich biotinylated glutathionylated proteins by streptavidin agarose beads. Using this 
method, glutathionylated proteins can be visualized in a Western blot using streptavidin-
horse radish peroxidase (strep-HRP). This method was also used with mass spectrometry 
method in identifying glutathionylated proteins. After performing biotin pull-down, 
glutathionylated proteins was digested by trypsin and the subsequent elution allows to 
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identify modified peptides by mass spectrometry analysis (202). Further, this method was 
modified to identify and quantify the degree of glutathionylation among different ROS. 
Such improvements include addition of isotope-labeled biotin-GSH and the cleavable tags 
to identify modification sites (197,202).  
1.7.2 Biotin-switch method  
Another method is a biotin switch method. In this method, S-glutathionylated 
proteins are identified indirectly (203). First, cells are induced for glutathionylation by 
ROS. After cell lysis, all free-thiols are blocked by reacting with thiol-reacting agents, such 
as iodoacetamide (IAM) or N-ethylmaleimide (NEM). After irreversible blocking of all 
unmodified thiols, S-glutathionylated cysteine residues are reduced by dithiothreitol 
(DTT), tris(2-carboxyethyl)phosphine (TCEP) or a mutant form of Grx3 (202,204,205). 
The reduced cysteine residues then react with biotin-NEM or biotin-IAM. Biotinylated 
proteins that represent S-glutathionylated proteins can be visualized by Western blotting 
(Figure 1.11). Similar to BIOGEE, biotin-switch method was used with mass spectrometry 
(LC-MS/MS). Therefore, identification of glutathionylated proteins as well as their cysteine 
modification sites can be deduced using biotin-switch method. A modified version of 
biotin-switch method has been reported and successfully used to visualize 
glutathionylated proteins within different compartments of fixed tissues or cells (205). 
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Figure 1.11 – The example of a biotin switch method. After inducing glutathionylation, the 
remaining cysteine residues were blocked with N-ethylmaleimide (NEM) and subsequent 
reduction by Grx3 will expose glutathionylated cysteine residues. Then cysteine residues are 
reacted with biotin-containing cysteine reactive reagent for the enrichment and identification by 
LC-MS/MS. This figure adopted from Samarasinghe et al. 2015 (199). 
1.7.3 Biotin-glutathionylspermin  
GSH is present in a high concentration in eukaryotic cells as well as in prokaryotes. 
In several types of bacteria, while a carboxylic group of a glycine residue in GSH molecule 
is further modified with spermidine by glutathionylspermidine synthetase (GspS). The 
synthesized gluathionylspermidine can be hydrolyzed by glutathionylspermidine amidase 
(GspA) (206-208). In a recent study, GspS was used to generate biotin-
glutathionylspermine (biotin-Gsm) in mammalian cells to identify S-glutathionylated 
proteins by LC-MS/MS (209). In this method, first, GspS is transiently expressed into 
cells. Biotin-spermine was then incubated to generate biotin-Gsm inside the cell. Because 
biotin-Gsm was synthesized inside the cell, this method can avoid an incubation of an 
exogenous modified GSH, such as BIOGEE, in a high concentration, which may minimize 
the perturbation of an intracellular redox status. In the presence of ROS stimulus, biotin-
Gsm can undergo S-glutathionylation (Figure 1.12). Biotin-Gsm modified proteins can be 
visualized by Western blotting and identified by LC-MS/MS. This approach was used to 
identify 1400 modified cysteine residues in LC-MS/MS analysis.   
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Figure 1.12 – A strategy to identify S-glutathionylated proteins using biotin-spermine and 
glutathionylspermidine synthetase (GspS). Transfection of GspS followed by the incubation of 
biotin-spermine generates biotin-glutathionylspermine (biotin-Gsm). In the presence of ROS, 
sensitive cysteine residues can be modified by biotin-Gsm and the subsequent LC-MS/MS 
analysis can identify glutathionylated proteins. This figure adopted from Samarasinghe et al. 2015 
(199).   
1.8 Current dissertation work in examining S-glutathionylation 
Protein S-glutathionylation is implicated in a range of human diseases including 
age-related diseases such as diabetes, neurodegenerative diseases, cardiovascular 
diseases and cancer. Many of these diseases are associated with altered metabolism 
and cellular redox homeostasis. For example, cancer cells rely on a high rate of glucose 
uptake in order to provide enough energy for rapidly proliferating cells. Many cancer cells 
are shown to produce high levels of ROS and RNS. S-glutathionylation is an oxidative 
cysteine modification that regulates protein function due to its reversible nature. 
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Identification and evaluation of functional consequences of S-glutathionylation in such 
proteins allow basic understanding for development of therapeutics in the future. 
However, despite several available biochemical approaches, identification and 
characterization of S-glutathionylated proteins are challenging.  
In this dissertation work, I will describe development of a novel chemical method 
to detect S-glutathionylated proteins, and the application to identify S-glutathionylated 
proteins in response to metabolic alteration. Moreover, functional roles of S-
glutathionylation in cancer metastasis will also be elucidated. 
In chapter 2, development of a clickable glutathione approach for detection of 
glutathionylation will be discussed. In this study, we developed a selective and versatile 
method for identifying and characterizing glutathionylation in cells by using a mutant of 
glutathione synthetase (GS). We have engineered the active site of GS to catalyze an 
incorporation of azido-Ala in place of glycine.  This generates the azide-containing 
glutathione in cells, which undergoes glutathionylation upon ROS stimulus. The 
subsequent bioorthogonal copper-catalyzed 1,3-dipolar cycloaddition reaction (click 
reaction) with biotin-alkyne or fluorophore-alkyne allows a direct enrichment or detection 
of glutathionylated proteome by biotin pull-down and fluorescence imaging, respectively. 
The method presents a unique metabolic labeling of intracellular glutathione without 
disturbing thiol-redox states and a chemical method for characterization of 
glutathionylated proteins in response to ROS. 
Chapter 3 will describe identification of glutathionylated proteins induced in 
response to glucose metabolism and/or mitochondrial dysfunction Mitochondrial ROS 
(mROS) are the key components of cellular damage and redox signaling. Cancer, 
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ischemia and other pathological conditions are accompanied by elevated levels of mROS. 
Although glucose metabolism is known to be associated with redox regulation, 
glutathionylation in response to glucose metabolism remains unknown. To address this, 
we employed a clickable glutathione approach in a HEK293-GS M4 stable cell line that 
stably overexpresses the mutant of glutathione synthetase (GS M4). glutathionylation was 
induced in response to antimycin A (AMA), glucose starvation, a combination of AMA and 
glucose starvation.  Interestingly, glutathionylation was reversed by the addition of 
glucose or pyruvate, suggesting that reversibility of glutathionylation is regulated by 
glucose availability under mitochondrial dysfunction. We identified over 1200 
glutathionylated proteins by LC-MS/MS analysis including several new glutathionylated 
proteins, including PP2Cα. PP2Cα is a metal- dependent protein phosphatase involved 
in metabolic stress and AMPK signaling. We found that PP2Cα is glutathionylated at C314 
residue in response to metabolic stress, and glutathionylation of PP2Cα disrupted its 
interaction with mGluR3, an important metabotropic glutamate receptor associated with 
neurological disorders. Together, this study provides the importance of glucose 
availability in regulating protein glutathionylation under mitochondrial dysfunction. 
Chapter 4 will describe the functional role of PP2Cα S-glutathionylation in cancer 
cell migration and invasion in response to metabolic alterations. PP2Cα is a 
serine/threonine protein phosphatase which acts as a negative regulator of stress 
responsive pathway. First, glutathionylation was systematically analyzed under a limited 
concentration of glucose and oxygen availability. We found different glutathionylation 
pattern in different cell lines in response to low glucose. Glutathionylation was selectively 
induced in an invasive breast cancer cell line MDA-MB 231 compared to non-invasive 
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MCF7 cells, indicating a distinct redox response by metastatic cancer cells.  Further, an 
incubation of L-glutamic acid reversed the effect of low glucose. We also showed that 
oxygen availability is also important for glucose deprivation-induced protein 
glutathionylation. Moreover, we found that PP2Cα glutathionylation enhances cancer cell 
migration potentially by dephosphorylating and inactivating JNK under metabolic stress 
in MDA-MB231 cells. Altogether, our data reveal an important regulatory role of PP2Cα 
glutathionylation in cancer cell migration in response to metabolic stress. 
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CHAPTER 2 METABOLIC SYNTHESIS OF CLICKABLE GLUTATHIONE FOR 
STUDYING PROTEIN GLUTATHIONYLATION 
 2.1 Introduction  
Protein glutathionylation is implicated in redox signaling under controlled 
generation of reactive oxygen species by cytokines and growth factors (210). Most of 
available chemical methods suffer from poor specificity and/or sensitivity. To overcome 
these limitations and to develop a reliable method for identification of glutathionylated 
proteins, we developed a chemical method which uses enzyme engineering, metabolic 
synthesis and biorthogonal chemistry (199,211). First, we generated clickable glutathione 
inside the cell which excludes the incubation of high concentrations of exogenous 
glutathione. Glutathione biosynthesis is catalyzed by two enzymatically catalyzed 
reactions (Figure 2.1). In the first step, γ-glutamylcysteine ligase (GCL), which is the rate 
limiting enzyme, catalyzes the formation of an amide bond between a side chain 
carboxylic group of glutamate (Glu) and an amine group of cysteine (Cys) to generate 
γGlu-Cys dipeptide. The second step of glutathione biosynthesis is catalyzed by 
glutathione synthetase (GS). GS catalyzes the formation of tripeptide (γGlu-Cys-Gly) by 
ligating glycine (Gly) with a dipeptide γGlu-Cys (212,213).  
We planned to incorporate a small clickable functional group onto a glycine residue 
in glutathione. We envisioned that we can add clickable moiety on Gly of glutathione by 
engineering GS. Since GCL involve in the rate-limiting step of glutathione biosynthesis, 
metabolic synthesis of clickable glutathione may not affect the total glutathione or thiol 
concentration in the cell (214). In addition, a glutathione-degrading enzyme, γ-glutamyl 
transpeptidase, retains the specificity towards Glu in glutathione. Therefore, we further 
envisioned that clickable glutathione may be degraded by glutathione-catabolic pathways 
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(215). Also, interestingly, there are other naturally existing glutathione derivatives 
containing β-Ala, Ser, or Glu in place of Gly in glutathione in plants (216), which may 
justify the modification in clickable glutathione. 
 
Figure 2.1- A scheme for GSH and azido-GSH biosynthesis. The First reaction is catalyzed 
by γGluCys ligase to generate dipeptide γGlu-Cys. Glutathione synthetase catalyzes the second 
step of GSH biosynthesis. GS mutant catalyzes azide- or alkyne-containing Gly derivatives to 
form clickable GSH. 
2.2 Design of clickable glutathione 
Our design is based on a synthesis of azido-glutathione or glutathione containing 
alkyne group in situ in cells. We thought that the GS active site could be engineered to 
accommodate azide-or alkyne- containing Gly derivatives. Overexpression of GS mutant 
allows metabolic synthesis of clickable GSH inside the cell. First, transient overexpression 
of a GS mutant in HEK 293 cells will metabolically synthesize clickable glutathione in the 
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presence of azide- or alkyne- containing Gly derivatives, such as L-azidoAlanine (L-
AzAla), L-homopropargylglycine (L-HPG) or L-propargylglycine (L-PG). After 
glutathionylation is induced by incubation of exogenous H2O2, cells are lysed in the 
presence of a thiol-blocking reagent. The subsequent bio-orthogonal click reaction with 
appropriate alkyne or azide containing biotin or fluorophore is expected to selectively 
detect glutathionylation by Western or in-gel fluorescence respectively (Figure 2.2). This 
novel approach provides not only detection of glutathionylation by gel analysis, but also 
identification of glutathionylated proteins by mass spectrometry analysis.  
 
Figure 2.2 - Schematic diagram for the detection of glutathionylation by clickable GSH. 
2.3 Results  
2.3.1 Generation of glutathione synthetase mutants and kinetic analysis 
Glutathione synthetase is a specific enzyme towards its substrates including 
glycine. In the active site, there are several amino acids which are important for specificity 
towards glycine. We noticed in the crystal structure of GS (PDB:2HGS) that two amino 
acids (F152 and S151) are in a close proximity to a glycine residue of GSH (Figure 2.3 
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A).  We thought that a bulky structure of F152 in the GS active site does not allow 
formation of glutathione derivatives containing other amino acids than glycine.  
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Figure 2.3 – Crystal structure of GS WT and rearranged active site structures of GS M4. A) 
Crystal structure and active site amino acid residues of glutathione synthetase enzyme. B) Model 
structures of the active site in glutathione synthetase (GS) WT and mutants. Space filling (upper) 
and stick (bottom) models of GS mutants are drawn from GS WT (PDB:2HGS) by using PyMol 
program. The structure of azido-Ala is drawn in an arbitrary conformation that appears to have a 
low steric hindrance.    
Therefore, we thought we can mutate F152 and/or S151 in the active site of GS to 
provide an extra space that may accommodate the azide- or alkyne-containing glycine 
derivatives (Figure 2.3 B). We have generated several GS mutants with mutation of F152 
and S151 residues. GS WT and GS mutants were overexpressed in bacteria and purified 
by affinity chromatography (Figure 2.4 A and Figure A.2.1) and characterized by an ADP-
coupled enzyme assay with pyruvate kinase (PK) and lactate dehyrogenase (LDH) 
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(Figure 2.4 B) (217). Initial rates were fitted to the Michaelis-Menten equation. Km and kcat 
values were calculated for all GS mutants and GS WT (Figure 2.4 C and Figure A.2.2). 
 
 
Figure 2.4 – Purification and kinetic analysis of GS mutants. A) GS WT and GS mutants were 
purified with high purity.  B) Kinetic assays by enzyme coupled reactions using ATP consumption. 
C) Michaelis-Menten plot for L-AzAla and GS M4 (F152A/S151G). 
Kinetic data for all GS enzymes are summarized in Table 2.1.  Since GS WT is 
specific towards Gly, it did not catalyze other amino acids. GS WT catalyzes Gly with a 
high catalytic efficiency (kcat/Km = 1095) and has a high binding affinity to Gly. 
Interestingly, GS M1 (F152G) did not catalyze Gly and displayed a poor binding affinity 
towards Gly compared to L-AzAla. The mutation of bulky F152 to a small glycine may 
have created an enough space to accommodate glycine derivatives.GS M1 catalyzed L-
AzAla with high catalytic efficiency compared to other amino acids. Although GS M1 
prefers L-AzAla over other substrates, GS M1 was not ideal. The binding affinity is still 
poor and the Km value was high (2.46 mM). Also, the kcat/Km value is 25 times lower than 
kcat/Km value for Gly by GS WT. We further hypothesized that a bigger space in the active 
site pocket will increase the binding affinity of GS mutant towards L-AzAla.   
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Table 2.1 - Kinetic data of GS WT and GS mutants with different amino acids. 
 
Therefore, we generated a double mutant, GS M2 (F152G/S151G), that may give 
a more space to accommodate L-AzAla in the active site of GS. Although, GS M2 has a 
decreased Kcat value for L-AzAla, GS M2 improved the binding affinity by 10-fold when 
compared to GS M1. Overall, GS M2 showed a 5-fold higher catalytic efficiency with 
azido-Ala than GS M1, and only 6 times lower catalytic efficiency than GS WT for glycine. 
However, it was found that GS M2 can catalyze both L-Met and L-AzAla with the similar 
catalytic efficiency, suggesting that GS M2 lost its selectivity towards L-AzAla.  
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In addition, we noticed that GS M3 (S151G) with a small size of mutation showed 
significantly improved the selectivity towards L-AzAla over L-Met. Thus, we sought to 
mutate F152 to alanine which may reduce the active site space in GS M2.  Indeed, we 
observed that the mutation of F152A together with S151G (GS M4) improved the 
selectivity towards L-AzAla (Km = 0.09 mM) over Met (Km = 0.17 mM). GS M4 has the 
highest catalytic efficiency (Kcat/Km = 630.6) towards L-AzAla. In addition, GS M4 had a 
three-fold higher catalytic efficiency for L-AzAla over L-Met. GS M4 also could catalyze 
both L-HPG and L-PG with a similar or slightly lower kcat/Km value to L-AzAla. Overall, in 
vitro kinetic data provide evidences that GS M4 can efficiently catalyzes L-AzAla to 
synthesize clickable glutathione.  
2.3.2 Biosynthesis of clickable glutathione in HEK293 cells 
In vitro kinetic data showed that GS M4 is the most efficient GS mutant with azido-
Ala. However, GS M4 can also catalyze L-Met albeit 3-fold lower catalytic efficiency than 
azido-Ala. Therefore, we analyzed in vitro synthesis of glutathione derivatives by GS WT 
and GS M4.  Gly, L-AzAla, L-Met, γGlu-Cys and ATP were incubated with GS WT and/or 
GS M4, as shown in Figure 2.5. The synthesis of glutathione derivatives was analyzed by 
LC-MS with or without modification by fluorescein iodoacetamide (FL-IA). When the 
reaction mixture reacted with FL-IA, the masses corresponding to endogenous GSH (m/z 
308) and azido-GSH (m/z 363) shifted to m/z 695 and m/z 750, respectively. Masses 
corresponding to endogenous GSH, azido-GSH and GSH containing L-Met (Met-GSH) 
were extracted and overlaid in LC-MS analysis. In the presence of GS WT, the only mass 
corresponding to endogenous GSH was detected without observing other masses for 
azido-GSH and met-GSH (Figure 2.5 A and Figure A.2.3). In contrast, GS M4 synthesized 
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the glutathione derivatives containing azido-Ala, Met, or Gly, but with the highest intensity 
for azido-glutathione (Figure 2.5 B). In the presence of both GS WT and GS M4, there is 
still significant amount of azido-glutathione in comparison to endogenous glutathione 
(Figure 2.5 C).  
 
 
Figure 2.5 - LC-MS analysis of in vitro biosynthesis of clickable glutathione. Individual GS 
enzymes were incubated with γGlu-Cys, amino acids and ATP. The reaction mixture was then 
treated with FL-IA and injected to LC-MS. The masses of endogenous GSH, azido-GSH and met-
GSH were extracted and overlaid. A)   GS WT B) GS M4 C) GS WT and GS M4 were incubated 
with other reactants and injected to LC-MS.  
Next, we analyzed metabolic synthesis of clickable glutathione in cells. For 
mammalian cell transfection, we produced a mammalian vector that can express GS M4 
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(pCDNA3.1-GS M4) with n-terminal FLAG tag. A transient transfection of FLAG-tagged 
GS M4 into HEK293 cells induced approximately 15-20-fold overexpression of the GS 
mutant compared to endogenous GS WT (Figure 2.6 A). First, we analyzed total thiol 
concentrations in cell lysate to check whether metabolic synthesis of clickable glutathione 
interfere with intracellular redox state. Cells were lysed by three freeze-thaw cycles and 
protein free lysates were analyzed for free thiols using bromobimane assay. 
 
 
Figure 2.6 – GS M4 overexpression in cells. A) FLAG tagged GS M4 was transiently 
transfected to HEK 293 cells and overexpression of GS M4 probed with anti-GS and anti-flag. B) 
Intracellular thiol levels were determined by bromobimane assay. After transfection of GS M4, 
cells were incubated with different concentrations of L-AzAla for 20 h. Cells were lysed by freeze-
thaw cycles and protein free lysates were subjected to bromobimane assay.  
An incubation of increasing concentrations of L-AzAla did not change the total thiol 
concentration when compared to cells without transfection of GS M4 and incubation of L-
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AzAla. The data indicated that metabolic synthesis of clickable glutathione by GS M4 may 
not alter intracellular redox state.   
We further demonstrated the biosynthesis of azido-GSH in cells. L-AzAla, L-HPG 
or L-PG were incubated for 20 h with GS M4-transfected cells. Cells were lysed by several 
freeze-thaw cycles in 1X PBS with or without fluorescein-iodoacetamide. Protein free cell 
lysates injected to LC-MS. The masses corresponding to endogenous GSH (m/z 308) 
and azido GSH (m/z 363) were extracted and overlaid. only endogenous GSH was found 
in cells without expression of GS M4 (Figure 2.7 A and 2.8 A). Masses corresponding to 
other glutathione derivatives including azido-GSH were not detected in LC-MS analysis. 
In contrast, when HEK 293 cells were transfected with GS M4 and incubated with L-
AzAla, we observed a mass ion peak for azido-GSH together with endogenous GSH 
(Figure 2.7 B). The amount of azido GSH was gradually increased with an increasing 
incubation time of L-AzAla. Incubation of L-AzAla for 6 h, 20 h and 40 h increased the 
amount of azido-GSH up to 10%, 40% and 70% of endogenous GSH, respectively (Figure 
2.7 C). In addition, the amount of azido-GSH was increased dose dependently when cells 
were incubated with increasing concentrations of L-AzAla (Figure A.2.4). When HEK293 
cells without transfection of GS M4 were incubated with L-AzAla, we observed only one 
mass ion peak which is corresponding to endogenous GSH (Figure 2.8 B). We also 
analyzed GS M4 selectivity towards L-AzAla over other amino acids for synthesizing 
glutathione derivatives in cells.  
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Figure 2.7 - LC-MS analysis of biosynthesis of clickable GSH. A) Protein free lysates from 
control cells without azido-Ala and GS M4 transfection were injected to LC-MS.  Masses 
corresponding to endogenous GSH and azido-GSH were extracted and overlaid. B) Cell lysates 
were prepared after transfection of GS M4 and incubation of azido-Ala to HEK29C3 cells. Protein 
free lysate were injected to LC-MS. C) Cells were lysed and derivatized with FL-IA after incubating 
azido-Ala for different times.  
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Figure 2.8 - LC-MS analysis of biosynthesis of other GSH derivatives. A) Masses 
corresponding to different glutathione derivatives were extracted and overlaid with HEK293 cells 
in the absence of azido-Ala. B) Masses for GSH and azido-GSH were analyzed from HEK293 
cells in the absence of GS M4 overexpression after incubation of azido-Ala. C) Masses 
corresponding to GSH, azido-GSH, L-Met containing GSH (Met-GSH), alanine containing GSH 
(Ala-GSH) and reduced form of azido-GSH (aminoalanine-GSH) were analyzed from cells after 
transfection of GS M4 and an incubation of azido-Ala. 
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Importantly, overexpression of GS M4 and incubation of L-AzAla led to a selective 
synthesis of azido-GSH. We did not detect any glutathione derivatives containing either 
methionine (Met-GSH) or alanine (Ala-GSH) (Figure 2.8 C). Despite the fact that an azide 
group can be reduced to an amine group in an intracellular environment, we did not 
observe a mass (m/z 724) corresponding to a reduced form of azido-GSH (glutathione 
with amino-alanine) indicating the relatively high stability of an azido group inside the cell 
(Figure 2.8 C).  
 
 
Figure 2.9 - Biosynthesis of clickable GSH using L-HPG and L-PG. Cell lysates prepared from 
cells with A) L-HPG and B) L-PG were subjected to LC-MS analysis after modifying with FL-IA. 
 Moreover, we checked the biosynthesis of GSH derivatives containing an alkyne 
group. HEK293 cells were transfected with GS M4 and incubated with L-PG or L-HPG. 
An incubation of L-PG or L-HPG produced their corresponding glutathione derivatives 
(Figure 2.9 A and B). We detected a lower intensity of GSH containing L-HPG when 
compared to GSH containing L-PG. L-HPG is a methionine surrogate which is known to 
be incorporated into proteins. These LC-MS study further provides the evidence that 
clickable GSH can be synthesized upon expression of the GS M4 mutant in cells. 
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2.3.3 Analysis of glutathionylated proteins by in-gel fluorescence and Western 
blotting 
Metabolic tagging of clickable glutathione is a selective and versatile chemical 
approach to detect glutathionylated proteome in cells. To induce glutathionylation in 
HEK293 cells, GS M4 transfected cells were incubated with L-AzAla for 20 h followed by 
the Incubation of hydrogen peroxide (H2O2). Then, cells were lysed and subjected to click 
reaction with fluorophore-alkyne or biotin-alkyne in the presence of CuBr. We used CuBr 
instead of common CuSO4 / TCEP method because of disulfide in glutathionylation. After 
one hour of click reaction, glutathionylation was visualized by in-gel fluorescence or 
chemiluminescence with streptavidin-HRP. All negative controls without GS M4, L-azido-
Ala, or H2O2 (Figure 10 A lanes 1-7) did not show fluorescence signals for 
glutathionylation. In contrast, in the presence of GS M4, L-AzAla and H2O2 (Figure 10 A 
lane 8), click reaction produced numerous fluorescence bands corresponding to 
glutathionylated proteins. To confirm that the fluorescence signal results from 
glutathionylated proteins, we treated cell lysate (used in lane 8 Figure 10 A) with DTT 
prior to click reaction with rhodamine-alkyne. A treatment of DTT showed disappearance 
of fluorescence signal suggesting that the fluorescence signal results from a disulfide 
bonds formation between azido-GSH and protein cysteine residues in response to ROS 
stimulus (Figure 10 A lane 12). We observed the similar result after click reaction with 
biotin-alkyne and the subsequent Western blotting analysis with streptavidin-HRP (Figure 
A.2.5 A).  
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Figure 2.10 - Analysis of glutathionylated proteins using metabolically synthesized azido-
GSH. A) HEK 293 cells were incubated with or without L-Azido-Ala and induced with 1 mM H2O2 
or B) varying concentration of H2O2 for 15 minutes, followed by cell lysis and click reaction. 
Glutathionylation probed as shown above.      
To assess the sensitivity of clickable glutathione approach, GS M4 overexpressing 
cells were treated with an increasing concentration of H2O2 (0.1-1 mM) (Figure 2.10 B). 
There was a significant intensity of glutathionylated proteins even at a low concentration 
of H2O2 (100 µM) (Figure 2.10 B lane 6). We did similar experiment by varying the L-
Azido-Ala concentration, which showed similar levels of detection for glutathionylation 
even with a low concentration of L-Azido-Ala (0.3 mM) (Figure A.2.5 B). We also analyzed 
glutathionylation in different cell lines using the clickable glutathione approach. GS M4 
was transiently transfected to three different cell lines including HEK293, HBEC3-KT and 
A549 cells. After incubation of L-AzAla, cells were induced for glutathionylation. The 
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intensity of glutathionylation was similar between HEK 293 and HBEC3-KT cells while A 
549 cells displayed a relatively lower signal of glutathionylation in response to H2O2 
(Figure A.2.6). These data demonstrated that clickable glutathione can be used to study 
glutathionylation in different cell lines in response to ROS stimuli.  
Several clickable glycine derivatives can be incorporated into proteins during de 
novo protein biosynthesis. For example, L-HPG is a well-known methionine surrogate. It 
has been shown that L-HPG can be incorporated into proteins (218). We further 
compared detection of glutathionylation using L-azido-Ala versus L-HPG and L-PG. 
HEK293 cells expressing GS M4 were incubated with clickable Gly derivatives (L-HPG or 
L-PG). After ROS stimulation and click reaction with rhodamine alkyne or rhodamine 
azide, glutathionylation was detected by in-gel fluorescence (Figure 2.11). In the absence 
of GS M4, L-AzAla or H2O2, cells did not produce significant amount of signal compared 
to the cells with all three components (Figure 11 lane 1-3 compare with lane 4). The 
diminished fluorescence signal in L-azido-Ala incubated cells without GS M4 
overexpression and H2O2 incubation (Figure 11 lane 2), indicates that L-azido-Ala is not 
incorporated into proteins during protein biosynthesis.  In contrast, an incubation of L-
HPG alone (Figure 11 lane 6) produced numerous bands even without GS M4 and ROS 
stimuli, suggesting that L-HPG is incorporated into proteins.  
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Figure 2.11 – Studying possible incorporation of amino acid derivatives to protein 
biosynthesis. After incubating L-AzAla, L-HPG and L-PG separately with or without GS M4 
overexpression and ROS stimuli, prepared cell lysates were subjected to click reaction with 
rhodamine alkyne and glutathionylation detected by in-gel fluorescence.  
An incubation of L-PG did not produce any labeling of proteins (Figure 11 lane 9-
11). After treatment of H2O2, there was a significant signal for glutathionylation albeit a 
slightly lower intensity of signals when compared to glutathionylation detected by L-azido-
Ala or L-HPG (Figure 11 lane 12). From this study, we concluded that L-AzAla is the most 
efficient clickable amino acid for identifying protein S-glutathionylation. 
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2.3.4 Reversibility of azido-glutathionylated proteins 
Glutathionylation is a highly dynamic post translational modification due to the 
reversibility of the disulfide bond. Glutaredoxin (GRX1) is a well-known redox enzyme that  
catalyzes the reduction of disulfide bond in glutathionylated proteins and GRX1 is 
involved in maintaining the redox balance in the cell (219). We carried out in vitro GRX1 
assay to examine whether azide group in clickable glutathione interferes with GRX1-
mediated deglutathionylation. GS M4-transfected cells were incubated with L-AzAla and 
treated with H2O2 for 15 minutes prior to lysis. The lysates were then incubated with 
recombinant GRX1. glutathionylation was significantly decreased after incubation with 
GRx1 when compared to without GRX1 (Figure 2.12 A). This suggests that a small azide 
functional group in glutathione may be tolerated for deglutathionylation by GRX1 
(compare lane1 and 2 in Figure 2.12 A). 
Next, we evaluated protein deglutathionylation in HEK293 cells. After transfecting 
and incubating L-AzAla, cells were induced with H2O2 for glutathionylation. After 15-
minute induction, cell culture medium was replaced with a fresh medium without H2O2 for 
different time points. cells were then lysed at 0, 0.5 and 1 h time points and were analyzed 
for glutathionylation after click reaction with biotin-alkyne. 
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Figure 2.12 – Reversibility and clickable glutathionylated proteins. After incubating L-AzAla 
with GS M4 overexpressing HEK293 cells and ROS stimuli cell lysates were prepared and 
subjected to click reaction with rhodamine alkyne and glutathionylation detected by in-gel 
fluorescence. A) Lysates were incubated with purified GRX1 protein and subjected to click 
reaction, probed by fluorescence. B) HEK293 Cells were washed with PBS for different time 
points after induction with H2O2 for 15 minutes. Then click reaction was performed with rhodamine-
alkyne to assess reversibility of glutathionylation.   
Deglutathionylation was readily induced after removing H2O2 from cells (lane 4 and 
lane 3, Figure 2.12 B). These data confirm that deglutathionylation can be detected by 
azido-GSH, showing that clickable glutathione can be used to detect a reversible change 
of glutathionylation in cells. 
2.3.5 Fluorescence imaging 
The clickable glutathione approach can be used to study various aspects of protein 
glutathionylation. For example, we envision that clickable glutathione can be used to 
59 
 
visualize glutathionylated proteins and the localization by fluorescence imaging. This 
technique excludes the incubation of primary and secondary antibodies for visualization. 
In addition, a clickable glutathione approach can be coupled with a proximity ligation, a 
sensitive technique that is used to study protein-protein interactions and to visualize 
PTMs in individual proteins by fluorescence imaging (220). Therefore, we sought to 
demonstrate fluorescence imaging of glutathionylated proteins in cellular context. HEK 
293 cells were grown on a glass cover slip and L-AzAla was incubated in cells with or 
without GS M4 transfection. Cells were then induced for glutathionylation by 15 min 
incubation of 1 mM H2O2. Cells were fixed by cold methanol and washed with PBS to 
remove an excess amount of cellular glutathione.  Then, click reaction was performed 
with Alexa Fluor 647 alkyne (AF647). cells were then extensively washed and mounted 
on glass cover slips using a mounting solution containing DAPI.  
Cells incubated with L-azido-Ala in the presence of GS M4, produced a strong 
fluorescence signal (Figure 2.13 E). Glutathionylated proteins were localized in the 
cytoplasm and in the nucleus. On the other hand, cells without GS M4 did not produce 
any fluorescence signal for glutathionylation (Figure 2.13 B), supporting that clickable 
glutathione can be used to visualize glutathionylated proteins using fluorescence imaging.  
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Figure 2.13 – Visualization of glutathionylated proteins by fluorescence imaging. L-AzAla 
was incubated with HEK 293 cells with (D-F) or without (A-C) GS M4 for 20 hours. Cells were 
fixed, blocked and subjected to click reaction with AF647-alkyne. Fluorescence images were 
captured for DAPI (A, D) and Cy5, for glutathionylation (B, E). Overlaid images shown in (C and 
F).   
2.3.6 Identification of individual glutathionylated proteins 
We further sought to couple a clickable glutathione approach with mass 
spectrometry techniques to identify new glutathionylated proteins. As a proof of concept, 
we carried out a pull-down experiment of glutathionylated proteins. To enrich 
glutathionylated proteins, cell lysates were subjected to click reaction with biotin-alkyne. 
Then, glutathionylated proteins were bound to streptavidin agarose beads (221). Proteins 
were then eluted by heating in a SDS loading buffer, and the eluted proteins were 
separated by running SDS-PAGE. Glutathionylated proteins were visualized by silver 
staining. There were significant amount of glutathionylated proteins when compared to 
the control (Figure 2.14 A lane 4).  
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Also, this method can be used to probe individual glutathionylated proteins by 
immunoprecipitation and Western blotting. After metabolic labeling, individual 
glutathionylated proteins were immunoprecipitated using relevant primary antibodies and 
subjected to on-bead click reaction with biotin alkyne. PTP1B and Hsp90 are known to 
undergo glutathionylation. Therefore, PTP1B and Hsp90 were selected for the analysis 
of glutathionylation by immunoprecipitation and Western blotting (5,222). After 
immunoprecipitation and on bead-click reaction (223), the eluted protein were probed for 
glutathionylation with strep-HRP.  
 
Figure 2.14 – Identification of glutathionylated proteins. A) Lysates subjected to click reaction 
with biotin alkyne and biotinylated protein were enriched with streptavidin-agarose beads, and 
eluted.  Glutathionylated proteins were visualized by silver staining. B) After metabolic labeling, 
HSP90 and PTP1B were immunoprecipitated, followed by on bead-click reaction with biotin 
alkyne. Eluted proteins were probed as shown above. 
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There was a strong signal of glutathionylation for both PTP1B and HSP90 after incubation 
of H2O2 (Figure 2.14 B). These data showcase that clickable glutathione can be used to 
enrich glutathionylated proteins and the potential mass spectrometric studies.  
2.4 Discussion 
Protein glutathionylation is a reversible cysteine oxidative modification that 
controls protein function (6). Glutathionylation is the disulfide bond formation between a 
GSH and cysteines in proteins that take place in the presence of ROS or RNS. Many 
proteins are likely to be regulated by glutathionylation (156). Therefore, identification of 
protein glutathionylation would make a significant contribution to understanding protein 
glutathionylation. Although there are several methods to study protein glutathionylation, 
most of tools still suffer from limitations (224). To overcome these limitations, we 
developed a versatile chemical method, which metabolically synthesizes clickable 
glutathione by a mutant of glutathione synthetase.  
Glutathione biosynthesis is an enzyme catalyzed two-step process where the first 
enzyme GCL catalyzes the rate limiting step of the formation of dipeptide γGlu-Cys 
(213,225). The second enzyme GS catalyzes a ligation of Gly with g-Glu-Cys to form 
γGlu-Cys-Gly tripeptide (GSH). we sought to engineer a GS active site in a way that 
catalyzes azide- or alkyne-containing Gly derivatives to make clickable glutathione. After 
performing a series of site-directed mutagenesis within vitro GS kinetic assay, we found 
GS M4 efficiently catalyzes L-AzAla, L-PG and L-HPG to generate clickable glutathione.  
Because L-AzAla, L-HPG and L-PG are amino acid derivatives, there is a 
possibility of these amino acids being incorporated into proteins during translation. 
Consistent with previous studies, our data indicated that L-HPG was significantly 
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incorporated into protein biosynthesis while L-AzAla and L-PG were not incorporated into 
proteins (226). Although L-PG was not incorporated into proteins, L-PG did not detect 
glutathionylation sensitively. Therefore, we concluded that L-AzAla is the best Gly 
derivative to generate clickable glutathione inside the cell and to study protein 
glutathionylation. 
Next, LC-MS analysis confirmed efficient metabolic synthesis of azido-GSH. 
Importantly, metabolic synthesis of azido-GSH did not affect the total thiol content of the 
cell. Clickable glutathione approach sensitively detected glutathionylated proteins in 
response to low concentrations of H2O2. Compared to other methods, azido functional 
group is small and tolerated by cellular redox enzymes such as GRX1. Pulse-chase 
experiment, where cells were induced for de-glutathionylation by removing ROS 
containing medium, showed that azido-GSH containing proteins readily undergo 
deglutathionylation by intracellular redox enzymes. In vitro GRX1 assay data also 
supported towards similar conclusion that azido-GSH can be tolerated by redox enzymes 
unlike other bulky glutathione derivatives such as BIOGEE.    
One advantage of clickable glutathione approach is it can couple with mass 
spectrometry for the identification of glutathionylated proteins and their modified cysteine 
residues. Our data indicated that azido-GSH can use to enrich glutathionylated proteins 
by biotin pull-down. Bioorthogonal click reaction allows selective detection and 
enrichment of glutathionylated proteins. This method can be improved to identify those 
proteins after trypsin digestion and LC-MS/MS analysis. Further, this method can be used 
to identify modified cysteine residues by using a cleavable biotin-alkyne with click 
reaction. Selective cleavage of glutathionylated peptides can identify by mass 
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spectrometry. In addition to identification by mass spectrometry, azido-GSH also can be 
used to identify or used to validate glutathionylated proteins by Western blotting. 
Immunoprecipitation of individual proteins and on bead click reaction with biotin-alkyne 
identified several known glutathionylated proteins by probing with streptavidin-HRP.  This, 
can also be approached by doing biotin pull-down with clicked lysate and subsequent 
analysis of eluted proteins by primary antibodies against protein of interest. Another 
important application of clickable glutathione approach is that visualization of 
glutathionylated proteins by fluorescence imaging in live or fixed cells. Our data indicated 
that glutathionylated proteins can be readily visualized by cellular fluorescence without 
using antibodies. This approach can further improve to visualize individual 
glutathionylated proteins by coupling with other advanced technologies such as proximity 
ligation assay. In future, these applications will allow to study the effect of site specific 
glutathionylation on protein interaction and their cellular localization.  Overall, we have 
generated GS M4 mutant that catalyzes the synthesis of azido-GSH with high catalytic 
efficiency, in cells. Thus, our chemical approach with clickable glutathione provides a 
chemoselective and versatile handle for studying glutathionylation without altering the 
thiol content of the cell.  
2.5 Experimental procedure 
2.5.1 Reagents and materials 
N-Ethylmaleimide (NEM), 5-(Iodoacetamido)fluorescein (FL-IA), phosphoenol 
pyruvate (PEP), adenosine 5′-triphosphate disodium salt hydrate (ATP),  type II rabbit 
muscle lactate dehydrogenase (LDH), type II rabbit muscle pyruvate kinase (PK), γ-
glutamylcysteine, β-nicotinamide adenine dinucleotide, reduced disodium salt hydrate 
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(NADH), L-glycine (Gly), L-alanine (Ala), L-methionine (Met), L-valine (Val), copper(I) 
bromide, anti-FLAG antibody and anti-GS antibody were purchased from Sigma Aldrich. 
Streptavidin-horseradish peroxidase (HRP) was purchased from Thermo Scientific. HRP-
conjugated anti-mouse and anti-rabbit secondary antibodies were purchased from GE 
healthcare (U.K). Polyethyleneimine “MAX” was purchased from Polysciences, Inc 
(USA). 3-Azido-L-alanine HCl (L-AzidoAla) was purchased from Jena Bioscience 
(Germany). L-homopropargyl-glycine (HPG) and L-propargyl-glycine (PG) were 
purchased from Life Technologies and Pep-Tech Corporation, respectively. Ni-NTA 
agarose was purchased from QIAGEN. EDTA-free protease inhibitor cocktail was 
purchased from Roche. All cell culture reagents and medium were purchased from Life 
Technologies. 
2.5.2 Competent cell preparation 
DH5α cells were used to extract plasmid DNA and BL21 cells were used for protein 
overexpression. To generate chemically competent DH5α and BL21 cells, first, a tiny 
amount from both cell stocks were streaked on two separate agar plates without any 
antibiotic. Agar plates were incubated in a bacterial incubator at 37 oC for overnight 
(approximately 16 h). On the following day, a single colony was inoculated in a 5 mL of 
Luria broth (LB) medium without any antibiotic and incubated in a bacterial shaker for 16 
h. LB media (5 mL) containing bacterial cells were diluted into an autoclaved 1 L LB 
medium and incubated in a bacterial shaker until OD600 reach to 0.4. Then cells were 
transferred into autoclaved, ice-cold centrifuge bottles and cells were harvested by 
spinning at 5000 rpm for 15 minutes. After this step, all other steps were done on ice or 
at 4 0C. Cells were washed once with sterile filtered ice-cold 100 mL of 100 mM MgCl2 
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solution and centrifuged to remove supernatant. Then cells were re-suspended in 100 mL 
of 100 mM CaCl2 and incubated for 20 minutes. After centrifugation, supernatant was 
removed and the resultant pellet was re-suspended in 100 mL of 85 mM CaCl2 and 15% 
glycerol (v/v) and incubated for another 30 minutes. After the 30 minute incubation, cells 
were collected by centrifugation and re-suspended in 10 mL of 85 mM CaCl2 and 15% 
glycerol (v/v) and aliquoted (100 µL) into autoclaved and chilled eppendorf tubes. 
Competent cells were flash frozen in liquid nitrogen and stored in -80 0C freezer.     
2.5.3 Long term storage of bacterial cells 
 A single colony was inoculated in 5 mL of LB media and incubated for 16 h in a 
bacterial shaker at 37 0C. In the following day, a portion (750 µL) of overnight culture was 
mixed with 250 µL of autoclaved 65% glycerol in an eppendorf tube, flash froze in liquid 
nitrogen and stored in -80 0C freezer. 
2.5.4 Bacterial transformation  
 An aliquot of competent DH5α or BL21 cells were thawed in ice. Once competent 
cells are thawed, 50 µL of cells were mixed with ice-cold plasmid DNA (50 ng) and 
incubated on ice for 20 minutes. Then tubes were incubated in a heat block at 42 0C for 
45 seconds and immediately placed on ice for another 2 minutes. Then cells were mixed 
with 400 µL of super optimal broth with catabolite repression (SOC) medium and 
incubated for 30 minutes in a bacterial shaker at 37 0C. Then cells were briefly collected 
by centrifugation at 4000 rpm for 5 minutes and a half of media was removed and cells 
were re-suspended in the rest of medium and evenly spread on agar plates containing 
appropriate antibiotic. Plates were then incubated in a bacterial incubator at 37 0C for 16 
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h. Always included a negative control (cells without DNA) for the confirmation and to 
check for possible contamination. 
2.5.5 Plasmid DNA isolation (mini and maxiprep)  
A clump from cell stock containing plasmid DNA was inoculated in LB (5 mL for 
miniprep and 250 mL for maxiprep) containing appropriate antibiotic and incubated in a 
bacterial shaker (200 rpm) at 37 0C for 16 h. Overnight 5 mL culture was centrifuged 
(4000 rpm for 5 min) and cell pellet was resuspended in 250 µL of P1 solubilizing buffer 
(50 mM Tris-Cl, pH 8.0, 10 mM EDTA, 100 μg/mL RNAse A). Then cells were incubated 
with 250 µL of P2 lysis buffer (200 mM sodium hydroxide, 1% SDS) for 3-5 minutes (no 
more than 5 minutes). Lysis buffer was neutralized with the addition of 350 µL N3 buffer 
(3.0 M potassium acetate, pH 5.5) and incubated for 5 minutes at room temperature. Cell 
debris were precipitated by centrifugation at 13 000 rpm for 10 minutes. Clear cell lysate 
was carefully transferred to DNA binding spin columns without any solid debris. Extracted 
plasmid DNA was bound to the membrane after high speed centrifugation at 13 000 rpm 
for 1 minute and flow through was discarded. Then spin columns were washed twice with 
500 µL of washing buffer (Qiagen) and liquid was discarded by high speed centrifugation 
after each wash. Bound DNA was eluted with 50 µL water by centrifugation at high speed 
for 1 minute. DNA concentrations were measured by nanodrop before using in cloning 
procedures. For DNA purification by maxiprep, manufacturer protocol was followed as 
described in protocols under product number K0491 from ThermoFisher Scientific.  
2.5.5 Subcloning  
2.5.5.1 Polymerase chain reaction (PCR)  
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GS WT gene was amplified from pCMV6-GS vector by performing Polymerase 
chain reaction (PCR). PCR was carried out using a thermocycler (Eppendorf Mastercycler 
Gradient). Approximately 50 ng of plasmid DNA (2 μL from 50 ng/uL stock) containing GS 
WT gene incubated with 5 µL of 10X ultra pfu buffer, (200 mM Tris, 100 mM (NH4)2SO4, 
100 mM KCl, 1% TritonX-100, 20 mM MgSO4, 1 mg/mL BSA, pH 8.8), forward and 
reverse primers (1 μL from 10 μM stocks), and dNTPs (2 μL of 10 mM; 2.5 mM of each 
base). The final PCR reaction volume adjusted to 49 μL by adding deionized water.  After 
mixing well, 1 μL of Pfu ultra-enzyme was added and incubated in a thermocycler 
programmed as indicated in the Table 2.2. Amplified DNA was purified by gel extraction 
method after running a DNA agarose gel as described in QIAgen gel extraction kit (cat # 
28704). 
Table 2.2 - PCR program for GS amplification. 
Cycle Temp (0C) Time Number of 
cycles 
Initial denaturation 95  5 min 1 
Denaturation 95 45 sec 
 
35 
 
35 
Annealing 65 
 
45 sec 
Extension 72 1.5 min 
Final extension 72 15 min 1 
 
2.5.5.2 Restriction digestion 
GS WT gene was inserted into pET28A (Novagen Catalogue number – 698643) 
bacterial expression vector after double restriction digestion with NdeI and HindIII. 
Amplified GS WT (1 μg) were incubated with 5 μL of 10X cutsmart NEB buffer and 1 μL 
from each NdeI (20,000 units/mL) and HindIII-HF (20,000 units/mL) restriction enzyme, 1 
69 
 
μL from 10 mg/mL BSA stock and finally reaction volume was set to 50 μL with deionized 
water. After mixing well, reaction mixture was incubated in an incubator at 37 0C. After 1 
h of incubation, 10 μL from 6X DNA loading dye (10 mM Tris-HCl (pH 7.6) 0.03% 
bromophenol blue, 0.03% xylene cyanol FF, 60% glycerol 60 mM EDTA) was added and 
digested GS gene was separated in an agarose gel (120 mV for 30 minutes) and purified 
by gel extraction. Similarly, restriction digestion by same restriction enzymes and gel 
extraction was performed for empty pET28A bacterial expression vector and used for 
ligation. 
2.5.5.3 Ligation 
 Double digested GS WT and pET28A were mixed in 1:3 ratio (0.020 pmol and 
0.060 pmol) with 2 μL of 10X T4 DNA ligase buffer, 1 μL from 100 mM ATP stock,1 μL 
from T4 DNA ligase (400,000 units/ml) and final reaction volume set to 20 μL with 
deionized water. Ligation mixture was mixed well and incubated in an incubator at 16 0C 
for 20 h. Ligase enzyme was heat inactivated by incubating ligase reaction mixture at 65 
0C for 15 min. Then mixture was chilled on ice for another 15 minutes, transformed into 
DH5α and plated on agar plates containing 50 μg/mL Kanamycin according to the protocol 
described in 2.5.4. A single colony was inoculated in LB containing 50 μg/mL Kanamycin 
and incubated for 16 h and plasmid DNA (pET28A-GSWT) was purified using the protocol 
described in section 2.5.5. After purification, DNA concentration was measured by 
nanodrop and ligation was confirmed by DNA sequencing.   
2.5.6 Site-directed QuickChange mutagenesis  
GS mutants were generated by QuickChange mutagenesis. pET28A-GSWT was 
used as the template to generate GS M1 (F152G). pET28A-GSWT 50 ng was mixed with 
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5 μL of pfu buffer. Quick change forward and reverse primers (all quick-change primers 
are listed in Table 2.4) were incubated in two separate PCR tubes with template and pfu 
buffer. After adjusting the volume to 49 μL with deionized water, 1 μL of pfu ultra enzyme 
was added to each tube. Two tubes containing above components were incubated in a 
thermocycler and subjected to 2 thermocycles as indicated in the Table 2.3. After that, 
reaction mixtures in two tubes were mixed together and incubated in the thermocycler for 
another 18 cycles using the program shown in table 2.3. Reaction mixture was then 
incubated with 1 μL of Dpn1 (20,000 units/mL) for 1 h at 37 0C. Finally, 2 μL from Dpn1 
digested PCR reaction was transformed into DH5α using the protocol described in section 
2.5.4. 
Table 2.3 - PCR program for QuickChange mutagenesis. 
Cycle Temp (0C) Time Number of 
cycles 
Initial denaturation 95  5 min 1 
Denaturation 95 45 sec 
 
2 or 18 
 
35 
Annealing 55 
 
45 sec 
Extension 72 10 min 
Final extension 72 20 min 1 
 4 Hold  
 
Table 2.4 - QuickChange primers for GS mutants.  
Mutant enzyme Primer sequence 5’ to 3’ 
 F-primer GAA ATC  AAC  ACC  ATC  TCT GCC  AGC  GGT  
GGG  GGC  CTG  GCC  TCC  
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GSM1 R-primer GGA GGC CAG  GCC  CCC  ACC  GCT  GGC  AGA  
GAT  GGT  GTT  GAT  TTC 
GSM2 F-primer GAA  ATC  AAC  ACC  ATC  TCT GCC  GGC  GGT  
GGG  GGC  CTG  GCC TCC 
R-primer GGA  GGC  CAG  GCC  CCC  ACC  GCC  GGC  
AGA  GAT  GGT  GTT  GAT TTC 
GSM3 F-primer GAA  ATC  AAC  ACC  ATC  TCT GCC  GGC  TTT  
GGG  GGC  CTG  GCC TCC             
R-primer GGA  GGC  CAG  GCC  CCC  AAA GCC  GGC  AGA  
GAT  GGT  GTT  GAT TTC 
GS M4 F-primer GAA  ATC  AAC  ACC  ATC  TCT GCC  GGC  GCT  
GGG  GGC  CTG  GCC TCC 
R-primer GGA  GGC  CAG  GCC  CCC  AGC  GCC  GGC  
AGA  GAT  GGT  GTT  GAT TTC 
 
2.5.7 Generation of expression vectors 
Wild type GS (GS WT) gene was amplified by PCR using a forward primer with 
NdeI restriction site (5'-GGT GGT CATATG GCC ACC AAC TGG GGG AGC-3') and a 
reverse primer with Hind III restriction site (5'-GGT GGT AAGCTT CTA CAC AGG GTA 
TGG GTT GTC CAG GAC TGC-3'). Amplified GS WT PCR products were subcloned into 
the pET28a bacterial expression vector. All GS mutant (M1, M2, M3 and M4) constructs 
were made using pET28a-GS WT as the template by site-directed quick-change 
mutagenesis (Primers used in QuickChange mutagenesis listed in the Table S1). GS M2 
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clone was PCR amplified using a forward primer with HindIII restriction site and N- 
terminal FLAG-tag sequence (5'-GGT GGT AAG CTT ATG GAT TAC AAG GAT GAC 
GAT GAC AAG ATG GCC ACC AAC TGG GGG AGC-3') and a reverse primer with XhoI 
restriction site (5'-GGT GGT CTCGAG CTA CAC AGG GTA TGG GTT GTC CAG GAC 
TGC-3'). Amplified GS M2 PCR product was sub-cloned into the pCDNA3.1(+) 
mammalian expression vector. QuickChange mutagenesis was performed using 
pCDNA3.1-GS M2 as the template to introduce Kozak sequence with a forward primer 
(5'-GCT AGC GTT TAA ACT TAA GCT TGC CAC CAT GGA TTA CAA GGA TGA CG-
3') and a reverse primer (5'-CGT CAT CCT TGT AAT CCA TGG TGG CAA GCT TAA 
GTT TAA ACG CTA GC-3'). pCDNA3.1-GS M2 plasmid was used to generate GS M4 for 
mammalian expression. For glutaredoxin (GRX1), the gene was amplified by PCR using 
a forward primer (5’-GAC GAC CAT ATG GCT CAA GAG TTT GTG AAC TGC-3’) and a 
reverse primer (5’-GGT GGT AAG CTT CTA CTG CAG AGC TCC AAT CTG CTT TAG-
3’).  GRX1 PCR product was subcloned into pET28a. All cloned plasmids were confirmed 
by DNA sequencing of entire open reading frames.   
2.5.8 Bacterial protein expression and purification 
All the bacterial expression constructs were transformed into E. coli BL21 (DE3) 
cells and transformed cells were inoculated in Luria broth (LB) media containing 
Kanamycin (50 μg/mL), and incubated overnight at 37 oC in a bacterial shaker. Growing 
bacterial cells were diluted into 1L of LB media containing kanamycin. Cells were grown 
at 37 oC until OD600nm reached at 0.8 and then induced with isopropyl-1-thio-β-D-
galactopyranoside (IPTG) (0.4 mM) at 16 oC. After 20 h of induction, cells were collected 
by centrifugation at 4,000 rpm for 20 min at 4 oC. Collected cells were re-suspended in 
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lysis buffer (50 mM Tris-HCl pH 8.3, 300 mM NaCl and 10 mM imidazole) and lysed by 
double passing through a chilled French press at 1,000 psi. After removing the cell debris 
by high speed centrifugation at 14,000 rpm for 30 min at 4 oC, supernatant was incubated 
with Ni-NTA beads (prewashed with lysis buffer) for 1 h at 4 oC. Lysates were then drained 
and beads were washed three times with wash buffer (50 mM Tris-HCl pH 8.3, 300 mM 
NaCl) containing 25 mM imidazole and His-tagged GS protein was eluted with elution 
buffer (50 mM Tris-HCl pH 8.3, 300 mM NaCl) containing 300 mM imidazole. Positive 
fractions were collected and dialyzed against 50 mM Tris buffer pH 7.4, 10% glycerol and 
1 mM DTT overnight, followed by concentrated using a centrifugal filter device (Millipore). 
Protein concentration was measured by Bradford assay (Bio-Rad) using bovine serum 
albumin as the standard. Grx1 was expressed as described above, but with induction at 
37 oC for 5 h.  
2.5.9 Enzyme assay 
Kinetics parameters for GS WT and other GS mutants were determined by 
measuring consumption of NADH with ATP-regenerating system, pyruvate kinase (PK) 
and lactate dehydrogenase (LDH).S4 The NADH consumption was monitored by UV 
absorbance at 340 nm. The reaction mixture (0.2 mL) contained 100 mM Tris-HCl buffer 
(pH 7.4), 150 mM NaCl, 25 mM MgCl2, 0.2 mM NADH, 2 mM phosphoenolpyruvate 
(PEP), 5 mM ATP, 15 units of LDH, 10 units of PK, 2 mM γ-glutamylcysteine and 0.5 μg 
of GS enzyme. Different amino acids, including Gly and L-azido-Ala, were used as 
substrates ranging from 0.01 mM to 5 mM while γ-glutamylcysteine was kept at saturated 
levels. Reactions were started by adding 0.5 or 1 μg of GS WT or mutants, and the 
decrease of absorbance was measured at 340 nm using DU730-Beckman coulter UV/Vis 
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spectrophotometer. To calculate initial rates for different substrate concentrations, the 
linear region of the curve was considered. Initial rates were then fitted to the Michaelis-
Menten equation V = Vmax [S] / (Km + [S]) using Graphpad prism 5.01 to calculate Km and 
Kcat values for individual substrates.  
2.5.10 Cell culture 
Human embryonic kidney (HEK) 293 cells were grown in high glucose Dulbecco’s 
Modiﬁed Eagle’s Medium (DMEM) supplemented with heat inactivated 10% fetal bovine 
serum (FBS) and 5 U/mL of penicillin and 5 μg/mL of streptomycin. Cells were plated at 
least two days before being subjected to any experimental procedure in a humidified 
incubator at 37 oC and 5% CO2.  
2.5.11 Starting a new cell line 
A cell stock stored in liquid nitrogen vapor phase was taken out and thawed in 37 
oC water bath. Then cells were centrifuged at 1000 rpm for 5 minutes and supernatant 
was discarded. Cell pellet was resuspended in 1mL of complete medium and transferred 
to a 10 cm dish containing 9 mL of complete DMEM medium. Cells were incubated in a 
humidified incubator at 37 oC and 5% CO2.    
2.5.12 Mammalian cell splitting  
When HEK293 cells are nearly 80-90% confluent, cells were washed with 10 mL 
of warm PBS. Then, 1 mL of 0.25% trypsine-EDTA solution was added to a10 cm dish 
(0.5 mL for 6 cm dish) and incubated for 3-5 minutes at 37 oC. After trypsinization, 10 mL 
of complete DMEM medium was added to neutralize trypsin activity and cells were 
resuspended to avoid clumping. Then 1 mL of trypsinized cells were transferred to fresh 
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sterile 10 cm dishes containing 9 mL of complete DMEM medium and incubated in the 
humidified incubator at 37 oC and 5% CO2.                     
2.5.13 PEI-max transfection 
When cells were about 70-80% confluent, GS M4 was transfected using 
polyethylenimine (PEI-max) as the transfecting agent. A stock solution of PEI-max was 
prepared by dissolving 10 mg of PEI-max in 1 mL of autoclaved deionized water. Then 
solution was basified with 6 M NaOH until pH reached 7-7.5. After adjusting pH, stock 
solution was sterile filtered using a syringe filter (0.2 µm, 13 mm). Working solution of 1 
mg/mL PEI-max solution was prepared by 10 times dilution of 10X stock solution in sterile 
water. First, cell culture media was removed from 10 cm dishes and replaced with 9 mL 
of DMEM without penstrep and FBS. To two1.5 eppendorf tubes, 500 µL of DMEM without 
penstrep and FBS was added.  To a one tube, 12 µL of 1X PEI-max was added and to 
the other tube, 5 µg of DNA was added and incubated for 10 minutes in room temperature. 
After ten minutes, both tubes were mixed together and a single tube containing PEI-max 
and DNA was incubated for another 15 minutes at room temperature. Then 1 mL of DNA-
PEI-max complex was added dropwise to a single 10 cm dish, mixed gently and incubated 
in a mammalian cell culture incubator. After 6 h, medium containing DNA-PEI-max 
complex was removed and cells were incubated for another 18 or 42 h in fresh complete 
DMEM medium.  
2.5.14 Cell lysis 
To detect glutathionylation sensitively, cells must lyse immediately after removing 
ROS containing medium.  Lysis buffer was prepared by adding 1 mL of 10% SDS, 1 mL 
of IGEPAL, 100 µL of TWEEN-20 to 98 mL of Tris buffer saline (TBS, pH-7.4, 150 mM 
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NaCl). TBS lysis buffer can store in cold room for months. To make 1 mL of complete 
lysis buffer, 100 µL of protease cocktail mixture (prepared by dissolving one crushed 
protease tablet in 2 mL of sterile water) and 50 µL from 1 M N-ethylmaleimide (NEM) 
were mixed with 850 µL of TBS lysis buffer. Lysis buffer was kept on ice until use. Cells 
were washed once with ice-cold PBS and all remaining liquids were aspirated in to the 
waste container.  Then 500 µL of lysis buffer was immediately added on to the cells and 
cells were scraped out with a cell lifter. Cells were collected by lifting cell culture dish to 
a 45-degree angle and with a 1mL pipet. Tubes containing cells and lysis buffer were 
placed in a rotary shaker for 30 minutes at 4 0C. After incubation, cell debris were removed 
and clear cell lysate was collected to a fresh eppendorf tube after centrifugation at 14,000 
rpm for 20 minutes.   
2.5.15 Sodium Dodecyl Sulfate Polyacrylamide Gel Electrophoresis (SDS-PAGE) 
SDS-PAGE gel was prepared using separating and stacking buffers. Prior to that, 
glass plates (1.5 mm, BioRad) were washed and dried before mounting on the gel 
preparing rack. Separating bufer mixture for 12% gel was prepared by mixing 2 mL of 4X 
Tris/SDS buffer (1.5 M Tris, 0.24 M HCl; pH 8.8, 0.4% SDS), 2.4 mL of 40% acrylamide 
(BioRad; 37:1), 3.62 mL of distilled water, 80 µL of 10% (w/v) of freshly made ammonium 
persulfate (APS) and 8 µL of N, N, N’, N’-tetramethylthylenediamine (TEMED; Sigma) 
and carefully added in between the glass plate up to ¾ of the short glass plate. After 
pouring separating layer, methanol or isopropanol was immedietly added over the 
separating layer. After 30 minutes, stacking buffer mixture was prepared (by mixing 1 mL 
of 4X Tris/SDS buffer (1.5 M Tris, 0.24 M HCl; pH 6.8, 0.4% SDS), 0.5 mL of 40% 
acrylamide, 2.48 mL of distilled water, 20 µL of fresh 10% (w/v)  APS, and 4 µL TEMED) 
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and poured over the separating layer after removing methanol or isopropanol and drying. 
Immediately after pouring the stacking layer, 10-well or 15-well comb was put through the 
glass plates and kept for another 30 minutes before using. Once samples are ready for 
electophoretic separation, comb was removed and transferred to the SDS-PAGE running 
container together with electrodes. Then, SDS-running buffer (1X; 0.025 M Tris; 0.05 M 
glycine 0.5% SDS) was poured up to the level indicated in the container and closed the 
lid before running for desired time at 150 V or 200 V. After running the gel, glass plates 
were separated, gel was exposed and washed with water before staining or Western 
blotting.   
2.5.16 Coommassie staining 
After running  SDS-PAGE, protein contaning gel was washed twice in distilled 
water and fixed in fixing solution (50% methanol and 10 glacial acetic acid) for 30 minutes. 
Then fixing solution was discarded and the gel was stained in staining solution (0.1% 
Coomassie Brilliant Blue R-250 in 50% methanol and 10 % glacial acetic acid) for 1 h 
after microvawing for 1 minute at full power or incubated overnight without microvawing. 
Before destaining, gel was washed three times with distilled water to remove excess 
staining solution. Then the gel was destained  in 40% methanol and 10% glacial acetic 
acid overnight. The destained gel stored in 5% glacial aceic acid until imaging.  
2.5.17 Western blotting 
To transfer protein bands in SDS-PAGE gel to a PVDF membrane, Westen blotting 
was carried out. First, stacking layer of the gel was removed and separarting layer was 
washed several times using distilled water and transfer buffer (10% methanol,24 mM Tris 
and 194 mM glycine). To make the gel sandwich, black side of the cassette was placed 
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on the surface of the bench and pre-wetted fiber pad was placed on the top of it. Then 
pre-wetted filter paper and the gel was placed on the fiber pad one after the other. Then 
pre-wetted membrane was placed on the top of the gel followed by the second filter paper 
and fiber pad to complete the sandwich. At this stage, it is critical to remove any air 
bubbles from the membrane before closing and locking the cassette. Place the cassette 
in the module facing black side of the cassette to black side of the module. Take the whole 
set up to the transfer container with an ice block and fill the tank with transfer buffer. 
Transfer is carried out at 90 V for 2 h on ice. After the transfer, cassette was unlocked by 
unclamping the white latch and fiber and filter paper was removed. The membrane was 
washed once with 1X TBST and proceeded to the antibody probing.  
2.5.18 Metabolic labeling and click reaction 
At 70-80% confluence, 2.5 μg of GS M4 plasmid was transfected using PEI-Max 
as the transfecting agent in 6 cm dishes. After 48 hours, different concentrations of L-
azido-Ala, HPG and PG were incubated (separately in individual experiments) with cells 
for another 20 h or varying time periods. Cells were then treated with hydrogen peroxide 
for 15 min. For glutathionylation turn-over studies, the medium containing hydrogen 
peroxide was removed and replaced by fresh medium. Cells were then lysed in TBS-
Tween lysis (50 mM Tris-HCl, 150 mM NaCl, 0.1% SDS, 1% IGEPAL, 0.1% TWEEN-20) 
containing 50 mM N-ethylmaleimide and EDTA-free protease inhibitor. Protein 
concentration was determined by Bradford assay. For click reactions, 100 μg of cell 
lysates were precipitated by adding cold acetone (4 times volume to cell lysates) and 
incubation at -20 oC for 1 hour. The precipitate was re-dissolved in 100 mM Tris buffer pH 
7.4. Lysates were then mixed with click reagents, [0.1 mM biotin-alkyne, rhodamine-
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alkyne or rhodamine-azide, 0.2 mM Tris[(1-benzyl-1H-1,2,3-triazol-4-yl)methyl]amine 
(TBTA) and 0.4 mM CuBr] for 1 h at RT. To monitor in vitro deglutathionylation by Grx1 
enzyme, lysate was incubated with 10 µg of purified GRX1 in the presence of 1.5 mM 
GSH for 30 min at 37 oC. Lysates were then subjected to click reactions. Lysates labeled 
by click reaction were resolved on 12% SDS-PAGE, followed by Western blotting or direct 
detection of in-gel fluorescence. After transferring to PVDF membrane, the membrane 
was blocked with 5% BSA in TBST (50 mM Tris-HCl, 150 mM NaCl, 0.1% Tween) and 
incubated with streptavidin-HRP (1:1000) in 5% BSA in TBST for 2 h at RT, and analyzed 
for chemiluminescence to visualize biotinylated proteome. Anti-GS (1:1000) and anti-
FLAG antibody (1:1000) and appropriate HRP-conjugated secondary antibodies were 
used to visualize expression levels of GS WT or M4 mutant. 
2.5.19 LC-MS analysis of glutathione  
To monitor in vitro biosynthesis of glutathione and glutathione derivatives, in vitro 
assay was analyzed by LC-MS (SHIMADZU, Nexera X2). In a reaction mixture, 5 mM γ-
glutamylcysteine, 10 mM ATP, 5 mM Gly, 5 mM Met and 5 mM Azido-Ala were incubated 
with GS WT, GS M4, or a mixture of GS WT and GS M4 in a ratio of 1:5 for 2 h at 37 oC. 
The reaction was quenched by spin-filtering enzymes with centrifugal device (MW cutoff 
3,000 Da, Millipore). The filtrate free of proteins was treated with fluorescein-
iodoacetamide (FL-IA) (1.5 mM) for 1 h at RT and injected into LC-MS. To monitor 
biosynthesis of azido-glutathione in cells, cells were lysed in 1xPBS by repeating freeze-
thaw three times in the presence or absence FL-IA. Lysates were spin-filtered through 
centrifugal device (MW cutoff 3,000 Da) to remove proteins. Proteins-free filtrate was then 
injected into LC-MS.  In mass ion chromatogram, the masses corresponding to 
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glutathione or glutathione derivatives were extracted. Individual mass extraction ion 
chromatograms were overlaid.  
2.5.20 Bromobimane assay  
To calculate the overall thiol content, protein-free lysates were incubated with 0.5 
mM bromobimaneS5 in 0.1 M Tris buffer for 30 min at 25 oC in the dark. Fluorescence (λex 
390 nm and λem 478 nm) was measured using Synergy H1 Hybrid Multi-Mode Microplate 
Reader (Biotek).  
2.5.21 Fluorescence imaging of glutathionylation 
HEK 293 cells were grown on glass cover slips in a six well plate. At about 40% 
confluence, HEK 293 cells were transfected with GS M4 mutant, using PEI-Max as the 
transfecting agent. Cells with or without GS M4 mutant were incubated with L-azido-Ala 
(1 mM) for 20 h, and treated with H2O2 (1 mM) for 15 min. Cells were then washed with 
PBS once, fixed with cold methanol for 15 min at -20 oC, and washed with PBS three 
times. All free thiols were blocked by N-ethylmaleimide (50 mM) for 15 min at RT. After 
washing with PBS, cells were blocked with 1xTBS containing 0.1% TWEEN-20 and 3% 
BSA for 30 min at RT. Cells were rinsed twice with PBS, and subjected to click reaction 
in 1xTBS in the presence of TBTA (0.1mM) and CuBr (0.2 mM) and Alexa Fluor 647-
alkyne (Invitrogen) (20 μM) for 30 min at RT. After extensive washing with PBS, the glass 
cover slips were mounted on microscope slides with a mounting solution containing DAPI. 
Slides were stored at 4 oC in dark until imaging. Fluorescence images were monitored 
and captured with Olympus fluorescence microscopy (BX 41) for nucleus staining with a 
DAPI channel (λex 350 nm, λem 470 nm) or for glutathionylation with Cy5 channel (λex 650 
nm, λem 670 nm).  
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2.5.22 Enrichment of glutathionylated proteins by streptavidin-agarose 
HEK 293 cell lysates (2 mg) were prepared after GS M4 transfection and 
incubation of L-AzidoAla (1 mM). Lysates were subjected to click reaction with biotin-
alkyne. Reaction was performed at RT for 1 h in 1xTBS (0.5 mL) containing 0.2 mM biotin-
alkyne, 0.4 mM TBTA and 1 mM CuBr with gentle vortex at least twice during the reaction. 
Each reaction tube was incubated with1 mL of ice-cold acetone for 30 minutes at -20 0C. 
Precipitated proteins were centrifuged at 6500xg for 4 min. Protein pellets were washed 
with cold methanol (0.5 mL) twice, followed by centrifugation. Proteins were re-dissolved 
with a brief sonication in 1xTBST (0.2 mL) containing 1.2% SDS. The final SDS 
concentration was diluted to 0.2% by adding 1xTBST (1 mL). Proteins were then mixed 
with pre-washed streptavidin-agarose beads (100 μL) for 1 h at RT. Streptavidin-agarose 
beads were washed three times with 1xTBST and eluted with 1X SDS loading buffer (100 
μL). Proteins were separated by SDS-PAGE. Enriched glutathionylated proteins were 
visualized by silver staining.     
2.5.23 Identification of individual glutathionylated proteins (Immunoprecipitation 
and on bead click) 
HEK 293 cell lysates (1 mg) were prepared after GS M4 transfection and 
incubation of L-AzidoAla (1 mM). Lysates were incubated with primary antibodies for 
PTP1B (Santacruz) and HSP90 (BD Bioscience) at 4 oC. After 1 hour, cell lysates were 
incubated with pre-washed protein G agarose (Invitrogen) (50 μL) overnight at 4 oC. After 
washing three times with 1xTBST (0.5 mL), proteins on beads were subjected to on bead-
click reaction with biotin-alkyne. Click reaction was performed in 1xTBST containing 
biotin-alkyne (0.2 mM), TBTA (0.4 mM) and CuBr (1 mM) for 20 h at 4 oC. Proteins on 
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beads were then washed with TBST (1 mL) three times and eluted with a SDS-loading 
buffer. Eluted samples were separated on SDS-PAGE, and probed with streptavidin-HRP 
(1:1000, 3% BSA in TBST) or primary antibodies for PTP1B (1:1000 dilution) and HSP90 
(1:1000 dilution), followed by secondary antibodies.   
2.5.24 Determination of protein concentration using Bradford protein assay 
Cell lysates were diluted by 20X and 40X using distilled water. First, 19 µL and 39 
µL of distilled water were transferred to two 500 µL eppendorf tubes. Then 1 µL from 
lysate was mixed in each tube to give 20X and 40X diluted lysates. Out of 20 µL and 40 
µL of total diluted mixture, 10 µL was pipetted out and transferred to two wells of clear 
96-well plate. Then 200 µL from quick start 1X Bradford reagent was mixed and air 
bubbles were removed using a needle. Absorbance was then measured at 595 nm using 
a plate reader. Lysate concentrations were calculated using the standard curve equation.  
For standard curve, 10 mg/mL BSA was serially diluted to make 0.5, 0.4, 0.25, 0.15 and 
0.05 mg/mL.  In a similar manner, 10 µL from each standard BSA solution was mixed with 
200 µL of quick start 1X Bradford reagent and absorbance was measured at 595 nm.  
2.5.25 Silver staining 
After electrophoresis, gel was washed for 5 minutes with distilled water. Washing 
continued for another two times before fixation. Then gel was incubated in fixing solution 
(30% ethanol, 10% acetic acid) for 15 minutes. Fixing solution was discarded and fix 
again with fresh fixing solution for 15 minutes. After fixation, gel was washed twice with 
10% ethanol solution for 10 minutes at room temperature followed by two time washing 
with distilled water for another 10 minutes. Sensitizer solution (Pierce Silver Stain Kit, 
catalog number 24612) was prepared by mixing 25 µL of sensitizer solution in 10 mL of 
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distilled water and the gel was sensitized for 1 minute and two washings with distilled 
water for 1 minute each. Next, gel was stained in stain working solution (0.5 mL of Silver 
Stain Enhancer in 10 mL of Stain solution) for 30 minutes. Gel was washed with distilled 
water for 20 seconds twice quickly before developing the stain with developer working 
solution (0.25 µL of Enhancer in 10 mL of Developer solution) for 3-5 minutes until protein 
bands appear. Staining was quenched by the addition of 5% acetic acid solution. Gel was 
washed well with distilled water before taking pictures.   
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CHAPTER 3 CHARACTERIZATION OF GLUTATHIONYLATED PROTEINS IN 
RESPONSE TO METABOLIC ALTERATION 
3.1 Introduction 
Glucose metabolism provides necessary metabolites for generation of ATP via the 
electron transport chain (ETC) in mitochondria (227). Reactive oxygen species (ROS) are 
produced in mitochondria as a byproduct of respiration (228). Many cancer cells have an 
elevated level of ROS when compared to normal cells, partially due to their increased 
cellular metabolism (229). Importantly, glucose or its metabolite is fluxed into pentose 
phosphate pathway (PPP) to generate NADPH, a reducing source for many redox 
enzymes that are important for maintaining redox homeostasis. Therefore, cancer cells 
appear to rely on excess glucose availability and its metabolism for both energy 
generation and redox homeostasis (230). An elevated level of mitochondrial ROS in 
cancer cells can trigger redox-mediated signaling associated with cancer cell phenotypes, 
such as increased proliferation rate, decreased apoptosis, cell survival and migration 
(231-234). Similarly, high levels of mROS were observed in pancreatic β cells, in 
response to high glucose or hyperglycemia (235-237).    
On the other hand, a low concentration of glucose in cells also induces generation 
of ROS (238,239). One study showed that increased levels of H2O2 and superoxide were 
produced in isolated rat β cells when they were exposed to a low concentration of glucose 
(0-5 mM) (240). Similar response was observed also in several insulin-secreting cells 
(241,242). Cells with a low level of glucose can produce superoxide specifically by 
mitochondrial complex 1. ROS production is further intensified, partially due to a low 
expression level or activity of anti-oxidant enzymes (243-246). Under these conditions, it 
was shown that AMP activated kinase (AMPK) initiates apoptosis in pancreatic β cells 
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(247). Since AMPK activation is interconnected with mTOR/autophagic pathway, a low 
level of cellular glucose also plays a role in autophagy (248,249).  
In addition, it is reported that glucose depletion together with hypoxia increases 
the production of ROS via activating unfolded protein response (UPR) (250). The UPR is 
known to induce ROS by several enzyme-catalyzed reactions, such as protein disulfide 
isomerase and ER oxidoreductin 1 (251,252). UPR is also associated with cell death by 
inducing apoptosis through activating ATF4, C/EBP-homologous protein (CHOP) and 
caspases-12, highlighting significant cellular phenotypes in response to glucose depletion 
or metabolism (250,253,254). It is further shown that glucose deprivation induces cell 
death in MCF7/ADR cells via activation of mitogen-activated protein kinase (MAPK) 
pathway (255).  
NADPH is an essential reducing agent, which is important for maintaining cellular 
redox homeostasis (256). PPP is one of NADPH synthesizing processes in cell. In cancer 
cells, glucose is fluxed into PPP to produce NADPH, which is necessary for anabolic 
reactions and detoxification of reactive species. Thus, glucose depletion slows down 
NADPH production and disturbs redox homeostasis and ROS detoxification (225). 
Glucose depletion also increase ROS production in the mitochondrial electron transport 
chains, contributing to a metabolic oxidative stress in the cell (255).   
Age-related diseases, including cancer and diabetes, are associated with an 
increased production of mROS. High levels of ROS leads to mitochondrial DNA 
mutations.  Mitochondrial dysfunction is a common feature of many age-related diseases. 
Although mitochondrial dysfunction and glucose depletion are involved in production of 
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mROS, glutathionylation is not systematically evaluated under glucose depletion and/or 
mitochondrial dysfunction.   
3.2 Approach 
To induce mitochondrial ROS, we used the electron transport chain blockers. 
Antimycin A (AMA) and rotenone are well-known for blocking the ETC, which generates 
ROS at complex III and complex I, respectively (257). To investigate protein 
glutathionylation in the presence of AMA or rotenone, we employed our clickable 
glutathione approach with GS M4 mutant (211). First, we generated HEK293-GS M4 
stable cells which stably overexpress a GS M4 mutant. L-AzAla was then incubated with 
HEK293-GS M4 cells for 20 h. After serum starvation for another 4 h, cells were treated 
with AMA (2 μg/mL) with or without glucose for different time points. Glutathionylated 
proteins were visualized by a bioorthogonal click reaction using fluorophore-alkyne or 
biotin-alkyne. Glutathionylated proteins were further identified by LC/MS/MS analysis 
(Figure 15). 
 
Figure 3.1 - The work flow for identifying glutathionylated proteins in response to 
mitochondrial ROS.  
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3.3 Results 
3.3.1 Characterization of HEK293-GS M4 stable cells for the generation of azido-
GSH 
First, HEK293-GS M4 cell line was evaluated for synthesis of clickable glutathione. 
After generation of HEK293-GS M4 stable cell line, L-AzAla was incubated for the 
synthesis of azido-GSH. It was found that cells generated the similar amount of azido-
GSH (N3-GSH) to endogenous GSH within 20 h (Figure 3.2 A). In addition, a free thiol 
content and several redox enzyme levels were examined in HEK293-GS M4 stable cells. 
HEK293-GS M4 and HEK293 cells showed the similar thiol concentrations and 
expression levels of redox enzymes (Figure 3.2 B and C). Therefore, these data support 
that the stable expression of GS M4 in HEK293/GS M4 did not alter an intracellular redox 
state significantly. 
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Figure 3.2 - Evaluation of azido-glutathione (N3GSH) biosynthesis, cellular thiol 
concentration and redox enzyme levels in HEK293-GS M4 cells. (A) HEK293 cells, stably 
expressing GS M4, was incubated with (bottom) or without (top) azido-Ala for 20 h. Cell lysates 
were injected for LC-MS and extracted ion mass of endogenous glutathione (black) and azido-
glutathione (pink) were overlaid. B) Protein free cell lysates were analyzed for free thiol content 
by bromobimane assay. C) Cells were lysed using TBST (0.1% TWEEN20) and checked for redox 
enzyme levels including TRX1 and GRX1.  
3.3.2 Mitochondrial ROS and protein glutathionylation 
After confirming efficient synthesis of azido glutathione in stable cells, we next 
evaluated glutathionylation in response to mROS. To study protein glutathionylation, 
HEK293-GS M4 stable cells were incubated with azido-Ala (0.6 mM) for 20 h. Cells were 
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then washed once with PBS. After serum starvation for 4 h, different concentrations of 
AMA were added to cells for different time points with or without glucose. After click 
reaction with fluorophore-alkyne, glutathionylated proteins were visualized by in-gel 
fluorescence. An incubation of AMA to KEK293/GS M4 cells for 2 h did not induce 
glutathionylation (Figure 3.3, lane 3). However, AMA induced glutathionylation in a time-
dependent manner. Incubation of AMA for 22 h induced a significant intensity of 
glutathionylation (Figure 3.3, lane 4).  
 
Figure 3.3 - Glutathionylation in response to mitochondrial ROS generation. HEK293-GS 
M4 cells were treated with L-AzAla for 20 h. Then AMA was incubated for different time points. 
After lysing, cell lysates were subjected to click reaction with fluorophore alkyne and analyzed by 
in-gel fluorescence.  
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3.3.3 Glucose availability controls protein glutathionylation under mitochondrial 
dysfunction 
To investigate the role of cellular metabolism in glutathionylation, we evaluated 
HEK293-GS M4 cells in the presence and absence of glucose or glutamate. Cells were 
serum starved for 4 h and treated with glucose or glutamine free medium for 2 h. After 
cell lysis, lysates were analyzed for glutathionylation by in-gel fluorescence. Both glucose 
(Figure 3.4 lane 2) and glutamine (Figure 3.4 lane 4) removal did not induce 
glutathionylation within 2 h period. This suggests shorter incubation time was not 
sufficient to induce enough stress in the cells.  Next, we evaluated how glutathionylation 
will be changed upon incubation of AMA in the absence of glucose. 
 
Figure 3.4 – Glutathionylation in response to depletion of glucose and glutamate. After 
incubation of azido-Ala to HEK293-GS M4 cells for 20 h, cells were subjected to the following 
stimulus. Cells were incubated in glucose-free medium and glutamine free medium for 2h. Cells 
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were lysed and performed click reaction with cy-5 alkyne and analyzed by in-gel fluorescence 
after running SDS-PAGE. 
Cells were treated with AMA in the presence and absence of glucose. 
Glutathionylation was significantly induced within 1 h in response to AMA in the absence 
of glucose (Figure 3.5 A, lane 4, 5 and 6). On the other hand, an incubation of AMA at a 
high concentration of glucose (25 mM) did not induce glutathionylation (Figure 3.5 A, lane 
3). These data clearly indicate that glucose availability is important to induce 
glutathionylation. Also, under glucose starvation, glutathionylation was induced by AMA 
in a dose dependent manner. Importantly, the level of glutathionylation was inversely 
correlated with glucose availability. When cells were incubated with decreasing 
concentrations of glucose in the presence of AMA, the level of glutathionylation was 
increased, indicating dependence of glutathionylation on glucose availability (Figure 3.5 
C). 
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Figure 3.5 - Protein glutathionylation is highly dependent on glucose metabolism in the 
presence of the electron transport chain blocker. After incubation of azido-Ala to HEK293-GS 
M4 cells, cells were subjected to the following stimulus. (A) glucose starvation with antimycin A in 
a time-dependent manner, (B) glucose starvation with an increasing concentration of antimycin 
A, (C) decreasing glucose concentrations with antimycin A. After stimulus, cell lysates were 
subjected to click reaction with rhodamine-alkyne, and analyzed for in-gel fluorescence. 
 
 
Figure 3.6 - Glutathionylation under physiological glucose concentration. L-AzAla treated 
cells were incubated in 5 mM glucose containing medium for different time intervals with or without 
AMA treatment. After lysing and click reaction with cy-5 alkyne glutathionylation was analyzed by 
in-gel fluorescence.  increasing incubation time of antimycin A in a physiological glucose 
concentration (5 mM).  
Similarly, glutathionylation was induced under a physiological glucose 
concentration (5 mM) when cells were treated with AMA for different times (Figure 3.6). 
HEK293-GS M4 stable cells displayed a time dependent increment of glutathionylation 
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when treated with increasing concentrations of AMA under a physiological glucose 
concentration (5 mM).  This suggest that ETC blockers alter the cellular redox state by 
generating high levels of ROS under limiting glucose concentrations, thereby inducing 
protein glutathionylation. More importantly, this study found that glucose metabolism is 
an important factor for controlling the level of protein glutathionylation.  
3.3.4 Glutathionylation under glycolysis inhibition and mitochondrial dysfunction 
 To further confirm that glucose metabolism is important for protein 
glutathionylation, we examined glutathionylation after inhibiting glycolysis by a known 
pharmacological inhibitor. 2-deoxygluocose (2-DG) is an analogue of glucose which is 
lack of 2-hydroxyl group. 2-deoxyglucose binds and inhibits hexokinase, which decrease 
glycolysis (258). 2-deoxyglucose has been used to study the importance of glucose 
metabolism (259). In this project, we evaluated glutathionylation in response to glycolysis 
inhibition, which is likely to mimic glucose depletion.  
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Figure 3.7 - Induction of glutathionylation by treatment of 2-deoxyglucose (2-DG) with 
electron transport chain blockers. After incubation of azido-Ala to HEK293-GS M4 cells for 20 
h, cells were serum-starved for 4-h. Cells were then incubated in glucose (5 mM) and antimycin 
A (2 µg/mL) with an increasing concentration of 2-DG for 2 h. After stimulus, cell lysates were 
subjected to click reaction with rhodamine-alkyne, and analyzed for in-gel fluorescence.  
HEK293/GS M4 cells were incubated with L-AzAla (0.6 mM) for 20 h, followed by 
serum starvation and incubation of 2-deoxyglucose different concentrations in the 
presence of 2 µg/mL of AMA for 2 h. All conditions were carried out in the presence of 5 
mM glucose in the medium. After cell lysis and click reaction with cy-5 alkyne, 
glutathionylation was analyzed by in-gel fluorescence. In the absence of AMA and 2-DG, 
glutathionylation did not induce in response to a physiological glucose concentration. 
However, glutathionylation was significantly induced when cells were treated with AMA 
and 2-DG under similar condition (Figure 3.7). Interestingly, glutathionylation was further 
increased with an incubation of increasing concentrations of 2-DG, indicating AMA 
induces glutathionylation in response to glycolysis inhibition (Figure 3.7).  
3.3.5 Reversibility of glutathionylation controlled by glucose availability  
Next, we evaluated whether glutathionylation is reversible depending on glucose 
availability. After inducing glutathionylation under glucose starvation with AMA, we re-
introduced  glucose to glucose starved cells. Interestingly, glutathionylation signal was 
decreased when glucose was re-introduced to cells, showing the importance of glucose 
availability (Figure 3.8 A lane 6-8). 
Interestingly, the similar deglutathionylation was observed when pyruvate was 
added to cells instead of glucose. pyruvate is an intermediate metabolite of glycolysis 
(Figure 3.8 A lane 3-5).  glutathionylation level was decreased upon addition of pyruvate. 
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However, addition of lactate, a reduced form of pyruvate, did not change the level of 
glutathionylation (Figure 3.8 B). Overall, these data prove that glucose acts as a key 
regulator for maintaining redox state of the cells and regulating the level of global protein 
glutathionylation. 
 
Figure 3.8 - Glutathionylation is reversed by re-addition of glucose. After incubation of azido-
Ala to HEK293-GS M4 cells for 20 h, glutathionylation was induced by glucose starvation with the 
treatment of antimycin A for 2 h. Subsequently, (A) glucose (GL, 5 mM), pyruvate (Py, 5 mM) or 
(B) lactate (La, 10 mM) was individually added to the cells for the indicated time periods. Cell 
lysates were subjected to click reaction with rhodamine-alkyne, and analyzed for fluorescence.  
3.3.6 Glutathionylation by different ETC blockers 
ETC blockers increase ROS generation at different sites in oxidative 
phosphorylation. In order to investigate the differential effects of ETC blockers, 
HEK293/GS M4 cells were treated with inhibitors of complex I and complex III. In a similar 
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manner to AMA, an incubation of rotenone, a complex I inhibitor, induced glutathionylation 
under glucose starvation. (Figure 3.9 A and B). Next, we analyzed and compared 
glutathionylation upon incubation of two complex III inhibitors, myxothiazol and AMA. Both 
complex III inhibitors induced the similar level of glutathionylation under glucose 
deprivation, indicating similar effects on glutathionylation by different ETC blockers.  
 
Figure 3.9 - Glutathionylation in response to ETC blockers and glucose deprivation. A) After 
incubating stable cells with L-AzAla, cells were induced with rotenone different concentrations 
with or without glucose. B) Direct comparison of the effect of AMA and complex I inhibitor 
rotenone. C) Direct comparison of AMA and another complex III inhibitor myxothiazol.   
3.3.7 ROS and glutathione levels in response to glucose deprivation and 
mitochondrial dysfunction 
The ETC blockers, including AMA, are known to induce ROS and alter the redox 
state of the cell (260). To investigate how AMA affects cellular redox state, we analyzed 
ROS levels, GSH and GSSG upon incubation of AMA in the presence or absence of 
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glucose. HEK293/GS M4 cells were incubated with L-AzAla (0.6 mM) for 20 h. Cells were 
then induced for glutathionylation. The level of ROS was measured by 2′,7′-
Dichlorofluorescin diacetate (DCF) for 1 h at 37 0C in phenol red free DMEM. An 
incubation of AMA or glucose depletion increased the level of ROS. Obviously, the level 
of ROS was further increased when AMA was treated to cells under glucose depletion 
(Figure 3.10 A).  
Figure 3.10 - ROS and glutathione levels in HEK293-GS M4 stable cells. A) ROS levels were 
determined by DCF assay in AMA treated and non-treated cells in the presence and absence of 
glucose. Thiol levels were determined by bromobimane fluorescence assay after inducing with 
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AMA with or without glucose supply. After lysis by freeze and thawing, protein free lysates were 
reacted with bromobimane and fluorescence data for B) reduce thiol levels C) total thiol levels 
were measured using a plate reader. D) By subtracting reduce GSH from total GSH level, oxidized 
GSH was calculated and shown as a GSSG/GSH ratio.   
The cellular level of GSH was also measured by bromobimane assay. Cells were 
lysed by several freeze-thaw cycles in PBS and protein-free lysates were analyzed for 
thiols. In the presence of AMA, the level of reduced GSH was decreased in a time-
dependent manner (Figure 3.10 B). However, total thiol concentration did not change 
upon incubation of AMA (Figure 3.10 C). Overall, the ratio of GSSG/GSH was significantly 
increased when cells were treated with AMA for 2 h under glucose starvation, suggesting 
a significant oxidative stress in cells. These data suggest an important role for glucose 
metabolism in maintaining ROS levels. 
3.3.8 Protein glutathionylation in response to glucose deprivation  
We further evaluated glutathionylation under glucose starvation condition without 
using the ETC blockers. HEK293/GS M4 cells were subjected to glucose starvation with 
different incubation times. Depletion of glucose in HEK293/GS M4 cells did not induce 
glutathionylation significantly within 5 h, but induced a strong level of glutathionylation at 
20 h (Figure 3.11 A and B).  
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Figure 3.11 - Clickable GSH approach for detection of protein glutathionylation in response 
to different glucose concentrations. A) Stable cells were treated with different concentrations 
of glucose for 5 h. Lysates were analyzed by in-gel fluorescence after the click reaction with Cy5-
Alkyne. B) Stable cells were treated with glucose free media for 20 h. Then analyzed by in-gel 
fluorescence. C) Detection of protein glutathionylation in glucose dose dependent manner for 20 
h. 
 Importantly, the level of glutathionylation was increased with decreasing 
concentrations of glucose. Interestingly, glutathionylation were readily observed even at 
physiological (5 mM) and hypoglycemic (3 mM) concentrations. (Figure 3.11 C).  It was 
also found that glutathionylation was induced under glucose deprivation for 13 h (Figure 
B.3.1). All together, these data further support that glucose availability is an important 
factor for regulation of glutathionylation.  
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3.3.9 Glutathionylation in response to oxygen availability  
It was known that oxygen availability is an important factor for generation of ROS. 
We next evaluated whether glutathionylation is induced depending on oxygen availability. 
Cells were subjected to different conditions of oxygen and glucose concentrations. L-
AzAla was incubated with HEK293-GS M4 cells for 20 h. Two cell culture dishes, 
containing high glucose and no glucose medium were incubated under normal oxygen 
concentration (21%). Another two cell culture dishes were incubated with or without 
glucose, inside a hypoxic modular chamber saturated with low oxygen concentration 
(1%).  Cells were lysed immediately after incubation and glutathionylation was detected 
by in-gel fluorescence after click reaction. Glucose starvation under normoxic condition 
(21% oxygen) induced a significant level of glutathionylation (Figure 3.12 lane 2 vs 1). 
However, glucose starvation under hypoxic condition (1% oxygen) did not show a 
significant level of glutathionylation induction (Figure 3.12 lane 3 and 4). These data 
indicated that oxygen is necessary for inducing glutathionylation under glucose 
deprivation.    
The induction of hypoxia was confirmed by monitoring the elevated level of hypoxia 
inducible factor 1 α (HIF1α) (Figure 3.14 A). In addition, redox enzymes, such as GRX1 
and catalase, did not significantly change under hypoxic or normoxic conditions, 
suggesting the detected glutathionylation difference is not due to a change in redox 
enzyme levels (Figure 3.14 B). Next, we evaluated glutathionylation under different 
oxygen concentrations. Consistently, we did not observe detectable level of 
glutathionylation when oxygen concentration maintained at 0 or 1% (Figure 3.13 lane 1-
6). In contrast, glutathionylation was readily induced with an increasing oxygen 
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concentrations (5 or 21%) under glucose starvation condition. These data showed a dose 
dependent increment of glutathionylation in response to different oxygen supply (Figure 
3.13 lane 8 and10). Overall, these data support the fact that oxygen availability is an 
important factor for inducing protein glutathionylation.  
 
 
Figure 3.12 – Glutathionylation under a limited oxygen supply. Stable cells were incubated 
with L-AzAla and incubated with or without glucose in a hypoxia chamber containing 1 and 21% 
oxygen. After 13 h cells were immediately lysed and performed click reaction and analyzed by in-
gel fluorescence.   
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Figure 3.13 - Oxygen availability regulates protein glutathionylation. HEK293-GS M4 stable 
cells were incubated with 0.6 mM L-AzAla for 20 h and media was replaced with serum free 
medium containing different amounts of glucose prior to the incubation in hypoxic chamber 
containing 0%, 1%, 5% and 21% oxygen. Cells were lysed and analyzed by in-gel fluorescence 
after click reaction.  
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Figure 3.14 – Levels of HIF1α and redox enzymes in response to glucose-oxygen depletion. 
A) Cell lysates, prepared from normoxic and hypoxic conditions were analyzed by Western 
blotting for the induction of HIF1α and B) the detection of redox enzymes including GRX1 and 
catalase.  
Next, we evaluated glutathionylation in a hypoxic condition with subsequent re-
oxygenation. HEK293-GS M4 stable cells were first subjected to oxygen-glucose-
depletion (OGD) (1% O2 and no glucose) for 8 h. Subsequently, cells were exposed to a 
normal oxygen atmosphere for 0, 20 and 120 minutes under normal or depleted glucose 
conditions. cells were then lysed and analyzed for glutathionylation after performing click 
reaction with Cy5-Alkyne (Figure 3.15). Glucose deprivation or OGD did not induce a 
significant level of glutathionylation during 8 h. (Figure 3.15 lane 1-6). However, we 
observed time dependent glutathionylation in cells after OGD and re-oxygenation for 20 
and 120 minutes (Figure 3.15 lane 9 and 12). Similar results were observed in HEK293-
GS M4 cells after 13 h OGD and 1h re-oxygenation experiment (Figure B.3.3).  Altogether, 
these data indicated that oxygen availability is important for inducing glutathionylation 
under prolonged glucose starvation.   
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Figure 3.15 - Detection of the effect of re-oxygenation on protein glutathionylation. After L-
AzAla incubation for 20 h, HEK293-GS M4 cells were maintained under 1% oxygen with or without 
glucose for 8 h (OGD). Then cells were exposed to 21% oxygen for different time points (OGD/R). 
Cells were lysed at indicated time points and analyzed by in-gel fluorescence after click reaction 
with Cy-5 Alkyne.   
3.3.10 Identification of glutathionylated proteins using LC-MS/MS 
Glucose starvation together with AMA treatment induces glutathionylation in 
numerous proteins. To identify these proteins, we used a biotin pull-down experiment 
followed by LC-MS/MS analysis (Figure 3.16 A). Global glutathionylation was induced in 
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HEK293-GS M4 cells after treating AMA together with glucose deprivation. After 
induction, cells were lysed and subjected to click reaction with biotin alkyne.  
 
Figure 3.16 – Biotin pull-down and elution for analysis of glutathionylated proteins. A) 
Approach for pull-down and mass analysis: after click reaction with biotin-alkyne, glutathionylated 
proteins enriched by streptavidin-agarose were eluted for silver staining or directly digested on-
beads for LC-MS/MS analysis. B) Analysis of enriched proteins by silver staining. 
Biotinylated proteins were then incubated with streptavidin agarose beads and 
eluted by a SDS loading dye. Eluted samples were analyzed by silver staining. 
Glutathionylated proteins were significantly enriched in a condition of glucose starvation 
with incubation of AMA. In contrast, enrichment of glutathionylated proteins were 
minimum with high glucose (25 mM) and lack of AMA treatment (Figure 3.16 B lane 4 
against lane 1-3). 
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Figure 3.17 – Proteomic analysis of glutathionylated proteins. A) The number of identified 
glutathionylated proteins by LC-MS/MS analysis are displayed as a venn diagram. ‘Positive’ and 
‘negative’ indicate proteins enriched in Figure 3.16 B lane 4 and 1, respectively. B) Comparison 
of identified proteins according to the spectral count in positive and negative samples.  
We further analyzed the samples prepared for lane 1 and lane 4 (Figure 3.16 B) 
by mass spectrometry. After enrichment of glutathionylated proteins on streptavidin 
beads, proteins were digested with trypsin on bead. Then eluted samples were subjected 
to LC-MS/MS analysis. From mass analysis, we identified 1249 candidate proteins in the 
positive sample (lane 4 in Figure 3.15 B) and 278 proteins in the negative sample (lane 1 
in Figure 3.15 B). Relatively smaller number of proteins (244) were found in both positive 
and negative samples (Figure 3.17 A). More importantly, 1291 proteins had 10-fold or 
higher enrichment in the positive sample over negative sample (Figure 3.17 B). 
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We analyzed identified proteins using the DAVID gene ontology program. This 
analysis allows us to categorize proteins depending on their localization, molecular 
function and cellular process. The majority of glutathionylated proteins were found in 
cytosol. Proteins were involved in many different cellular processes, such as RNA 
processing, cell cycle, DNA repair, aging and stress sensing (Figure 3.18 C, D, E)). In 
addition, we compared identified glutathionylated proteins with previously known 
glutathionylated proteins (figure 3.19 A). It was found that a half of candidate proteins that 
we identified were previously reported for glutathionylation, but there were 800 new 
glutathionylated proteins in our LC-MS/MS analysis. Also, we compared our data with 
sulfenylated proteins reported previously (figure 3.18 B). Approximately a half of 
sulfenylated proteins were found as potential candidate proteins for glutathionylation in 
our analysis, indicating a close interconnection between sulfenylation and 
glutathionylation. In addition, top 120 proteins that were found in our mass analysis with 
high spectral counts were analyzed by DAVID Program for their localization, cellular 
function and processes, which is listed in a table. Also, these proteins were compared 
with databases of previously reported glutathionylated and sulfenylated proteins (Table 
B.3.1).  These data provide evidences for the sensitivity and the versatility of clickable 
GSH in studying protein glutathionylation.   
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Figure 3.18 – Gene ontology analysis of identified glutathionylated proteins. A) Comparison 
of glutathionylated proteins in glucose starvation/antimycin A with previous proteomic data of 
glutathionylome B) or sulfenylome by treatment of exogenous H2O2. C) DAVID gene ontology 
(GO) analysis of identified glutathionylated proteome. Identified proteins were annotated to 
depending on subcellular location, D) molecular function and E) cellular processes.  
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3.3.11 Validation of glutathuonylated proteins by biotin pull-down and Western 
blotting  
Next, we sought to validate the candidate proteins identified from mass analysis 
by pull-down and Western blotting. After inducing glutathionylation by incubating AMA 
under glucose starvation, cells were lysed. After cell lysis, click reaction was performed 
with biotin-alkyne, followed by enrichment of glutathionylated proteins by biotin pull-down. 
Enriched proteins were eluted and probed with primary antibodies againts different 
individual proteins.  Cell lysates were probed with same antibodies before and after 
streptavidin pull down. We confirmed several proteins for glutathionylation: Hsp90, actin 
and catalse were glutathionylated within 1 h of induction while other proteins such as 
PTP1B, PP2cα and AMPK are found to be glutathionylated at 2 h (Figure 3.19 A). 
Importantly, we identified several new gluathionylated proteins including catalase, 
SMYD2 and PP2Cα (Figure 3.19 A).  
We further evaluated the reversibility of several individual glutathionylated proteins 
upon incubation of pyruvate. It was found that PTP1B, catalse and PP2Cα are readily 
undergoing deglutathionylation within 30 minutes of pyruvate treatment (Figure 3.19 B). 
In contrast, actin and catalse did not show significant deglutathionylation upon incubation 
of pyruvate within 1 h, indicating that there may be differential selectivity of 
deglutathionylation in a time-dependent manner (Figure 3.19 B).  
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Figure 3.19 - Validation of glutathionylated proteins by pull-down and Western blotting. A) 
After incubation of azido-Ala to HEK293-GS M4 cells for 20 h, cells were subjected to glucose 
starvation with antimycin A in a time-dependent manner. B) After glucose starvation with 
treatment of antimycin A for 2 h, pyruvate was added to cells. After click reaction with biotin-
alkyne, the individual proteins were probed by specific antibodies before and after the pull-down.   
3.4 Discussion  
Glutathionylation is a protein cysteine oxidation and taking place under elevated 
ROS conditions, found in many pathological conditions (173). Although many proteins are 
found to be glutathionylated in response to exogenous ROS stimulus, protein 
glutathionylation in response to glucose metabolism and/or induction of mitochondrial 
ROS is not systematically analyzed. In this chapter, we studied glutathionylation in 
response to mitochondrial dysfunction using clickable glutathione approach (211). 
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We prepared a stable cell line HEK293-GS M4 that express GS M4. It was found 
that stable expression of GS M4 in HEK293 cells did not significantly alter the total free 
thiol content and expression levels of redox enzymes. LC-MS analysis showed that a 
significant amount of azido-GSH was synthesized in HEK293/GS M4 cells. Overall, our 
data support that clickable glutathione is well-tolerated in cells. Therefore HEK293-GS 
M4 cells behave similar to normal HEK293 in terms of intracellular redox state.  
Next, to evaluate glutathionylation under mitochondrial dysfunction, we used 
pharmacological inhibitors of the ETC, such as rotenone, AMA and myxothiazol (261). 
AMA and myxothiazol are complex III inhibitors while rotenone is a specific inhibitor of 
complex I. Because ETC inhibitors are known to generate mROS, these inhibitors may 
mimic mitochondrial dysfunction. Cellular metabolism is an important factor that 
associated in regulating redox homeostasis (229). Specially, glucose metabolism plays 
an important role by generating two important metabolic products, including pyruvate and 
NADPH (230). While pyruvate acts as free radical scavenger, NADPH is the major 
reducing source which used antioxidant machinery (Figure 3.20) (122,130). Indeed, 
glutathionylation was readily induced in response to AMA treatment under physiological 
glucose concentrations and this effect was significantly increased when cells exposed to 
glucose deprivation. Moreover, in agreement with glutathionylation data, AMA treatment 
increased ROS production, reduced GSH levels and increased GSSG levels. Therefore, 
we hypothesized that ETC inhibitor induced mROS were detoxified by high glucose.     
Interestingly, AMA did not induce glutathionylation when cells incubated in high glucose, 
suggesting an important regulatory role for glucose metabolism in glutathionylation.  
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We further confirmed the significance of glucose availability in glutathionylation by 
evaluating both global and individual protein deglutathionylation. After induction, cells 
were treated with either glucose or its metabolic intermediate pyruvate. Addition of these 
metabolites could induce rapid deglutathionylation. Our data for glutathionylation and 
deglutathionylation demonstrate an important role of glucose metabolism in controlling 
protein glutathionylation.  
 
Figure 3.20 – Schematic representation of glucose and mitochondrial metabolism in redox 
homeostasis and glutathionylation. 
Since glucose availability is an important determinant of protein glutathionylation 
and glucose deprivation is known to induce ROS, we next evaluated protein 
glutathionylation under glucose deprivation (262). When stable cells were exposed to 
glucose deprivation for longer incubation (20 h), glutathionylation was significantly 
induced compared to shorter time incubation (2 h and 5 h). Also, decreasing 
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concentrations of glucose induces glutathionylation in a dose dependent manner within 
20 h.       
In the ETC, ROS are generated by reduction of molecular oxygen. Because there 
are reports showing that hypoxia induces ROS, we examined protein glutathionylation in 
response to O2 availability (Figure 3.20) (250). When stable cells incubated in a low 
oxygen environment, glucose deprivation did not induce glutathionylation even under a 
long incubation, indicating that glucose deprivation induced-ROS levels are low or not 
enough to induce glutathionylation in a hypoxic condition compared to a normoxic 
condition. On the other hand, when cells were exposed to increasing concentrations of 
oxygen, glucose deprivation could induce glutathionylation significantly. These data were 
further supported by reoxygenation experiments. As our data show, re-oxygenation could 
induce glutathionylation after hypoxic incubation of stable cells. Overall, a systematic 
evaluation of glutathionylation in response to glucose and oxygen deprivation 
demonstrated that oxygen availability as an important factor for inducing glutathionylation.  
In addition to sensitive detection of glutathionylation in both global and individual 
proteins, clickable glutathione method is compatible with mass spectrometry to identify 
glutathionylated proteins under different physiological and pathological conditions. 
Therefore, we employed our clickable glutathione approach to find glutathionylated 
proteins under mitochondrial dysfunction and glucose deprivation. Click reaction with 
biotin-alkyne and pull-down with streptavidin agarose beads enriched numerous 
glutathionylated proteins. Trypsin digestion of enriched proteins and LC-MS/MS analysis 
identified more than 1400 glutathionylated proteins. Among identified proteins, 434 and 
285 proteins were previously known for glutathionylation and sulfenylation respectively. 
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Also, GO analysis by DAVID program indicated that many identified proteins are involved 
in various cellular processes, indicating importance of glutathionylation in range of cellular 
events. We further validated the identified proteins by pull-down and Western blotting, 
including PP2Cα, which is a metal dependent serine/threonine protein phosphatase. 
PP2Cα is known to be involved in different cellular processes such as proliferation, 
apoptosis, cell cycle and cell migration by directly acting on several mitogen activated 
protein kinases (MAPK), including p38, JNK (263-265). Mostly PP2Cα acts as a negative 
regulator of stress sensing pathways. Therefore, further characterization and functional 
studies on PP2Cα glutathionylation is sought and described in Chapter 4.       
3.5 Experimental procedure 
3.5.1 HEK293-GS M4 Stable cell preparation 
To determine the minimum hygromycin B concentration that required for killing 
HEK293 cells, different concentrations of hygromycin B were incubated with HEK293 
cells and monitored over 10-14 days. First, a serial dilution of hygromycin B was carried 
out as listed in Table 3.1. After trypsinization, 1 X 105 cells, per well, were seeded on a 
six-well plate and incubated at 37 0C for 24 h. Then cell culture medium was replaced 
with fresh medium containing different concentrations of hygromycin B (Table 2.1). Cells 
were monitored over two weeks and minimum concentration of 200 µg/mL of hygromycin 
B was selected for the stable cell preparation. HEK293 cells were transiently transfected 
with pCDNA3.1-GS M4 plasmid using lipofectamine 2000 as a transfecting agent. 
Another 10 cm cell culture dish was maintained without transfection as the control. After 
24 h of transfection, cells were trypsinized and maintained in a 12-well plate in fresh 
complete medium for 24 h. Then cells culture medium was replaced with fresh complete 
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medium with or without 200 µg/mL hygromycin B for two to three weeks. Cell culture 
medium was replaced every day until most of the cells are dead. Once all cell debris are 
washed away with warm PBS, stable cells containing cell colonies were picked using a 
200 µL pipet tip and transferred to a well of 96-well plate. Cells were maintained in 200 
µg/mL of hygromycin B containing medium until cells become confluent. Then cells were 
split in to a 24-well plate. When cells become confluent, cells were transferred to a 6-well 
plate. After 24 h, cells were lysed and lysates were analyzed for GS M4 overexpression 
by probing with anti-flag antibody. Rest of the cells were maintained in 10 cm cell culture 
dishes and stable cell stocks were prepared and stored in liquid nitrogen vapor phase for 
long term usage.           
3.5.2. PEI-max transfection 
General transfection procedure using PEI-max was described in Chapter 2, section 
2.5.13.   
3.5.3 Cell lysis 
Detailed cell lysis procedure was described in Chapter 2, section 2.5.14. 
3.5.4 Cell culture and assays 
  HEK293-GS M4 cell line, which is stably overexpressing glutathione synthetase 
mutant 4 (GS M4), was prepared according to a stable cell generation protocol. Briefly, 
after transfection of GS M4, HEK293 cells expressing GS M4 was selected and grown in 
the presence of hygromycin B (100 µg/mL). FLAG-tagged GS M4 expression in HEK293-
GS M4 cells was confirmed by Western blotting with anti-FLAG antibody. Cells were 
maintained in DMEM (high glucose) with 10% fetal bovine serum (FBS), penicillin (100 
units/mL), streptomycin (100 μg/mL), and hygromycin B (100 µg/mL) at 37°C in 5% CO2 
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humidified incubator. PP2Cα wild type and mutant plasmids were transfected using PEI-
max at 80% confluency in DMEM without FBS/antibiotics. Cells with or without 
transfection were incubated with 0.5 mM L-azido-alanine (azido-Ala) for 20 h. Cells were 
then washed with PBS once, and incubated for serum-starvation for 4 h in the presence 
of azido-Ala (0.25 mM). After washing with PBS, cells were incubated with and without 
antimycin A or rotenone in glucose-free (glucose starvation) or glucose-containing DMEM 
for different time points. For deglutathionylation, glucose (5 mM), pyruvate (5 mM), or 
lactate (10 mM) was added for another 2 h. Cells were lysed using a lysis buffer [Tris HCl 
100 mM, NaCl 150 mM, pH 7.4, 0.1% Tween 20, a protease inhibitor cocktail tablet, 100 
µM PMSF and 50 mM N-ethylmaleimide (NEM)]. After incubation for 0.5 h at 4°C and 
centrifugation at 14,000 rpm, the cell lysates were collected and protein concentration 
was measured by Bradford assay.   
3.5.5 SDS-PAGE  
General SDS-PAGE procedure was described in Chapter 2, section 2.5.15 
3.5.6 Western blotting 
General Western blotting procedure was described in Chapter 2, section 2.5.17 
3.5.7 Click reaction and biotin pull-down 
Concentrations of cell lysates were measured using Bradford assay as described 
in 2.5.15. Lysates (100 µg), prepared by addition of NEM during cell lysis, were 
precipitated by adding cold acetone (1:4 by volume) for 30 min in -20°C. Samples were 
then centrifuged at 14,000 rpm for 3 min, and the pellet was redissolved in click buffer 
(0.1 M Tris-HCl pH 7.4) by sonicating for 5 seconds. Click reaction was performed as 
described in the previous study.(266) Briefly, click reaction was carried out for 1 h at room 
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temperature with biotin-alkyne (0.2 mM) or rhodamine alkyne (0.2 mM) in the presence 
of CuBr (1 mM) and Tris[(1-benzyl-1H-1,2,3-triazol-4-yl)methyl]amine (TBTA) (0.4 mM). 
Click reaction was terminated by adding a SDS-loading buffer and proteins were 
separated by SDS-PAGE. Glutathionylated proteins were visualized by in-gel 
fluorescence or Western blotting using streptavidin-HRP. For pull down experiments, after 
click reaction, all the proteins were precipitated by cold acetone, centrifuged, and washed 
once with cold methanol. The precipitate was completely dissolved in PBS containing 
1.2% SDS, and further diluted ten times with PBS before incubating with streptavidin 
agarose beads (100 µL) at room temperature for 3 h. Beads were washed extensively 
with PBS and finally with water. Proteins on beads were eluted by a SDS-loading buffer, 
separated by SDS-PAGE, transferred to PVDF membrane, and probed with various 
primary antibodies. Alternatively, proteins on beads were digested by trypsin, and eluted 
for LC-MS/MS analysis. 
3.5.8 LC/LC-MS/MS analysis 
The streptavidin agarose beads after enrichment were pelleted and washed twice 
by Dulbecco’s phosphate-buffered saline (DPBS). After resuspending in 50 µL of 6 M 
urea/PBS, the beads were incubated at room temperature for 1 h. 100 µL DPBS was then 
added to dilute urea to a final concentration of 2 M. On-bead trypsin digestion was 
performed overnight at 37 °C with sequencing-grade trypsin (2 µg) and 1 mM CaCl2 (100 
mM stock in water). The peptide digests were centrifuged and the supernatants were 
collected. The beads were washed twice with water (2 × 75 µL). All supernatants and 
washes were combined and acidified with 15 µL formic acid. The samples were stored at 
-20 °C until mass spectrometry analysis. LC/LC-MS/MS analysis was performed on an 
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Agilent 1200 series HPLC coupled to an LTQ-Orbitrap Discovery mass spectrometer 
(ThermoFisher). Peptide digests were pressure loaded onto a 250 µm fused silica 
desalting column packed with 4 cm of Aqua C18 reverse-phase resin (Phenomenex). The 
peptides were eluted onto a biphasic column (100 µm fused silica with a 5 µm tip, packed 
with 10 cm Aqua C18 reverse-phase resin (Phenomenex) and 3 cm Partisphere strong-
cation-exchange resin (SCX, Whatman) using a gradient of 5-100% Buffer B in Buffer A 
(Buffer A: 95% water, 5% acetonitrile, 0.1% formic acid; Buffer B: 20% water, 80% 
acetonitrile, 0.1% formic acid). The peptides were then eluted from the SCX onto the C18 
resin and into the mass spectrometer using four salt steps as previously described.(267) 
The flow rate through the column was set to ~0.25 L/min and the spray voltage was set 
to 2.75 kV. One full MS scan (FTMS) (400-1800 m/z) was followed by 18 data dependent 
scans (ITMS) of the nth most intense ions with dynamic exclusion enabled. The generated 
tandem MS data was searched using the SEQUEST algorithm against the human UniProt 
database. SEQUEST output files were filtered using DTASelect 2.0.(267) 
Glutathionylated proteins with two or higher fold enrichment were selected and analyzed 
using DAVID functional annotation tool. 
3.5.9 Cell viability assay 
HEK 293 cells were grown on a six-well plate by adding same number of cells into 
each well. After 24 h, cells were incubated in DMEM only for 3 h. Cells were then 
subjected to different conditions for 24 h: 1) no treatment (25 mM glucose, 0 μg/mL 
antimycin A), 2) glucose starvation (0 mM glucose), 3) antimycin A (1 μg/mL) 4) glucose 
starvation (0 mM glucose) with antimycin A (1 μg/mL antimycin A), and 5) 0.01% DMSO 
(amount used to dissolve antimycin A).  Antimycin A was dissolved in DMSO. Cells were 
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subjected to trypan blue cell viability assay. Briefly, cells were detached by treating with 
0.05% trypsin, and diluted with the medium. Then 100 µl of trypan blue reagent was 
added to the 100 µl of medium with the cells and 20 µl of sample was loaded on to the 
slide and analyzed the percentage of viable cells by TC 20 automated cell counter 
(Biorad). The data was shown after duplication of two independent experiments.  
3.5.10 ROS assays 
HEK293 cells (10,000 cells per well) were seeded and incubated at 37 oC, 5% CO2 
for 24 h for attachment on 96-well black plates with transparent flat bottom. Cells were 
then washed with warm PBS, and incubated in serum-free medium for 3 h. 2,7-
dichlorodihydrofluorescein diacetate (DCFH-DA, 25 µM) was then added, and cells were 
incubated in the same conditions for another 1 h. Cells were then washed with glucose-
free medium without phenol red, followed by treatment at the indicated conditions and 
incubated for 2 h. Untreated cells were used as a negative control. Fluorescence emission 
scan was measured at 528 nm after excitation at 485 nm. ROS levels were normalized 
using a negative control (25 mM glucose without antimycin A).  
3.5.11 Determination of thiol concentration 
HEK293-GS M4 cells were treated with 0.5 mM azido-Ala and cells were washed 
with PBS after 20 h. Cells were induced for glutathionylation for 0.5 h and 2 h as 
mentioned in the main text. After induction, cells were harvested and lysed in PBS by 3 
times of freeze-thaw cycles. The cell lysates were collected after centrifugation. Proteins 
were removed by 3 kDa centrifugal filter device, and the filtrate (FIL) that contains small 
molecules (including glutathione) was collected. The total and reduced form of thiol 
contents (mostly glutathione) were analyzed by fluorescence assay using bromobimane 
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(excitation - 390 nm, emission - 478 nm). Bromobimane assay was performed in 0.1 M 
Phosphate buffer, 0.5 mM bromobimane, and 10 µL of protein free lysates (FIL). The 
fluorescence signal was measured by using a plate reader. To calculate total GSH levels, 
protein free lysates (FIL) were incubated with 1 mM TCEP at 37 oC for 30 minutes before 
the bromobimane assay. All the data was duplicated and the background signal was 
corrected before the analysis by GraphPad Prism (version 5.01).  
  
121 
 
CHAPTER 4 S-GLUTATHIONYLATION OF SERINE/THREONINE PROTEIN 
PHOSPHATASE 2Cα (PP2Cα) PROMOTES CANCER CELL MIGRATION UNDER 
METABOLIC STRESS 
4.1 Introduction 
Glutathionylation is implicated in regulation of various signaling pathways that 
control cell survival, apoptosis and cancer metastasis (185). Cancer cells are adapted to 
an increased uptake of glucose to compensate high energy demand and to maintain 
redox homeostasis. While glucose metabolism provides necessary metabolic 
intermediates for a sustained energy production in cancer cells, glucose deprivation 
induces apoptosis, inflammation, and migration (268-270). For example, glucose 
deprivation increases the expression levels of monocarboxylate transporter 1 (MCT1) in 
cervical cancer cells and induces migration through mitochondrial ROS production (262).  
Protein phosphatases are a class of enzymes that act on phosphoproteins by 
removing phosphate group from different amino acid residues thereby regulating 
important cellular processes (271-273). Human genome encodes for more than 140 
phosphatases that are divided into two major categories, including Ser/Thr protein 
phosphatases and protein Tyr phosphatases. Protein Ser/Tre phosphatases consists of 
phosphoprotein phosphatases (PPPs) and metal ion-dependent protein phosphatases 
(PPM’s) (274). PPM’s are monomeric and structurally distinct from phosphoprotein 
phosphatases (PPP’s). PPPs are heteromeric and consist of both catalytic and regulatory 
subunits while PPMs are only made of a catalytic subunit (264).  
Among different isoforms of PPMs, PP2Cα is the most studied phosphatase and 
known to acts as a negative regulator of stress response pathways, such as mitogen-
activated protein kinases (MAPK’s) and transforming growth factor-β (TGF-β) signaling 
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(264) . PP2Cα is known to directly interact and dephosphorylate several key-signaling 
proteins, including p38-MAPK, extra cellular regulated kinase (ERK), c-Jun N-terminal 
kinase 1(JNK1) and SMAD2/3 (263,265,275). PP2Cα acts as a tumor suppressor and it 
is implicated in cancer migration and invasion through antagonizing a TGF-β- activated 
SMAD2/3 signaling in bladder cancer and breast cancer (263,276). Numerous evidences 
support that MAPK are also associated in cell migration and invasion (277). p38 and ERK 
are known to directly act on several substrate proteins that are involved in migration (278-
281). Inhibition or overexpression of a dominant negative mutant of MAPK has been 
shown to inhibit p38 or ERK-dependent cell migration (278,282).  
In addition to its more common roles in apoptosis, inflammation and differentiation, 
JNK is an important MAPK family member associated with cell migration. (283-285). 
Activation of JNK by EGF, ephrin B1, upstream MEK kinase, constitutively active MKK4 
or environmental stress are shown to increase migration in various cell types (286-288). 
The importance of active JNK in cell migration has also been documented in several 
different studies, by using an inhibitor (SP600125) of JNK, overexpression of a dominant 
negative mutant, JNK1AF, and a JNK knockout method (289-291). We found that glucose 
metabolism is known to regulate protein glutathionylation, and Ser/Thr protein 
phosphatase (PP2Cα) was identified to undergo glutathionylation in response to glucose 
deprivation (292). Migration towards nutrients would be important for cancer cells during 
a tumor growth. To our knowledge, there is no direct study correlating the expression of 
PP2Cα with cancer cell migration. However, there is one proteomic study that measures 
expression profiles of PP2Cα among noninvasive and invasive cancer cells, suggesting 
a potential positive correlation between cancer cell invasiveness and the expression level 
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of PP2Cα availability (293). For instance, invasive MDA-MB-231 cells have a low 
expression level of PP2Cα when compared to noninvasive MCF7 and A431 cells (294). 
Rapidly proliferating solid tumor cells experience metabolic stress, due to the lack of 
oxygen and glucose availability (295). Metabolic stress in primary tumor cells induces 
initiation of metastasis, thereby invading other organs, such as lung, brain and bones 
(296,297). Although, PP2Cα and MAPK’s are involved in tumor invasion and metastasis, 
regulation of PP2Cα function in cancer cell invasion under metabolic stress is not 
explored, thus motivated us to study PP2Cα glutathionylation under metabolic stress. 
In this study, we found PP2Cα undergoes glutathionylation at C314 in a C-terminal 
domain in response to metabolic stress. we further investigated functional role of PP2Cα 
glutathionylation under metabolic stress, i.e. limited nutrient availability. The response of 
glutathionylation varied depending on cancer cell types and glucose availability. We 
further demonstrate that PP2Cα glutathionylation in response to metabolic alterations 
enhances cancer cell migration and invasion potentially through activating JNK-MAPK 
pathway.  
4.2 Results 
4.2.1 S-Glutathionylation of serine/threonine protein phosphatase 2Cα (PP2Cα) 
PP2Cα is a protein phosphatase which utilizes metal coordinated water molecule 
to catalyze the dephosphorylation of several critical proteins including JNK, p38, MAPK, 
AMPK, Smad2/3 and NF-Kb (265). Also, a recent study showed that PP2Cα directly 
interact with metabotropic glutamate receptor 3 (mGluR3) and dephosphorylates serine 
845 (298). mGluR3 is a glutamate receptor which is important for the protection of 
neuronal cells against glutamate excitotoxicity (299). Considering the importance of 
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PP2Cα in different signaling pathways, we started to further evaluate the consequences 
of glutathionylation of PP2Cα.  
PP2Cα carries 11 cysteine residues from the available crystal structure (PDB: 
4RA2), we predicted Cys204 and Cys314 are potential cysteine for glutathionylation 
because of their solvent accessibility and charged lysine residues around Cys314. In 
addition, Cys238 was also considered as a potential modification site due to its proximity 
to a metal ion in the active site. (Figure 4.1). 
We generated all three cysteine-to-serine mutants of PP2Cα and transfected to 
HEK293-GS M4 stable cells. After 24 h of transfection, azido-Ala was incubated and cells 
were induced for glutathionylation with AMA in glucose-free medium for 2 h. Cells were 
then lysed, and lysates were subjected to click reaction with biotin-alkyne. Biotinylated 
proteins were captured by streptavidin beads and analyzed in a gel. 
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Figure 4.1 – Crystal structure of PP2Cα. Three potential cysteine residues (Cys204, Cys238 
and Cys314) out of 11 cysteine residues in PP2Cα are predicted for glutathionylation. Two 
manganese atoms (purple) and a phosphate (red) in active site of the crystal structure of PP2Cα 
(PDB:4RA2) are shown in space-filling model.                                 
Eluted proteins were probed with anti-HA antibody. As shown in Figure 4.2 A, 
PP2Cα WT, Cys204 and Cys238 are significantly glutathionylated. In contrast, PP2Cα 
Cys314 mutant showed a reduced signal for glutathionylation (Figure 4.2 A lane 5). Under 
similar conditions, there were many proteins, including PTP1B, that are glutathionylated 
in addition to PP2Cα (Figure C.4.1).  
 
Figure 4.2 – In cellulo and in vitro glutathionylation studies for identification of modified 
cysteine residue in PP2Cα. A) PP2C WT, and cysteine mutants, C204S, C238S and C314S 
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transiently transfected to HEK293-GS M4 cells and glutathionylation was induced by treating AMA 
in the presence and the absence of glucose. After performing click reaction with biotin alkyne and 
subsequent biotin pull-down, eluted proteins were probed with ant-HA antibody to detect 
glutathionylation levels of PP2Cα. B) Purified PP2Cα WT and C314S mutant subjected to in vitro 
glutathionylation by incubating azido-GSH and diamide. Glutathionylation was detected by in-gel 
fluoresce.  
S-Glutathionylation of PP2Cα was further confirmed by an in vitro glutathionylation 
assay. Briefly, purified PP2Cα WT and C314S mutant (50 μg each) were incubated with 
azido-GSH (1 mM). Diamide (50 μM) was then added to induce glutathionylation. 
Glutathionylation levels were analyzed by in-gel fluorescence after click reaction with 
Cy5-alkyne. In vitro glutathionylation studies showed that PP2Cα WT is strongly 
glutathionylated while glutathionylation was significantly decreased with PP2Cα Cys314, 
suggesting that Cys314 is the major cysteine for PP2Cα glutathionylation (Figure 4.2 B). 
Interestingly, Cys314 has a Lys310 in a close proximity that can enable hydrogen 
bonding. 
Proximity ligation assay (PLA) has been used to study protein-protein interaction, 
localization and posttranslational modifications of individual proteins in fixed cells 
(300,301). We sought to couple a clickable-GSH approach with PLA technology to detect 
PP2Cα glutathionylation and its localization in cells by fluorescence imaging. Briefly, after 
transfection of PP2Cα WT and C314S, cells were treated with 1mM H2O2 for 15 minutes 
to induce glutathionylation. Then cells were fixed and permeabilized before the click 
reaction with biotin-alkyne. Primary antibodies against PP2Cα and biotin were incubated 
for 16 h at 40C followed by incubation of secondary anti-rabbit and anti-mouse that are 
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conjugated with PLA probes for 1 h at 37 oC. After ligation and amplification, Images were 
captured using confocal microscope.  
  
 
Figure 4.3 – Schematic representation of visualization of PP2Cα glutathionylation by a 
proximity ligation assay.  
The PLA signal that represents glutathionylation was significantly detected with 
PP2Cα WT versus PP2Cα C314S mutant. Glutathionylated PP2Cα appear to be in the 
cytoplasm (Figure 4.4). This method may be useful to study the effect of PP2Cα 
glutathionylation on cellular localization and protein-protein interactions. 
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Figure 4.4 – Visualization of PP2Cα glutathionylation by proximity ligation assay. WT 
PP2Cα and mutant PP2Cα transiently transfected and induced for glutathionylation. Click reaction 
was performed to fixed cells followed by PLA and subsequent visualization of PP2Cα 
glutathionylation by confocal microscopy.   
4.2.2 Functional effects of glutathionylation on PP2Cα  
PP2Cα WT and C314S mutant proteins were purified using His-tag purification. It 
was found that there are two different sizes of PP2Cα: one matches with a full-length size 
(50 kDa) while another one appears to be 10-15 kDa smaller than a full-length mass (~35 
kDa). Because His-tag is present at a N-terminus and PP2Cα has a small C-terminal 
domain with about 15 kDa, we concluded that a smaller size of purified protein is likely to 
be truncated PP2Cα lacking the C-terminal domain. (Figure 4.5 A). First, we evaluated 
phosphatase activity of PP2Cα WT and C314S mutant using a simple colorimetric assay. 
After incubating PP2Cα WT and mutant enzyme with GSSG, phosphatase substrate 
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para-nitrophenyl phosphate (pNPP) was added to the reaction mixture. Phosphatase 
activity was quenched by adding NaOH (302). Enzyme activities were determined by 
measuring para-nitrophenol absorbance at 405 nm. Our in vitro assay showed that 
PP2Cα glutathionylation did not significantly inhibit its phosphatase activity. Although 
PP2Cα C314 mutant exhibited a lower catalytic activity compared to PP2Cα WT, it is 
unclear yet if this is due to a mutation at C314 Figure 4.5 B). But it should be noted that 
pNPP is a nonspecific small molecule substrates for alkaline phosphatases, which may 
not represent enzymatic activity on protein substrates that are often mediated by protein-
protein interaction. To examine the functional consequences of glutathionylation in the 
context of cellular environment, we tested the phosphorylation levels of AMPK that is a 
downstream target of PP2Cα. Under glucose depletion, AMPK is phosphorylated, which 
activates downstream signaling pathways as a stress response to metabolic changes. 
PP2Cα directly interact and inhibits AMPK activation (Figure 4.5 C) (303). Therefore, we 
evaluated phosphorylation level of AMPK in cells expressing PP2Cα WT and C314S in 
response to ROS.  After transfection of WT and Cys314 mutant, cells were induced for 
glutathionylation. Then cell lysates were analyzed for phosphorylation levels of AMPK 
using antibodies against p-AMPK and AMPK. Glucose starvation and AMA treatment 
significantly induced the phosphorylation of AMPK. However, the level of AMPK 
phosphorylation did not change in any of PP2Cα mutants compared to WT (Figure 4.5 
D). Because Cys314 is in a C-terminal tail of PP2Cα and C-terminal domain was 
suggested to be involved in the substrate specificity and protein-protein interaction (304), 
we tested whether glutathionylation can disrupts the interaction with its substrates. 
PP2Cα directly interacts and acts on phosphorylated metabotropic glutamate receptor 3 
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(mGluR3) (298). Therefore, we carried out co-immunoprecipitation study to investigate 
the effect of PP2Cα glutathionylation on mGLUR3 interaction with PP2Cα. After 
transfection of HA-tagged PP2Cα WT and Cys314 mutant, cells were induced for 
glutathionylation.  
 
Figure 4.5 – Functional effects of PP2Cα glutathionylation.  In vitro analysis of PP2Cα 
enzymatic activity upon glutathionylation. (A) A gel after purification of His-PP2Cα, which gave a 
full-length (FL) and a truncated form (TR) that appear to have excluded about 10 kDa size of the 
C-terminus domain. His-tag is on the N-terminus. (B) PP2Cα dephosphorylation assay with p-
nitrophenyl phosphate (pNPP): PP2Cα (50 ng/uL) and pNPP (20 mM) were incubated with and 
without oxidized glutathione (GSSG) (1 mM) for 30 min at 37 oC, and absorbance was measured 
at 405 nm.   
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Then cells were lysed, and lysates were subjected to immunoprecipitation using 
an antibody for mGluR3eluted proteins were analyzed using antibodies against HA-tag 
and mGluR3. PP2Cα WT decreased its interaction with mGluR3 under stress condition. 
On the other hand, PP2Cα C314 mutant retained the interaction with mGluR3 under the 
same stress condition. In agreement with these data, endogenous PP2Cα lost it 
interaction with mGluR3 under stress condition (Figure 4.6 lane 1 and 2). These data 
showed that PP2Cα glutathionylation disrupts PP2Cα interaction with mGluR3.  
 
Figure 4.6 – Co-immunoprecipitation assay for mGLUR3 and PP2Cα. After transfection of 
PP2Cα WT and C314S mutant, HEK293-GS M4 cells were induced for glutathionylation with 
AMA and glucose deprivation. After ci-immunoprecipitation, eluted samples were probed with 
antibodies against PP2Cα and mGLUR3.   
4.2.3 Glutathionylation in response to glucose depletion in different cell lines 
PP2Cα is known to have regulatory function in controlling cancer cell migration by 
antagonizing a TGF-β-induced SMAD signaling pathway. The correlation between PP2Cα 
expression and metastatic properties of several cancer cells are previously reported 
(263). PP2Cα expression levels vary by the cell type. For example, invasive breast cancer 
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cell line MDA-MB231 contains a lower expression level of PP2Cα when compared to 
noninvasive MCF7 and skin cancer cell line A431 (Figure 4.14 B). Therefore, to 
understand the significance of PP2Cα glutathionylation in cancer cells, we evaluated 
glutathionylation in two different cell lines, MCF7 and MDA-MB-231 cancer cells. Cancer 
cells rely on glucose metabolism to provide enough energy and biomass required to 
maintain high proliferation rate and to maintain the redox homeostasis (183). Therefore, 
we evaluated glutathionylation in response to metabolic changes in MCF7 and MDA-MD-
231 cells and cardiomyocyte H9c2 cells.  
 
Figure 4.7 - Glutathionylation in different cell lines. Adenovirus transduced to MCF-7, MDA-
MB-231 and H9c2 cells and incubated with 0.6 mM L-AzAla for 20 h. Then cells were maintained 
in different concentrations of glucose containing serum free medium for 5.5 h. Lysates were 
subjected to click with Cy-5Alkyne and glutathionylation was analyzed by in-gel fluorescence. A) 
H9c2 cells were differentiated using retinoic acid for four days followed by adenovirus 
transduction. After inducing glutathionylation detected by in-gel fluorescence. B) Induced MCF7 
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cells subjected to click reaction and visualized by in-gel fluorescence. C) Dose dependent 
glutathionylation in MDA-MB-231 cells. 
Differentiated H9c2 cells, MCF7 and MDA-MB-231 cells were transduced with 
adenovirus expressing a GS M4 mutant. After 24 h of virus transduction, cells were 
incubated with L-AzAla for another 20 h, followed by treatment of different glucose 
concentrations for approximately 5.5 h. Under these conditions, GS M4 stable cells and 
differentiated cardiomyocytes H9c2 did not induce protein glutathionylation (Figure 3.4 
and 4.7 A). However, Interestingly, there was a low but increase level of glutathionylation 
in MCF-7 cell under a low concentration of glucose (3 mM). MDA-MB-231 cells displayed 
a significant increment of glutathionylation in response to low glucose (3 mM) (Figure 4.7 
B and C). These data indicated that metastatic MDA-MB-231 cells are more sensitive for 
inducing glutathionylation in response to glucose availability than non-invasive MCF7.  
 We also analyzed glutathionylation in both MDA-MB-231 and MCF7 cells with a 
deceasing concentration of glucose. We found that glutathionylation was significantly 
induced at 3 mM of glucose concentration in MDA-MB-231 cells (Figure 4.8 B). Consistent 
with glutathionylation status, ROS levels were higher in MDA-MB-231 cells compared to 
MCF7 under glucose depletion (Figure 4.8 A). We confirmed that levels of GS M4 and a 
few redox enzymes are similar between MCF7 and MDA-MD-231 cells, suggesting that 
glutathionylation signals are likely to represent the different redox states between two cell 
lines. (Figure 4.8 C).  
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Figure 4.8 – Different redox responses in MCF7 and MDA-MB-231 cells. A) ROS levels were 
determined by DCF assay under different glucose concentrations. B) After adenovirus 
transduction, cells were induced for glutathionylation under different glucose concentrations for 5 
h. Glutathionylation was detected by in-gel fluorescence after performing click. In similar 
conditions, C) GS M4 and redox enzyme expression levels were analyzed by Western blotting. 
D) PP2Cα glutathionylation levels were determined by biotin pull-down and subsequent elution 
and probing with HA antibody.   
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Importantly, we confirmed PP2Cα glutathionylation in MDA-MB-231 cells under 
glucose depletion (Figure 4.8 C). When cells were incubated with decreasing 
concentrations of glucose, PP2Cα glutathionylation was increased in a dose dependent 
manner: PP2Cα glutathionylation was significantly increased in response to low glucose 
concentrations (3-5 mM) compared to a high concentration of glucose (25 mM) (Figure 
4.8 C).       
In addition to glucose deprivation, MDA-MB-231 cells displayed higher sensitivity 
towards oxygen and glucose deprivation (ODG). After OGD condition, cells were 
incubated in normal oxygen atmosphere (21%) for 30 minutes for reoxygenation. 
Glutathionylation was analyzed after click reaction with fluorophore-alkyne. Consistently, 
glutathionylation was induced in response to GD or OGD within 5 h (Figure C.4.3). 
Further, MDA-MB-231 cells slightly induced glutathionylation after 30 minutes of 
reoxygenation (Figure C.4.4). Altogether, data show that MDA-MB-231 cells are more 
sensitive to metabolic alterations.      
4.2.4 Glutamate availability and the metabolic stress in MDA-MB-231 cells 
Glucose depletion induces a metabolic stress and an increment of glutathionylation 
in the cell. we further evaluated glutathionylation upon addition of different metabolites, 
including pyruvate, glutamine and glutamate. MDA-MB-231 cells were incubated in a low 
glucose medium, but with addition of pyruvate, glutamine or glutamate for 5.5 h. Then 
cells were lysed and analyzed for glutathionylation by in-gel fluorescence. In agreement 
with an earlier study, glutathionylation was decreased by the addition of 5 mM pyruvate 
(Figure 4.9 A).  
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Figure 4.9 - Rescue of metabolic stress by pyruvate, glutamine and glutamate. A) MDA-MB-
231 cells were treated with low glucose in the presence of pyruvate, glutamine and glutamate for 
indicated time. B) Cells were supplemented with different concentrations of glutamate (0-8 µM) 
for 5.5 h. After induction, cells were lysed and subjected to click reaction before analyze by in-gel 
fluorescence. 
Interestingly, we found that glutathionylation was dramatically suppressed by 
glutamate. In contrast, an addition of glutamine did not change the level of 
glutathionylation. The gradual decrement of glutathionylation signal was observed upon 
addition of increasing concentrations of glutamate (Figure 4.9 B). Glutamine can be 
converted to glutamate by glutaminase (GLS). Glutamate can be fluxed to produce 
pyruvate and NADPH in cells. (Figure C.4.5). GLS enzyme activity may be inhibited to 
prevent glutaminolysis in our condition (305). Overall, supplementation of glutamine did 
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not rescue the cells from metabolic stress while glutamate supplementation rescued cells 
from metabolic stress (Figure 4.9 A).  
4.2.5 PP2Cα glutathionylation in cancer cell migration (wound healing assay) 
 Next, we investigated the functional importance of PP2Cα glutathionylation in 
MDA-MB-231, an invasive breast cancer cell line. Since PP2Cα is implicated in cell 
migration through SMAD and MAPK signaling pathways, we speculated that PP2Cα 
glutathionylation might be playing an important role in cell migration and invasion. To 
probe this hypothesis, we first investigated cell migration of MDA-MD-231 cells after 
expressing PP2Cα WT or C314S. Cells were evaluated for a wound-healing assay in high 
and low glucose conditions for 36 h. After making a wound across cells using pipet tip 
cells were monitored using a light microscope connected to a camera. Non-transfected 
MDA-MD-231 cells displayed a higher wound healing capacity in both high glucose (25 
mM) and low glucose concentrations (10 mM). Overexpression of PP2Cα WT completely 
attenuated the wound healing ability of MDA-MB-231 cells under a high glucose condition. 
The same pattern was observed in cells with PP2Cα C314S, indicating an inhibition of 
cell migration by PP2Cα (Figure 4.10).  
Interestingly, MDA-MD-231 cells with PP2Cα WT restored the wound healing 
capacity or increased the migration of cells when incubated in a low glucose condition 
(Figure 4.10). On the other hand, migration or wound healing did not increase for MDA-
MD-231 cells expressing PP2Cα C314 in a low glucose condition (Figure 4.10). These 
data suggest that PP2Cα may lead to a loss of its activity in a low glucose condition where 
PP2Cα can be glutathionylated (Figure 4.10).  
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Figure 4.10 – Wound healing assay with MDA-MB-231 cells. Similar number of PP2C WT and 
C314S mutant transfected cells were seeded in a 12-well plate and incubated in 25 mM and 10 
mM glucose containing medium for 36 h after creating a wound. After, 36 h, images were captured 
in the wounded area and analyzed cell migration by quantifying invaded area. Percent invasion 
or migration was represented as a bar graph, (p<0.05). 
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Next, we evaluated whether glutathionylation is induced under low glucose 
conditions.  glutathionylation was readily induced in at low glucose conditions (5-10 mM) 
(Figure 4.11 A). We also confirmed PP2Cα is glutathionylated in 10 mM glucose (Figure 
4.11 B). Overall, these data support that glutathionylation of PP2Cα leads to a loss of a 
negative activity of PP2Cα in cell migration. 
 
 
Figure 4.11 – Glutathionylation in MDA-MB-231 cells in response to a low glucose 
concentration. A) MDA-MB-231 cells were infected with adenovirus and glutathionylation was 
induced by incubating 10 mM and 5 mM glucose for 24 h. Glutathionylation levels were analyzed 
by performing click reaction with fluorophore alkyne. B) Induced cell lysate subjected to click 
reaction with biotin alkyne and subsequent biotin pull-down. Cell lysate and eluted proteins from 
biotin pull-down, were analyzed by HA antibody.  
In solid tumor, most cancer cells are lacking nutrients and oxygen supplementation 
due to the poor vascularization. Glucose and oxygen deprivation are the most common 
challenges that solid tumors encounter during later stages of cancer development. 
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Therefore, cancer cells adapt to overcome these challenges by growing towards the 
vasculature or gaining epithelial-to-mesenchymal transition (EMT) to migrate to other 
parts of the body (306). Hence, these data provide evidences on regulatory effects of 
PP2Cα glutathionylation in cancer cell invasion under glucose limiting condition.    
4.2.6 PP2Cα glutathionylation in response to metabolic stress promotes MDA-MB-
231 cell invasion: transwell invasion assay 
We further evaluated the role of PP2Cα glutathionylation in a transwell invasion 
assay. Transwell invasion assay consists of two chamber systems where an upper 
chamber holds cells and a lower chamber has the chemoattractant as a stimulant for 
invasion (Figure 4.12). Transwell inserts having a basement membrane that allows for 
cells to penetrate or invade. A similar number of MDA-MB-231 cells non-transfected or 
transfected with PP2Cα WT and C314S) were seeded on a transwell-insert containing 10 
mM glucose medium. A Lower chamber was filed with a medium containing 10% FBS. 
Cells were then incubated in the incubator for 24 h.  
 
Figure 4.12 – Diagram of transwell set up in a 24-well plate for investigating cancer cell 
invasion.  
Then invaded cells were fixed and permeabilized before staining with crystal violet. 
Images were captured using a camera attached to alight microscope. When cells were 
incubated in 25 mM glucose, the number of invaded MDA-MB-231 cells was significantly 
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decreased in cells with PP2Cα WT or C314 when compared non-transfected cells, 
indicating that PP2Cα WT and C314 showed a negative role in cancer cell invasion under 
a high glucose condition (25 mM). In contrast, the number of invaded cells were 
significantly increased within 24 h, when cells with PP2Cα WT were incubated in low 
glucose (10 mM). However, cells expressing PP2Cα C314 did not show any increased 
number of invaded cells. (Figure 4.13).  These data further support that PP2Cα 
glutathionylation at C314 enhances cancer cell invasion in response to metabolic stress.   
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Figure 4.13 – Transwell invasion assay with MDA-MB-231 cells. Transfected and non-
transfected cells were incubated in transwell inserts. Low glucose containing medium was added 
to upper chamber and 10% FBS containing medium was added lower chamber. After 24 h, 
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invaded cells were fixed and analyzed after crystal violet staining. Migrated cells were quantified 
after extracting crystal violet with 33% acetic acid and showed as a bar graph, (p<0.05).  
4.2.7 PP2Cα glutathionylation in A431 cells 
In order to test the role of endogenous PP2Cα glutathionylation in cancer cell 
migration, we carried out a transwell invasion assay in A431 cells. A431 cells have a high 
expression level of endogenous PP2Cα compared to other cell lines (294). We confirmed 
expression levels of PP2Cα in three different cell lines, including MDA-MB-231, MCF7 
and A431. MDA-MB-231 cells displayed lower expression levels of PP2Cα compared to 
both MCF7 and A431 cells (Figure 4.14 B). In similar to MDA-MB-231, A431 cells showed 
a significantly increased level of glutathionylation in response to low glucose (Figure 4.14 
A), indicating susceptibility of A431 cells to metabolic alterations.  
A Transwell invasion assay was performed to further investigate about PP2Cα 
glutathionylation in A431 cell migration under low glucose supplementation. In a similar 
manner to MDA-MB-231 cells, A431 cells gained more invasive properties in a low 
glucose condition compared to a high glucose condition.  (Figure 4.15 A). Under the same 
conditions, global and PP2Cα glutathionylation were induced (Figure 4.15 B and C). Next, 
we sought to understand the potential mechanism of PP2Cα glutathionylation in 
enhancing cancer cell migration   
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Figure 4.14 – Comparison of glutathionylation among MCF7, MDA-MB-231 and A431 cells. 
A) A431 cells induced for glutathionylation by low glucose for 5 h. Cell lysates from MCF7, MDA-
MB-231 and A431 were subjected to click reaction and analyzed by in-gel fluorescence. B) In 
similar experimental conditions, expression levels of GS M4 (flag), PP2Cα and actin were probed 
using appropriate antibodies.  
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Figure 4.15 – Effect of PP2Cα glutathionylation on A431 cell migration. A) Transwell invasion 
assay for A431 cells was performed under low glucose concentration. After seeding 
approximately similar number of cells in transwell insert, invaded cells were stained and captured 
using a light microscope. B) Glutathionylation of PP2Cα in A431 cells in response to different 
glucose concentrations. After pull down, eluted proteins were probed with anti-PP2Cα antibody. 
C) Global glutathionylation levels in A431 cells in response to different glucose concentrations. 
After induction, lysates were subjected to click reaction and analyzed by in-gel fluorescence.  
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4.2.8 PP2Cα glutathionylation activates c-Jun N-terminal kinase (JNK) in MDA-
MB-231 cells 
PP2Cα acts as a negative regulator of stress responsive pathways and controls 
different signaling pathways that are involved in apoptosis and cell migration. Specially, 
PP2Cα acts on MAPK pathways by dephosphorylating p38 and JNK. p38 and JNK are 
activated in response to cellular stress, such as metabolic stress, and Activation of p38 
and JNK is associated with an increased migratory property of cells. Therefore, we 
hypothesized that PP2Cα glutathionylation might interfere with dephosphorylation of p38, 
JNK, SMAD2 and SMAD3, which may lead to enhance cancer cell migration. To study 
the effect of PP2Cα glutathionylation of these proteins, MDA-MB-231 cells were 
transfected with PP2Cα WT and C314S. Cells were then induced for glutathionylation 
under a low glucose condition (5 mM) for 5 h. Cell lysates were then analyzed by Western 
blotting using appropriate antibodies (Figure 4.16). phosphorylation levels of SMAD2 or 
SMAD3 were not detectable in a basal level or under a low glucose condition, suggesting 
that SMAD2/SMAD3 may not play a crucial role for PP2Cα glutathionylation induced cell 
migration (Figure 4.16 C and D). p38 phosphorylation remains unchanged upon 
expression of PP2Cα WT or C314 or under both high glucose and low glucose conditions, 
suggesting a minimal involvement of PP2Cα in p38 dephosphorylation in MDA-MD-231 
cells (Figure 4.16 B). 
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Figure 4.16 – Evaluation of phosphorylation levels of several PP2Cα substrates that are 
involved in cell migration. After transfection of PP2C WT and C314S, MDA-MB-231 cells were 
induced for glutathionylation by incubating low glucose containing medium for 5 h. A) Lysates 
were analyzed for phosphorylation levels and total protein levels for A) JNK B) p38 C) SMAD2 D) 
SMAD3 using relevant antibodies. 
On the other hand, overexpression of PP2Cα WT and C314S mutant strongly 
inhibited JNK activation compared to non-transfected cells, indicating that PP2Cα WT 
and C314S are involved in dephosphorylating JNK in MDA-B-231 cells. More importantly, 
when cells expressing PP2Cα WT showed an increase level of JNK phosphorylation in a 
low glucose condition. In contrast, cells with PP2Cα C314S did not increase JNK 
phosphorylation under a low glucose condition. These data support that PP2Cα C314 
glutathionylation leads to a loss of PP2Cα dephosphorylation activity for JNK under a low 
glucose condition. Because an increased JNK phosphorylation is associated with 
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enhance migration and invasion of cells, our data support that PP2Cα glutathionylation 
promotes cancer cell migration potentially by increasing JNK activation.  
4.3 Discussion 
PP2Cα is a Ser/Thr protein phosphatase that acts as a negative regulator in 
various stress induced cellular pathways (264). Among many substrates, PP2Cα 
inactivates SMAD2, SMAD3, p38 and JNK MAPK’s (265,275). Several studies have been 
reported to have regulatory function and different expression pattern of PP2Cα in 
inflammatory homeostasis and wound healing (307). Previously, we identified PP2Cα as 
a potential candidate for S-glutathionylation in response to mitochondrial dysfunction. In 
this study, we further determined the role of PP2Cα glutathionylation in in cancer cell 
migration.  
PP2Cα has 11 cysteine residues and several cysteines are buried inside the 
structure, thus not directly accessible for ROS or GSH (308). According to the available 
crystal structure of PP2Cα, we predicted three potential cysteine residues for 
glutathionylation, including Cys204 and Cys314. Both cysteine residues are solvent 
exposed as seen in crystal structure (308). In addition, Cys314 is in close proximity with 
a positively charged amino acid Lys310. Therefore, it is possible that Cys314 thiol can be 
more nucleophilic or reactive. Because Cys238 is in a close distance to catalytic metal 
ion in the active site of PP2Cα, we also considered Cys238 as a potential candidate for 
glutathionylation. Our study showed that Cys314 is the major glutathionylated cysteine 
residue in response to mitochondrial dysfunction. This modification site is further 
confirmed by in vitro glutathionylation assay with purified PP2Cα WT and C314S mutant 
proteins.  
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 protein phosphatase 2A (PP2A) is a heterotrimeric protein where a B-regulatory 
subunit seems to govern the substrate specificity (309). However, PP2Cα does not have 
a regulatory subunit, its c-terminal α-helix may be involved in substrate specificity (310). 
Also, our data confirmed that Cys314 glutathionylation disrupts interaction with mGLUR3, 
indicating PP2Cα glutathionylation potentially regulates its function under cellular stress 
conditions. On the other hand, PP2Cα glutathionylation did not impact on AMPK 
activation, suggesting that the effect of PP2Cα glutathionylation can depend on individual 
substrate proteins.  
PP2Cα is known to regulate cancer cell migration through dephosphorylation of 
TGF-β induced SMAD signaling (263). Also, other substrates of PP2Cα, such as p38 and 
JNK are important players of cancer cell migration (311,312). Moreover, in solid tumor, 
cells are rapidly proliferating. Cells that grow away from vasculature may encounter with 
oxygen and nutrient deprivation (313). Some cancer cells appear to be more aggressive 
and invasive under metabolic stress (314). Therefore, we have investigated the role of 
PP2Cα glutathionylation in cancer cell migration under metabolic stress.  
First, we evaluated global glutathionylation status in different cell lines, including 
two breast cancer cell lines, A431, MCF7 and MDA-MB-231. We used adenovirus 
expressing GS M4, which allow to express GS M4 in many cell lines with a high 
transfection efficiency. Using adenovirus transduction, we could evaluate 
glutathionylation in differentiated cardiomyocyte, A431, MCF7 and MDA-MB-231 cells. 
Glutathionylation studies revealed that MDA-MB 231 and A431 cells are more sensitive 
for inducing glutathionylation under metabolic alterations. Also, levels of a few redox 
enzymes and GS M4 were not significantly different between MDA-MB-231 and MCF7 
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cells, indicating the glutathionylation difference is due to higher metabolic stress in MDA-
MB-231 cells.  We also noticed that MDA-MB-231 cells are associated with a higher ROS 
level, and a higher sensitivity to low glucose condition when compared to MCF7 cells.  
 
Figure 4.17 – Cell migration induces by PP2Cα glutathionylation under metabolic stress.  
Further, glutamate supplementation could rescue MDA-MB-231 cells from 
metabolic stress resulting from a low glucose condition. But, glutamine addition did not 
recover cells from metabolic stress. It may be explained by the fact that the enzymatic 
activity of GLS depends on the availability of phosphate, acetyl-CoA and succinyl-CoA, 
and metabolic state of the cells (315,316). Also, in many cancer cells, sirtuin 5 is 
overexpressed and involved in desuccinylating GLS to inhibits its catalytic activity 
(315,316). Therefore, glutamate availability rather than glutamine may be important for 
maintaining redox homeostasis under low glucose.  
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Next, we evaluated the functional roles of PP2Cα glutathionylation in cell migration 
using MDA-MB-231 cells. Wound healing experiments and transwell invasion assay 
revealed that overexpression of PP2Cα WT or C314 significantly inhibited cell migration 
under a high glucose concentration. Interestingly, cells expressing PP2Cα WT could 
recover its wound healing capacity under a low glucose condition. On the other hand, 
cells with PP2Cα C314S could not recover wound healing ability. We also found that 
PP2Cα is glutathionylated at C314 position in response to low glucose, indicating PP2Cα 
glutathionylation promotes cancer cell migration under metabolic stress. When tumor is 
growing away from vasculature, cells are always encounter glucose-oxygen deprivation. 
There are number of studies suggesting that cancer cells are more invasive under 
metabolic stress. In agreement with other studies, our data collectively provide evidences 
that cancer cells are gaining more invasive properties through PP2Cα glutathionylation. 
We also found that PP2Cα C314 glutathionylation inhibits its dephosphorylating activity 
toward JNK, suggesting that PP2Cα glutathionylation increases cancer cell migration 
potentially via activating JNK and subsequent activation of downstream signaling 
associated with cell migration.  
4.4 Experimental procedure 
4.4.1 Cloning and mutagenesis  
Human PP2Cα cDNA clone was purchased from OriGene and the gene was 
subcloned into pcDNA3.1/hygro (+) mammalian vector using BamHI and XhoI restriction 
sites. PCR reaction was performed using a forward primer (5'-GGT GGT GGA TCC GCC 
ACC ATG GGA GCA TTT TTA GAC AAG C-3') containing Kozak sequence and BamHI 
restriction site and a reverse primer containing HA tag and XhoI restriction site (5'-GGT 
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GGT CTC GAG CTA AGC GTA ATC TGG AAC ATC GTA TGG GTA CCA CAT ATC ATC 
TGT TGA TGT AGA G-3'). Both PCR product and the empty pcDNA3.1 vector were 
double digested with above two restriction enzymes and ligated using T4 DNA ligase. All 
the mutants were generated using pcDNA3.1-PP2Cα clone as the template. 
QuickChange mutagenesis was performed using following mutagenic primers. PP2Cα 
mutant C204S (forward: 5’-GCC CTT GGG GAT TTT GAT TAC AAA AGT GTC CAT 
GGA AAA GGT CC-3’ and reverse: 5’-GGA CCT TTT CCA TGG ACA CTT TTG TAA 
TCA AAA TCC CCA AGG GC-3’), C238S (forward: 5’-CAG TTC ATT ATC CTT GCA AGT 
GAT GGT ATC TGG GAT GTT ATG G-3’ and reverse: 5- CCA TAA CAT CCC AGA TAC 
CAT CAC TTG CAA GGA TAA TGA ACT G-3’) and C314S (forward: 5’-GGA CAA GTA 
CCT GGA AAG CAG AGT AGA AGA AAT CAT AAA GAA GC 3’ and reverse: 5’-GCT 
TCT TTA TGA TTT CTT CTA CTC TGC TTT CCA GGT ACT TGT CC-3’). pcDNA3.1-
PP2Cα and empty pET28a vectors were double digested using BamHI and XhoI. The 
digested PP2Cα and pET28a were gel purified and ligation was performed using T4 DNA 
ligase at 22 oC for 1h.  To generate adenovirus containing GS M4 gene, flag-GS M4 was 
subcloned into Dual-CCM+ shuttle vector.  All plasmids were confirmed by DNA 
sequencing of entire open reading frames. 
4.4.2 Purification of PP2Cα 
pET28a-PP2Cα was transformed in to BL21(DE3) cells and single colony was 
incubated overnight in LB containing 50 µg/mL kanamycin. Overnight culture (5 mL) was 
diluted into 1 L of LB and grown at 37 oC until OD600 reaches 0.4. Protein overexpression 
was induced for 4 h at 37 oC with 0.5 mM IPTG. Cells were harvested, lysed and purified 
as described in section 3.3. 
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4.4.3 Enzyme assay of PP2Cα 
PP2Cα enzyme (WT and C314S) activities were calculated by end point assay 
using para-nitrophenyl phosphate (pNPP) as the substrate. Proteins were incubated with 
or without 0.5 mM GSSG in 20 mM Tris, pH 7.4 for 15 minutes at 37 oC. Phosphatase 
assay was performed in the colorimetric assay buffer containing 20 mM Tris, pH 7.4, 5 
mM MgCl2, 1 mM ethylene glycol-bis(2-aminoethylether)-N,N,N′,N′-tetraacetic acid 
(EGTA)  and 0.1 mg/mL BSA. Different amounts of each protein were mixed with 20 mM 
pNPP in 100 µL final volume and incubated for 30 minutes at 37 oC before quenching the 
reaction with 50 µL of 5 N NaOH. Enzyme activities (µmoles/min/µg) were calculated 
using absorbance measured at 405 nm. Data analyzed by GraphPad Prism (version 5.01) 
software. 
4.4.4 Mammalian cell culture and transfection  
General cell culture and transfection methods were discussed in section 2.5.10 
and section 2.5.13. 
4.4.5 Adenovirus transduction  
Adenovirus production was performed by Vector BioLabs. Briefly, flag-GS M4 was 
cloned into dual-CCM+ shuttle vector and then transferred expression cassette to an 
adenovirus vector (pAd Vector). Then low-titer viral particles were produced by 
transfecting linearized adenoviral DNA to HEK293 cells over couple of weeks. Next, virus 
was amplified by growing in a 300 mL culture and then virus was concentrated to 2 mL in 
viral storage buffer. Concentration of viral particles was determined by performing a 
plaque formation assay. To find out the multiplicity of infection (MOI) of Ad-CMV-GS M4, 
different volumes from virus stock (corresponding to MOI- 10, 50 and 100) were infected 
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to MDA-MB-231 cells. After cells were reached to 85-90% confluency in 100 mm cell 
culture dish, growth medium was replaced with 5 mL of 2% FBS containing DMEM 
(without penstrep) and transferred back to the incubator. Viral particles were diluted in 
500 μL of 2% FBS containing DMEM medium in the presence of 1 mg/mL Polybrene in a 
sterile eppendorf tube. Virus and polycationic transfecting agent (Polybrene) complex was 
incubated for 20 minute at room temperature before adding to the cells. After 5-8 h of 
virus infection, virus containing medium was replaced with complete growth medium and 
incubated for 24 h or 48 h. During the use of virus in cell culture, extreme safety 
precautions must be followed. Cell culture dishes, pipette tips, and all other material 
should be touched with 10% regular bleach for at least 30 minutes. Cell culture medium 
containing virus should not aspirate into regular aspirator setup, instead, all contaminated 
medium and other liquids should be disposed in to bleach and final concentration of 
bleach should be 10%. Avoiding generation of splashes while transferring medium and 
cross contamination with other sterile cell culture medium or other equipment should be 
considered. Virus containing liquids on metal surfaces should disinfect with spore-Klenz 
for at least 30 minutes. Switching gloves is a must before leaving the cell culture room 
and appropriate waste disposal to a trash bin labeled with biohazard sticker for virus. 
Regular autoclaving of virus disposals must be maintained at least once a week.    
4.4.6 Cell lysis   
General mammalian cell lysis was described in section 2.5.14.    
4.4.7 Click reaction and biotin pull-down  
Click reaction and biotin pull-down experiments were described in section 2.5.18 
and section 2.5.23. 
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4.4.8 Proximity ligation assay 
HEK293-GS M4 stable cells were transfected with PP2C WT and C314S mutant 
using PEI-max as the transfecting agent. After 24 h of transfection, 0.6 mM of L-AzAla 
was incubated for another 20 h and induced for glutathionylation using 1 mM H2O2 for 15 
minutes. After induction, cells were washed several times with cold PBS, and fixed for 15 
minutes using ice cold methanol at -20 0C. After fixation, cells were then permeabilized 
with 1X PBST (pH-7.4, 10 mM Na2HPO4, 1.8 mM KH2PO4, 150 mM NaCl, 0.1% Trion-
X100) for 10 minutes at room temperature. Cells were washed three more times with PBS 
and subjected to click reaction with biotin-alkyne. Briefly, click reaction mixture was 
prepared by using the same protocol described in section 2.5.18. In this procedure, TBTA 
was replaced with THPTA (Tris(3-hydroxypropyltriazolylmethyl)amine) because of water 
solubility. Individual cover slips were incubated with 100 μL of click reaction mixture at 37 
0Chumidified incubator. Cover slips were then washed at least three times with 10-minute 
incubation at room temperature. Then, cells were incubated in the blocking buffer (pH-
7.4, 10 mM Na2HPO4, 1.8 mM KH2PO4, 150 mM NaCl, 0.3% Trion-X100, 5% BSA) for 1 
h at room temperature. Primary antibodies against PP2Cα (mouse anti-HA, 1:100 dilution) 
was prepared in the blocking buffer and incubated with cells for 16 h (overnight) at 4 oC.  
Cells were washed three times with PBS and primary antibodies against biotin (rabbit 
anti-biotin, 1:100 dilution) was incubated for 1 h at room temperature followed by three 
washings with PBS. PLA probes were diluted in 1:5 ratio with blocking buffer (for 40 μL 
of final antibody solution, 8 μL from each minus and plus PLA probes were mixed with 24 
μL of blocking buffer) and incubated with individual slides for 1 h in a humidified incubator 
at 37 oC. After incubation of PLA probes, cover slips were washed two times with Duolink 
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wash buffer A for 10 minutes. Ligation mixture was prepared by diluting ligation buffer in 
1:5 ratio with distilled water and 1 μL of ligase (1:40) was added just before the incubation. 
Ligation step was carried out at 37 0C in a humidified incubator for 30 minutes. 
Amplification-polymerase reaction mixture was prepared by diluting amplification stock 
1:5 in distilled water and 0.5 μL of polymerase enzyme (1:80) was mixed at the time of 
incubation. After 30 minutes of ligation, cells were washed tice with 1X Duolink wash 
buffer A or 5 minutes. Soon after washings, cells were incubated with amplification-
polymerase reaction mixture for 100 minutes at 37 0C. After amplification, cells were 
washed twice with 1X Duolink wash buffer B for 15 minutes and anti-mouse secondary 
antibody conjugated to Alexa-488 was incubated for 1 h at room temperature to detect 
total PP2Cα levels. After three times washings with 1X Duolink wash buffer B, cells were 
washed once with 0.01X wash buffer B and mounted on microscope slides with a 
mounting solution containing DAPI. Fluorescence images were captured using Leica 
DMi8 inverted confocal microscope and images were processed by LAS AF analysis 
software. Microscope filters were set for nucleus staining with a DAPI channel (λex 350nm, 
λem 470nm), for proximity ligation signal with Texas Red channel (λex 594 nm, λem 624 nm) 
and for total PP2Cα with Alexa-488 (λex 490 nm, λem 525 nm).  
4.4.9 Co-immunoprecipitation 
After transfection of PP2Cα WT and C314S mutant, cells were induced for 
glutathionylation with 2 μg/mL AMA treatment in the absence of glucose for 2 h. Co-
immunoprecipitation was performed after lysing cells using the protocol described in 
section 4.4.7. HEK293-GS M4 cells were transfected with PP2Cα WT and C314S mutant 
and incubated for glucose starvation with antimycin A. Cells were then lysed using a lysis 
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buffer PBST (pH-7.4, 50 mM Tris-HCl, 150 mM NaCl, 0.1% Tween) without NEM. Lysates 
(1 mg/0.5 mL) were incubated with mouse mGluR3 primary antibody (3 µg) at 4°C for 1 
h, mixed with pre-washed protein G agarose beads (30 µL), and incubated overnight at 
4°C. Beads were then washed three times with PBST (pH-7.4, 50 mM Tris-HCl, 150 mM 
NaCl, 0.1% Tween) for 10 min each time. Beads were eluted with a SDS-loading buffer 
in the presence of β-mercaptoethanol. Eluted proteins were separated by SDS-PAGE, 
transferred to PVDF membrane, and incubated with primary mouse mGluR3 or rabbit 
PP2Cα antibodies in a TBST buffer (Tris HCl 50 mM, NaCl 150 mM, 0.1% Tween 20, 3% 
BSA) overnight at 4°C. HRP-conjugated light chain specific secondary mouse and rabbit 
antibodies were incubated for 1 h at room temperature. After washing 3 times with a TBST 
buffer, immunoprecipitated proteins were visualized by chemiluminescence. 
4.4.10 SDS-PAGE and Western blotting 
SDS-PAGE and Western blotting were conducted using the protocol described in 
section 2.5.15 and 2.5.17. 
4.4.11 DCF assay for ROS detection 
HEK293 cells (10,000 cells per well) were seeded and incubated at 37 oC, 5% CO2 
for 24 h for attachment on 96-well black plates with transparent flat bottom. Cells were 
then washed with warm PBS, and incubated in serum-free medium for 3 h. 2,7-
dichlorodihydrofluorescein diacetate (DCFH-DA, 25 µM) was then added, and cells were 
incubated in the same conditions for another 1 h. Cells were then washed with glucose-
free medium without phenol red, followed by treatment at the indicated conditions and 
incubated for 2 h. Untreated cells acted as a negative control. Fluorescence emission 
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scan was measured at 528 nm after excitation at 485 nm. ROS levels were normalized 
using a negative control (25 mM glucose without antimycin A).  
4.4.12 Wound healing assay 
MDA-MB-231 cells were transfected with PP2Cα WT and C314S using 
lipofectamine 3000 (ThermoFisher, catalog number L3000015) transfecting agent 
according to the manufacturer’s instructions. After 24 h of transfection, approximately 
similar number of non-transfected and transfected cells (1X107) were seeded on a 12-
well plate and incubated for another 24 h. Next, an even wound was created using a 
sterile 10 L pipette tip across the well and washed with warm PBS twice to remove any 
floating cells. This time point was considered as the 0 h and cells were incubated in 25 
mM and 10 mM glucose containing medium for 36 h. Images of wounded area were 
captured at 0 h and after 36 h using a camera attached to a microscope. Images were 
analyzed by ImageJ software using MRI Wound Healing Tool. Briefly, an image can be 
opened by clicking on file and then hitting on open button. Once image is uploaded to the 
program, right click on ‘’m’’ button and set the method to find edges, variance filter radius 
to 10, threshold to 50, radius open to 4 and adjust min.size according to the picture quality 
or use default setting. Before analyzing the images, option black background was 
selected by following process>binary>options.  Then, images analyzed by clicking on 
‘’m’’. The area of the open wound will be calculated and give as number with arbitrary 
units.  By subtracting the area of the wound at 36 h from the area of the wound at 0 h, 
percent migration was calculated and data from three independent trial were showed as 
a bar graph using GraphPad Prism software.   
4.4.13 Transwell invasion assay 
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On the first day, MDA-MB-231 cells were transfected with PP2Cα WT and C314S 
using Lipofectamine 3000 according to the manufacturer’s protocol and incubated for 24 
h. On the same day, 0.5X Basement Membrane Extract (BME) was prepared by diluting 
5X BME stock solution in 1X Travigen Inc coating buffer. Briefly, 100 μL of 10X coating 
buffer was diluted in 900 μL of sterile water. Then 900 μL of 1X coating buffer was mixed 
with 100 μL of 5X BME to make working 0.5X BME solution.  Six Corning transwell 
permeable inserts were placed on six well of 24-well plate separately. Then 100 μL of 
0.5X BME solution was added to each transwell insert and incubated overnight. Following 
day, transfected cells were trypsinized and similar number of non-transfected and 
transfected cells (~3X105 cells) were seeded on all six transwell inserts. Trypsinized cells 
were mixed with glucose free medium and approximately 100 μL from each cell 
suspension was added to appropriate transwell inserts followed by another 100 μL from 
50 mM and 20 mM glucose containing, but FBS free medium to get final 25 mM and 10 
mM glucose concentrations respectively. Lower chamber was filled with 10% FBS 
containing medium without glucose. Whole setup was incubated in mammalian cell 
culture incubator for 24 h. After 24 h, cell culture medium was removed from both lower 
and upper chambers and washed three times with PBS. Non-invasive cells were removed 
using a cotton swab and bottom side of the membrane of transwell inserts were fixed with 
4% formaldehyde for 10 minutes at room temperature followed by permeabilization with 
PBST (pH-7.4, 50 mM Tris-HCl, 150 mM NaCl, 0.1% Triton-X100) for another 10 minutes. 
Inserts were washed once with PBS and stained with 0.2% (W/V) crystal violet solution 
for 20 minutes at room temperature. Inserts were then extensively washed with PBS to 
remove all excess dye. Imagers were captured using a camera attached to a microscope. 
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After taking pictures, stained dye was extracted with 300 µL of 33% acetic acid and 
absorbance was measured at 560 nm using a plate reader. Similar invasion assay was 
performed to A431 cells without transfection of PP2Cα.     
  
161 
 
APPENDIX A - CHAPTER 2 SUPPORTING FIGURES 
 
 
Figure A.2.1 – SDS-PAGE analysis of the purity of GS WT and GS mutants. A) Purified 
proteins were diluted to 1 μg/mL working concentrations and boiled with SDS loading dye in the 
presence of reducing agents. Protein samples were separated from SDS-PAGE and stained with 
Coomassie blue and captured. B) After overexpression lysis, GS M4 was purified by Ni-NTA 
beads. A portion of 5 μL from lysate, flow through (FT), washings (W1, W2) and elution (E1, E2, 
etc) was loaded to SDS-PAGE and analyzed by Coomassie staining. C) To measure the 
concentrations of purified GS mutants, protein band intensities were compared to BSA standards. 
According to gel comparison and Bradford assay, purified GS M4 concentration was ~ 8 mg/mL. 
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Figure A.2.2 – Kinetic analysis of GS WT and GS M4 mutant. Different concentrations of each 
substrate were analyzed by measuring the absorbance at 340 nm. To calculate initial rates for 
each concentration, initial absorbance data was plotted against time and slope was calculated. 
Then Michaelis-Menten constants were calculated by plotting initial rates against different 
substrate concentrations.    
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Figure A.2.3 – LC-MS analysis of in vitro GS enzyme assay reaction mixture. A) Ion 
extraction for FL-IA modified endogenous GSH and mass spectra showing m+1 for FL-IA modified 
GSH. B) Ion extraction for different GSH derivatives and m+1 for GSH, azido-GSH and Met-GSH.  
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Figure A.2.4 – LC-MS analysis of L-AzAla dose dependent azido-GSH biosynthesis. After 
transient transfection of GS M4, HEK293 cells were incubated with increasing concentrations of 
L-AzAla for 20 h. Protein free lysates were analyzed by LC-MS and masses corresponding to 
different glutathione derivatives were extracted and overlaid.  
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Figure A.2.5 – Glutathionylated proteome visualized by rhodamine-alkyne or biotin alkyne. 
Different concentrations or 1 mM of L-AzAla incubated with HEK293 stable cells with or without 
overexpression of GS M4, for 20 h. Cells were then induced for glutathionylation with or without 
H2O2. After induction, cell lysates were subjected to click reaction either with biotin-alkyne or 
rhodamine-alkyne. Glutathionylation was analyzed by in-gel fluorescence or by Western blotting.  
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Figure A.2.6 – Analysis of glutathionylation in different cell lines using azido-GSH. GS M4 
transfected using PEI-max. After 24 h, 1 mM L-AzAla was incubated for 20 h and glutathionylation 
was induced with H2O2 for 15 minutes. Glutathionylation levels analyzed in different cells by 
analyzing in-gel fluorescence after performing click reaction with fluorophore-alkyne.  
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APPENDIX B – CHAPTER 3 SUPPORTING FIGURES 
 
Figure B.3.1 – Glutathionylation in response to 13 h glucose deprivation. L-AzAla incubated 
with HEK293-GS M4 cells and induced for glutathionylation by incubating glucose free medium 
for 13 h. Lysates were analyzed for glutathionylation after performing the click reaction with biotin-
alkyne.   
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Figure B.3.2 – Glutathionylation in response to CoCl2 induced hypoxia and glucose 
deprivation. L-AzAla incubated with HEK293-GS M4 for 20 h. Cells were washed with PBS and 
treated with different concentrations of CoCl2 with or without glucose for 6 h. After cell lysis, cell 
lysates were subjected to click reaction with Cy5-alkyne and analyzed by in-gel fluorescence.  
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Figure B.3.3 – Analysis of glutathionylation in response to oxygen-glucose deprivation and 
reoxygenation (OGD/R). HEK293-GS M4 cells were induced for glutathionylation by incubating 
glucose free medium under high (21%) and low (1%) oxygen concentrations for 13 h. After 
hypoxic condition, cells were incubated under high oxygen (21%) environment for 15 minutes and 
60 minutes or immediately lysed. After lysis, cell lysates were subjected to click reaction and 
analyzed for in-gel fluorescence.  
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Table B.3.1 - A list of glutathionylated proteins identified in mass analysis that have a 
high spectral count and a high enrichment in the positive over negative sample.  
aNeg and Pos = spectral count of the negative and positive samples, respectively. 
bLoc = Localization (C: cytosol, N: nucleus, EC: extracellular, L: lysosome, M: 
mitochondrion) 
cFunction = molecular function determined by DAVID GO analysis  
dProcess = biological processes determined by DAVID GO analysis  
eG = glutathionylation proteomic result by exogenous H2O2 
fS = sulfenylation proteomic result by exogenous H2O2  
 
Gene Protein 
Neg
a 
Pos
a 
Loc
b 
Functionc Processd Ge Sf 
ACE 
Angiotensin-converting 
enzyme 
0.0 79.8 EC Peptidase 
Cell 
proliferatio
n 
+ - 
TBA1A Tubulin alpha-1A chain 0.0 59.5 C GTPase  
Cell 
division 
+ - 
CTPS1 CTP synthase 1 0.0 43.5 C ligase 
B cell 
proliferatio
n 
- + 
RRM1 
Ribonucleoside-
diphosphate reductase 
large subunit 
0.0 35.0 C 
ATP 
binding 
Cell 
proliferatio
n 
- + 
GMPS GMP synthase 0.0 30.5 C Ligase Metabolic  - + 
PPP2R
1A 
Serine/threonine-protein 
phosphatase 2A 65 kDa 
regulatory subunit A 
alpha isoform 
0.0 29.0 C 
Phosphat
ase 
regulatory 
Apoptosis - - 
NPEPP
S 
Puromycin-sensitive 
aminopeptidase 
0.0 28.8 C, N Peptidase 
Stress 
response 
- - 
DHX15 
Putative pre-mRNA-
splicing factor ATP-
dependent RNA helicase 
0.0 28.3 N Helicase 
mRNA 
processing 
+ - 
GSPT1 
Eukaryotic peptide chain 
release factor GTP-
binding subunit ERF3A 
0.0 24.8 C GTPase Cell cycle - + 
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PARP1 
Poly [ADP-ribose] 
polymerase 1 
0.0 23.5 N 
Glycosyltr
ansferase 
DNA repair + - 
NAA15 
N-alpha-
acetyltransferase 15, 
NatA auxiliary subunit 
0.0 23.0 C 
Acetyltran
sferase 
Angiogene
sis 
+ + 
VARS Valine-tRNA synthetase 0.0 20.0 C Ligase 
Protein 
biosynthesi
s 
- + 
CAND1 
Cullin-associated 
NEDD8-dissociated 
protein 1 
0.0 19.5 C, N 
Ubiquitin 
conjugatio
n 
Proteolysis - + 
CSTB Cystatin-B 0.0 19.0 C, N 
Peptidase 
inhibitor 
proteolysis - - 
USP7 
Ubiquitin carboxyl-
terminal hydrolase 7 
0.0 18.0 C, N Peptidase DNA repair - - 
DIS3 
Exosome complex 
exonuclease RRP44 
0.0 18.0 C,N 
Endonucl
ease 
rRNA 
processing 
- - 
TUBA3
D 
Tubulin alpha-3C/D chain 0.0 18.0 C GTPase  
Protein 
folding 
-  
TPP2  Tripeptidyl-peptidase 2 0.0 17.5 C, N Peptidase Proteolysis + + 
RBBP7 
Histone-binding protein 
RBBP7 
0.0 16.8 N 
RNA 
binding 
DNA 
replication 
+ - 
HSPA4
L 
Heat shock 70 kDa 
protein 4L 
0.0 16.8 C, N 
Chaperon
e  
Stress 
response 
- + 
MAP4 
Microtubule-associated 
protein 4 
0.0 16.3 C 
Microtubul
e binding 
Cell 
division  
+ + 
HSPH1 
Heat shock protein 105 
kDa 
0.0 15.8 C  
ATP 
binding 
Stress 
response 
- + 
TIPRL TIP41-like protein 0.0 14.8 C 
PP2A 
inhibitor 
Cell cycle + - 
HUWE1 
E3 ubiquitin-protein 
ligase 
0.0 14.8 C, N Ligase  DNA repair - + 
PPP2R
2A 
Serine/threonine-protein 
phosphatase 2A 55 kDa 
regulatory subunit B 
alpha isoform 
0.0 14.5 C 
Phosphat
ase  
Cell cycle - + 
MCMB
P 
Mini-chromosome 
maintenance complex-
binding protein 
0.0 14.3 N 
Chromatin 
binding 
Cell cycle + - 
UBA6 
Ubiquitin-like modifier-
activating enzyme 6 
0.0 14.3 C 
ATP 
binding 
Protein 
ubiquitinati
on  
+ + 
USP5 
Ubiquitin carboxyl-
terminal hydrolase 5 
0.0 14.3 L Hydrolase  
Protein 
catabolism 
- - 
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SNRNP
200 
U5 small nuclear 
ribonucleoprotein 200 
kDa helicase 
0.0 14.3 N Helicase  
mRNA 
processing 
- - 
GSTM3 
Glutathione S-
transferase Mu 3 
0.0 14.0 C 
Glutathion
e  binding  
Detoxificati
on  
+ - 
DNM1L Dynamin-1-like protein 0.0 14.0 C Hydrolase  Apoptosis     + - 
KHSRP 
Far upstream element-
binding protein 2 
0.0 14.0 N 
DNA 
binding 
mRNA 
processing 
- - 
AIMP2 
Aminoacyl tRNA 
synthase complex-
interacting multifunctional 
protein 2 
0.0 14.0 C, N 
Developm
ent-al 
protein  
Apoptosis  + + 
PABPC
4 
Polyadenylate-binding 
protein 4 
0.0 14.0 C 
mRNA 
binding 
mRNA 
processing 
- + 
NCAPD
2 
Condensin complex 
subunit 1 
0.0 14.0 N 
Chromatin 
binding 
Cell cycle - + 
MARS 
Methionine--tRNA ligase, 
cytoplasmic 
0.0 13.8 C 
tRNA 
ligase 
Gene 
expression 
- - 
UNC45
A 
Protein unc-45 homolog 
A 
0.0 13.8 C 
Chaperon
e  
Cell 
differentiati
on 
- - 
STIP1 
Stress-induced-
phosphoprotein 1 
0.0 13.5 C, N 
RNA 
binding 
Stress 
response 
+ + 
CORO1
C 
Coronin-1C 0.0 12.8 C 
Actin 
binding 
cytokinesis - + 
MSH6 
DNA mismatch repair 
protein Msh6 
0.0 12.5 N 
DNA 
binding 
DNA repair + - 
IARS 
Isoleucine--tRNA ligase, 
cytoplasmic 
0.0 12.5 C 
tRNA 
editing 
Gene 
expression 
- - 
PABPC
1 
Polyadenylate-binding 
protein 1 
0.0 12.0 C, N 
RNA 
binding 
mRNA 
processing 
- + 
EIF4G1 
Eukaryotic translation 
initiation factor 4 gamma 
1 
0.0 12.0 C 
Translatio
n factor 
Translation  - + 
SPAG9 
C-Jun-amino-terminal 
kinase-interacting protein 
4 
0.0 11.5 C 
Kinase  
binding   
Cell 
differentiati
on 
- - 
KHDRB
S1 
KH domain-containing, 
RNA-binding, signal 
transduction-associated 
protein 1 
0.0 11.5 N 
DNA 
binding 
Cell cycle - - 
PSMD2 
26S proteasome non-
ATPase regulatory 
subunit 2 
0.0 11.3 C 
MAPKK 
activator 
Cell 
proliferatio
n 
+ - 
ABCE1 
ATP-binding cassette 
sub-family E member 1 
0.0 11.0 C 
ATPase 
activity 
RNA 
catabolism 
- + 
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GFPT1 
Glucosamine--fructose-6-
phosphate 
aminotransferase 1 
0.0 11.0 C 
Carbohydr
ate 
binding 
metabolis
m 
- + 
SND1 
Staphylococcal nuclease 
domain-containing 
protein 1 
0.0 11.0 C, N Nuclease  
Transcripti
on 
+ - 
RNPEP Aminopeptidase B 0.0 10.8 EC peptidase Proteolysis  - - 
SMC4 
Structural maintenance 
of chromosomes protein 
4 
0.0 10.8 N 
ATP 
binding 
Cell cycle - - 
IPO11 Importin-11 0.0 10.5 C 
Protein  
transporte
r 
Protein 
transport 
- - 
USP9X 
Probable ubiquitin 
carboxyl-terminal 
hydrolase FAF-X 
0.0 10.5 C Hydrolase  Cell cycle - - 
CRKL Crk-like protein 0.0 10.3 C 
MAPKK 
activator 
Cell  
proliferatio
n 
+ + 
TBCD 
Tubulin-specific 
chaperone D 
0.0 10.3 C 
chaperon
e 
Protein  
folding 
+ - 
PSMD1 
26S proteasome non-
ATPase regulatory 
subunit 1 
0.0 10.3 C 
MAPKK 
activator 
Cell 
proliferatio
n 
+ - 
GTF2I 
General transcription 
factor II-I 
0.0 10.3 C, N 
DNA 
binding 
Transcripti
on  
+ + 
LARP1 La-related protein 1 0.0 10.3 C 
mRNA 
binding 
Cell 
proliferatio
n 
+ + 
TTLL12 
Tubulin--tyrosine ligase-
like protein 12 
0.0 10.0 C 
ATP 
binding 
Tubulin 
PTM 
- - 
EPRS 
Bifunctional 
glutamate/proline--tRNA 
ligase 
1.0 68.5 C Ligase Translation - + 
PFAS 
Phosphoribosylformylglyc
inamidine synthase 
0.7 34.5 C Ligase 
Purine 
biosynthesi
s 
- + 
NASP 
Nuclear autoantigenic 
sperm protein 
0.7 33.0 C, N 
Protein  
binding 
cell 
proliferatio
n 
+ + 
UBE2L
3 
Ubiquitin-conjugating 
enzyme E2 L3 
0.7 32.8 C, N 
Transfera
se   
Transcripti
on 
- - 
GARS Glycine--tRNA ligase 0.7 32.0 C Ligase Translation  - + 
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PRMT1 
Protein arginine N-
methyltransferase 1 
0.7 25.0 N 
Methyl 
transferas
e 
Gene  
expression  
- + 
FSCN1 Fascin 0.7 25.0 C 
Actin 
binding 
Cell 
migration 
+ - 
HNRNP
K 
Heterogeneous nuclear 
ribonucleoprotein K 
1.0 36.8 C, N 
Pre-
mRNA 
binding 
Apoptosis - + 
XPO1 Exportin-1 1.0 36.5 C, N 
Protein  
transporte
r 
Gene 
expression 
+ + 
PPA1 
Inorganic 
pyrophosphatase 
1.0 31.0 C 
Phosphat
ase  
Gene 
expression 
- + 
PAICS 
Multifunctional protein 
ADE2 
0.7 20.3 C 
Decarbox
y-lase 
Purine 
biosynthesi
s 
- + 
PREP Prolyl endopeptidase 0.7 20.3 C Peptidase  Proteolysis  - + 
CSE1L Exportin-2 0.7 18.0 C, N  
Protein  
transport 
Apoptosis  - + 
EEF2 Elongation factor 2 8.3 
201.
3 
C, N GTPase Translation  - + 
PCMT1 
Protein-L-isoaspartate(D-
aspartate) O-
methyltransferase 
2.3 54.3 C 
Methyl 
transferas
e 
Protein 
repair 
- - 
NPM1 Nucleophosmin 1.0 23.0 N 
Chaperon
e 
Cell 
proliferatio
n  
- - 
PLS3 Plastin-3 1.3 27.5 C 
Calcium  
binding 
Cell  
differentiati
on 
- + 
IMPDH
2 
Inosine-5'-
monophosphate 
dehydrogenase 2 
0.7 13.8 C, N 
Oxidoredu
-ctase  
Purine 
biosynthesi
s 
- - 
CLTC Clathrin heavy chain 1 1.7 33.5 C 
Protein or 
RNA 
binding 
Protein  
transport 
- + 
PRKDA
C 
DNA-dependent protein 
kinase catalytic subunit 
2.3 46.8 N kinase DNA repair + + 
YWHA
Q 
14-3-3 protein theta 0.7 13.3 C 
Protein 
binding 
Apoptosis  - + 
ACLY ATP-citrate synthase 2.0 39.5 M 
Transfera
se 
Lipid 
metabolis
m 
+ + 
EEF1G 
Elongation factor 1-
gamma 
3.0 58.3 C 
Transfera
se  
Gene 
expression 
- + 
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RCC2 Protein RCC2 1.3 25.3 N 
GTPase 
activator 
Cell cycle + + 
GART 
Trifunctional purine 
biosynthetic protein 
adenosine-3 
5.0 78.8 C Ligase  
Purine 
biosynthesi
s 
- + 
CPNE1 Copine-1 0.7 10.5 N Repressor 
Differentiat
ion  
- + 
CCT2 
T-complex protein 1 
subunit beta 
4.3 66.5 C 
Chaperon
e 
Protein 
folding 
- + 
FASN Fatty acid synthase 11.0 
165.
3 
C 
Hydrolase
, 
Transfera
se 
Fatty acid 
biosynthesi
s 
- + 
AHCY Adenosylhomocysteinase 1.3 20.0 C Hydrolase 
One-
carbon 
metabolis
m 
- - 
DYNC1
H1 
Cytoplasmic dynein 1 
heavy chain 1 
1.3 19.5 C ATPase Transport - + 
PTBP1 
Polypyrimidine tract-
binding protein 1 
1.7 24.0 N 
Pre-
mRNA 
binding 
mRNA 
processing 
- + 
TARS 
Threonine--tRNA ligase, 
cytoplasmic 
1.0 13.3 C Ligase  Translation  - - 
HSP90
AB1 
Heat shock protein HSP 
90-beta 
10.7 
137.
3 
C 
Chaperon
e 
Stress 
response 
- + 
DDX3X 
ATP-dependent RNA 
helicase DDX3X 
1.0 12.8 N 
Helicase/ 
ATPase 
Transcripti
on 
+ + 
TCP1 
T-complex protein 1 
subunit alpha 
2.7 33.8 C 
Chaperon
e 
Protein 
folding 
 + 
IPO5 Importin-5 1.7 21.0 C, N 
GTPase 
inhibitor 
Protein 
transport 
+ + 
GSPT2 
Eukaryotic peptide chain 
release factor GTP-
binding subunit ERF3B 
1.0 12.5 C GTPase Cell cycle - - 
CFL1 Cofilin-1 4.7 56.8 N 
Actin 
binding 
Cytokinesi
s 
- + 
CCT6A 
T-complex protein 1 
subunit zeta 
1.0 11.0 C 
Chaperon
e 
Protein 
folding 
- + 
PRDX2 Peroxiredoxin-2 2.3 24.3 
C, 
M 
Peroxidas
e 
     
Oxidative 
stress 
response 
- - 
PHGDH 
D-3-phosphoglycerate 
dehydrogenase 
1.3 13.8 C 
Oxidoredu
-ctase 
Amino-acid 
biosynthesi
s 
- + 
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GCN1L
1 
Translational activator 
GCN1 
2.3 21.5 C 
RNA 
binding 
Translation - + 
PRDX1 Peroxiredoxin-1 2.7 24.5 
C, 
M 
Peroxidas
e 
Oxidative 
stress 
response 
- - 
UBA1 
Ubiquitin-like modifier-
activating enzyme 1 
6.7 57.3 C,M Ligase proteolysis + + 
PKM 
Pyruvate kinase 
isozymes M1/M2 
6.3 53.5 C, N Kinase Glycolysis  - + 
RPL18
A 
60S ribosomal protein 
L18a 
2.0 16.3 C 
RNA 
binding 
Translation - - 
DDX1 
ATP-dependent RNA 
helicase 
1.3 10.8 N Helicase 
Transcripti
on 
+ - 
HNRNP
F 
Heterogeneous nuclear 
ribonucleoprotein F 
1.7 11.5 N 
RNA 
binding 
mRNA 
processing 
- + 
HSP90
AA1 
Heat shock protein HSP 
90-alpha 
20.7 
140.
5 
C 
Chaperon
e 
Stress 
response 
- + 
PRDX6 Peroxiredoxin-6 6.0 38.0 C 
peroxidas
e 
Oxidative 
stress 
response 
+ + 
QARS Glutamine--tRNA ligase 1.7 10.5 
C, 
M 
Ligase Translation - + 
HNRNP
L 
Heterogeneous nuclear 
ribonucleoprotein L 
5.0 25.5 C, N 
RNA 
binding 
mRNA 
processing 
- + 
EEF1A
2 
Elongation factor 1-alpha 
2 
12.3 60.5 N GTPase Translation - - 
XRCC6 
X-ray repair cross-
complementing protein 6 
2.7 13.0 N Helicase DNA repair - - 
XRCC5 
X-ray repair cross-
complementing protein 5 
6.3 29.5 N Helicase DNA repair - + 
EIF5AL
1 
Eukaryotic translation 
initiation factor 5A-1-like 
5.7 25.8 C, N 
mRNA 
binding 
mRNA 
transport 
- - 
EEF1A
1 
Elongation factor 1-alpha 
1 
18.3 79.8 C, N GTPase Translation  - + 
CAD CAD protein 2.7 11.5 C, N 
Hydrolase
, ligase 
Pyrimidine  
biosynthesi
s 
- - 
YWHA
E 
14-3-3 protein epsilon 4.0 14.8 C 
HDAC 
binding 
Apoptosis - + 
HSPA8 
Heat shock cognate 71 
kDa protein 
3.0 11.0 C 
ATPase, 
Chaperon
e 
Transcripti
on 
- + 
ALDOA 
Fructose-bisphosphate 
aldolase A 
3.0 10.0 C Lyase Glycolysis + + 
RPL10 
60S ribosomal protein 
L10 
4.7 14.0 C 
RNA 
binding 
Translation - + 
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CCT5 
T-complex protein 1 
subunit epsilon 
6.0 16.0 C 
ATP 
binding 
Protein 
folding 
- + 
GAPDH 
Glyceraldehyde-3-
phosphate 
dehydrogenase 
30.7 77.3 C 
Oxidoredu
ctase/tran
sferase 
Glycolysis  - + 
MCM3 
DNA replication licensing 
factor MCM3 
4.0 10.0 N Helicase 
DNA 
replication 
+ + 
NME1 
Nucleoside diphosphate 
kinase A 
7.3 18.3 C, N Kinase 
Cell 
differentiati
on 
- - 
PGAM1 
Phosphoglycerate 
mutase 1 
8.0 17.5 C Isomerase Glycolysis + - 
PPIA 
Peptidyl-prolyl cis-trans 
isomerase A 
7.7 15.5 
C, 
EC 
Isomerase 
Protein  
folding 
+ - 
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APPENDIX C – CHAPTER 4 SUPPORTING FIGURES 
 
Figure C.4.1 – Glutathionylation in response to mitochondrial dysfunction in PP2Cα 
transfected HEK293-GS M4 cells. PP2C transfected to HEK293-GS M4 using PEI-max and 
after 24 h, L-AzAla was incubated with Cells. After 20 h, cells were washed with PBS and 
incubated with 2 μg/mL AMA with or without glucose. Lysates were subjected to click reaction 
with biotin-alkyne and incubated with streptavidin agarose beads. After incubation bound protein 
were eluted and probed with strep-HRP, anti-HA and anti-PTP1B. 
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Figure C.4.2 – Cellular GSH levels in MCF7 and MDA-MB-231 cells. MDA-MB-231 and MCF7 
cells were infected with adenovirus for the overexpression of GS M4. After 24 h, L-AzAla 
incubated with cells for 20 h. Cells were induced for glutathionylation by incubating different 
concentrations of glucose for 5 h. Cells were trypsinized and collected by centrifugation. Cells 
were lysed using several freeze-thaw cycles and protein free lysates were subjected to the 
bromobimane assay.  
 
Figure C.4.3 – Glutathionylation in response to oxygen-glucose deprivation (OGD) and 
reoxygenation (OGD/R) in MDA-MB-231 cells. MDA-MB-231 cells were infected with 
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adenovirus having GS M4 gene. After 24 h, L-AzAla was incubated for another 20 h and induced 
for glutathionylation in low glucose medium under normal oxygen (21%) or low oxygen 
concentration (1%) for 5.5 h. After 5.5 h, cells were immediately lysed or incubated in normal 
oxygen environment for 30 minutes. Cell lysates were subjected to click reaction with Cy5-alkyne 
and analyzed for in-gel fluorescence.  
 
 
Figure C.4.4 – Glutamine metabolism and redox homeostasis. Glutaminase (GLS) catalyzes 
glutamate synthesis using glutamine as the substrate. Glutamate enters TCA cycle and takes part 
in NADPH and pyruvate production. Glutamate also a precursor for GSH biosynthesis.  
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APPENDIX D - COPYRIGHT PERMISSIONS 
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ABSTRACT 
DEVELOPMENT OF CHEMICAL TOOLS TO INVESTIGATE 
 PROTEIN S-GLUTATHIONYLATION IN RESPONSE TO METABOLIC ALTERATION 
 
by 
KUSAL T. G SAMARASINGHE 
August 2017 
Advisor: Prof. Young-Hoon Ahn 
Major: Chemistry (Biochemistry) 
Degree: Doctor of Philosophy 
 Oxidative stress is a common characteristic of age-related diseases such 
as vascular diseases, diabetes and cancer. Many diseases are known to be regulated by 
glutathionylation. Glutathionylation is referred to as the formation of disulfide bond 
between a protein cysteine and a glutathione. To understand the molecular mechanisms 
behind the disease initiation and progression, identification of such glutathionylated 
proteins is important. Even though existing methods have been widely used, several 
limitations of these methods hinder the identification of such proteins in disease 
conditions. Therefore, we developed a versatile chemical method that generates clickable 
glutathione inside the cells. In this method, we generated a mutant form of glutathione 
synthetase (GS M4) to metabolically synthesize clickable glutathione for studying and 
identifying proteins in disease conditions. Using clickable glutathione approach, we 
uncovered a regulatory role of glucose metabolism in glutathionylation. Also, we have 
identified over 1400 of glutathionylated proteins in response to mitochondrial dysfunction 
and glucose deprivation, a common characteristic found in metabolic disorders. 
Moreover, we have identified several new glutathionylated proteins including ser/thr 
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protein phosphatase 2Cα (PP2Cα). Further, we uncovered a new role for PP2Cα 
glutathionylation that promotes cancer cell migration through the activation of JNK in 
response to metabolic alterations.          
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